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ABSTRACT
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Doctor of Philosophy
Imaging of Mice and Men; Adventures in Multispectral Imaging
by Paul R. Hoy
Cancer of the brain and CNS account for only 2% of new cancer cases in the UK
however it is responsible for 7% of cancer deaths of those aged under 70 years of age.
Although surgery falls short of a cure it is the primary method of treatment. Two of
the key problems in tumour surgery in the brain are a) that many tumours are visually
indistinguishable from normal tissue even for experienced surgeons and b) that the risk of
post-surgical neurological decit is related to the proximity of functional (or `eloquent')
neurological tissue. In collaboration with surgeons at the Southampton University NHS
Hospitals Trust we seek to address both of these problems. Firstly there is literature
evidence that normal and neoplastic tissue have dierent spectral characteristics in the
visible and near-infrared region. We investigate whether these can be practically imaged
intraoperatively to establish disease state. Secondly the redox state of haemoglobin
is known to aect it's visible and near-infrared spectral characteristics. This project
investigates whether it is possible to identify the haemodynamic response associated
with functional activity intraoperatively in the human brain.
Prion diseases are fatal chronic neurodegenerative diseases of animals and man. They
have gained notoriety due to recent outbreaks of Bovine Spongiform Encephalopathy
(BSE) and the evidence that they can be transmitted between species, including to man.
Exposure to BSE infected material has been shown to cause variant Creutzfeldt-Jacob
disease in man. Prion disease is also used as a model of other neurodegenerative diseases,
such as Alzheimers disease. Remarkably little is known about this class of disease
including the specic cause of the neurodegeneration. Prions are a mis-folded protein
which have a dierent conformation than the normal protein. Certain spectral features in
the mid infrared region are associated with protein conformation. In collaboration with
neuro-biologists within the university and using a synchrotron light source we investigate
the application of multispectral imaging in early stage prion disease. By analysis of the
protein conformation sensitivity of the mid infrared spectra (with particular interest
in the Amide I band) we seek to identify structurally relevant markers in a mouse
model before clinical symptoms of the disease are evident. This may lead to better
understanding of the disease progression and the neurotoxic element.Contents
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observation of the vagina and cervical epithelial in vivo
CSF Cerebrospinal Fluid, the clear bodily 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CT Computed Tomography
CWL Centre Wavelength, the middle of the pass band of a lter
DECS Direct ElectroCortical Stimulation
EEG Electroencephalography, The nerophysiological measurement of
electrical activity of the brain
Eloquent Cortex An area of the brain that if removed will result in; loss of sensory
processing or linguist ability, minor paralysis, or paralysis
Epithelium Membranous tissue composed of one or more layers of tightly
packed cells forming the covering of most of the internal and
external surfaces of the body and organs
ES Early Stage, individual with early stage disease
fMRI functional Magnetic Resonance Imaging, c.f. MRI
fNIRS Functional Near Infrared Spectroscopy
Focal decit A problem in nerve function relating to a specic location (such
as the left arm) or a specic function (such as speech)
FTIR Fourier Transform Infrared - a spectroscopic technique
FWHM Full Width Half Maximum, the width of a band pass lter at
half the maximum transmission of that lterAbbreviations and selected medical terms xii
GBM Glioblastoma Multiforme - the most common and most aggres-
sive type of primary brain tumour, a type of malignant astro-
cytic gliomas (WHO grade IV)
GI Gastro-Intestinal
GTR Gross Total Resection, complete removal of a tumour
ICCD A CCD with coupled to an image intensier used to detect very
low signal levels
iMRI Intraoperative MRI, c.f. MRI
InGaAs Indium Gallium Arsenide, when used as imaging devices these
are sensitive from 800nm to around 2m
INIRS Intracranial Near Infrared Spectroscopy
Intraoperative Used during a surgical procedure
IR Infrared
JPEG Joint Photographic Experts Group, a commonly used compres-
sion standard for images
KPS Karnofskey Performance Status allows patients to be classied
as to their functional impairment, values range from normal;
100 to deceased; 0
LS Late Stage, individual with late stage disease
LWP Long Wave Pass, a lter that passes all light (of interest) with
a wavelength longer than a given wavelength
Meninges The membranes that enclose the Central Nervous System
Morbidity A diseased condition or incidence of a disease
Mortality Death rate
MRS Magnetic Resonance Spectroscopy see 4.1.2.5
NBH Normal Brain Homogenate - used as a control for the prion
study
NIR Near Infrared, dened here as the spectral region between visi-
ble light and the cut o of silicon sensors, i.e. 700nm to 1m
Oligodendroglioma A glial tumour thought to be originating from the oligoden-
drocytes. Typically WHO grade II or IIIAbbreviations and selected medical terms xiii
Oncology The study of tumours, this may include the diagnosis, treatment
and prevention of tumours
PET Positron Emission Tomography
Physiology The study of the function of an organism or part thereof (c.f. Anatomy)
PrP Prion protein precursor
PrPc Cellular (healthy) form of PrP
PrPsc Scrapie form of PrP
ROI Region of Interest
Sensitivity The probability of positively identifying a positive sample or
`true positives' (c.f. Specicity)
Specicity The probability of negatively identifying a negative sample or
`true negatives' (c.f. Sensitivity)
SPECT Single Photon Emission Computed Tomography
Tomography Any technique which images planes of a body with the exclusion
of material outside that plane
TSE Transmissible Spongiform Encephalopathy
Vs Symmetric stretching vibration
Vas Asymmetric stretching vibration
VGA Video Graphics Array, a video format with 640 x 480 pixels and
1.33:1 aspect ratio
wavenumbers see cm 1
WHO World Health Organisation
vCJD Variant Creutzfeldt-Jakob Disease, human fatal neurodegener-
ative disease caused by exposure to the BSE prion.Chapter 1
Introduction
This project started by investigating the possibility of developing a low cost
device for the remote detection of water in structural materials. This work
quickly came to an end as described in Chapter 2. The experience gained in
dierence spectroscopy enabled the opportunities described in the rest of this
thesis. There are two primary strands of this continuing work; the rst is
investigating an early stage prion disease model in mice, the second is developing
neurosurgical intraoperative imaging.
Prion diseases have been observed in animals since the mid 18th Century but it
was not until the early 20th Century that the rst prion disease of man was
described. Prion diseases are currently unique in that the infectious agent
appears to contain no nucleic acids; the current understanding is that this agent
is a mis-folded protein. The protein in question is termed PrP (Prion Precursor)
and is highly conserved between species and therefore, unlike most other
diseases, is transmissible between these species. These fatal neurodegenerative
diseases cause massive neuronal loss, astrocytosis and the deposition of amyloid
plaques of this mis-folded protein. This loss of neurons leaves cavities giving the
brain an appearance best described as `spongy'. Hence the term for these
diseases is Transmissible Spongiform Encephalopathies.
Prion diseases are good models for other chronic neurodegenerative diseases such
as Alzheimer's Disease. In all of these diseases a signicant number of neurons
and synapses are dead before the onset of clinical symptoms. However the
mechanism for the death of these cells is still unknown. Amyloid plaques are
found throughout the diseased brain but whether it is these plaques are
neuro-protective, neurotoxic or simply a by-product of neurodegeneration is still
questioned. It is this last question that this project seeks to investigate by
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attempting to identify these plaques at the point of the earliest signs of
degeneration.
The key problem the intraoperative imaging work is trying to address is how to
maximise surgical resection of tumours and minimise the risk of post-surgical
neurological decit. This problem arises because tumour tissue is visually
indistinguishable from normal healthy tissue, even for experienced surgeons.
Brain tissue moves signicantly during surgery so the registration accuracy with
images taken pre-operatively decreases as surgery progresses. Although still
debated the extent of resection has been correlated with increased survival.
Therefore there is a signicant need for an intraoperative system that can image
the tumour boundaries.
Post-surgical neurological decit arises due to damage to tissue associated with
the control of function for example the sensorimotor cortex controls motor
function. Physiological dierences between individuals and the pathology that
these individuals are suering mean that the precise location of this functional
tissue is impossible to predict before surgery; there are diagnostic imaging
systems that can identify these regions but they have their limitations including
the ones stated above regarding intraoperative registration. These regions can be
mapped during surgery (for instance by using cortical stimulation) however again
these techniques have limitations.
This project addresses the key problem in two ways; one side of the project looks
into identifying tumour margins and the other identifying functional tissue. The
aim of this work is to develop a real-time non-contact imaging system which can
identify the parameters required and present them in meaningful way.
1.1 Thesis structure
The rest of this chapter will briey introduce some concepts in optical
spectroscopy that will added to where needed in the following chapters.
Chapter 2 will outline the work done investigating the detection of water in
structural materials. This will introduce the reader to multispectral imaging in
the form of a short case study.
The work investigating prion disease will be presented in chapter 3 and will be
followed by the work on intraoperative imaging. Finally conclusions will be
drawn together and details of future work will be presented in chapter 5.Chapter 1 Introduction 3
1.2 Spectroscopy primer
All materials absorb light dierently, this is commonly known to give materials
their colour. This property is not limited to visible light and extends either side
of the visible part of the electromagnetic spectrum | gure 1.1 shows an
example of an absorbance spectrum. One area of the spectrum of interest is
Infrared (IR) particularly with frequencies between 4000 and 400cm 1
(wavenumbers). This area is important because all the fundamental vibrations of
interatomic bonds in organic compounds appear in this region. These vibrations
absorb radiation at dierent frequencies and intensities. IR spectroscopy involves
collecting this absorption information and analysing it in the form of a spectrum.
Figure 1.1: Absorption characteristic of water (image courtesy of Martin Chaplin
www.lsbu.ac.uk/water)
Materials absorb dierent frequencies of light depending on the characteristics of
the material and the mode of absorption. Table 1.1 broadly categorises these
dierent modes of absorption. Electronic absorptions give materials their colour,
these absorptions typically require the higher energy photons found in the very
near IR and shorter wavelength ranges. Pure rotational absorptions and the
more common torsional vibrations (where a full rotation is not possible) have
very low energies and so occur in the very long wave IR. Because of the low
energies they are very dicult to detect and isolate; in mid IR spectra theseChapter 1 Introduction 4
rotations cause additional bands either side of the main absorption peak or
broaden the main absorption depending on the type of sample. Vibrations have
their fundamental absorptions in the mid IR. These can be further broken down
into bending vibrations and stretching vibrations. Stretching vibrations generally
have higher energy than bending vibrations and so occur at higher frequencies |
the energy of all of these vibrations is dependant on the bond energy and the
masses of the atoms involved. Not all vibrations absorb IR radiation; bonds
where there is no change in electric dipole with vibration will not be IR active.
Raman spectroscopy can also be used to detect material characteristics in the
same frequency region as IR spectroscopy. The selection rule for Raman
spectroscopy is there must be a change in the polarisability of the molecule with
the vibrational molecule. In all but the simplest molecules bonds are typically
visible by both IR and Raman spectroscopy but often have diering intensities.
Absorption Type Location (wavenumbers) Location (wavelength)
Electronic 12500{50000cm-1 800{200nm
Vibration 400{4000 1 25{2.5m
Rotation 10{300cm 1 1mm{30m
Table 1.1: Location of typical vibration modes in small molecules
This project uses a number of dierent sensing techniques to build up images of
the target scene. The use of a number of images taken of the same scene using
dierent parts of the EM spectrum is called multispectral or hyperspectral
imaging. Multispectral imaging is the use of wider spectral bands or the use of
spectral regions that are not contiguous. Hyperspectral imaging is the use of
many small bands of the spectrum contiguously. The prion imaging work in
Chapter 3 is an example of hyperspectral imaging whereas the water and medical
imaging work in Chapters 2 and 4 uses specic and discrete absorption bands
and so are examples of multispectral imaging.Chapter 2
Low Cost Detection of Water
This chapter looks at a low cost method of detecting water in structural
materials. It gives a complete description on the work done on this part of the
project. It will describe; the problem and the operating restrictions, how this
problem was approached, the prototypes developed, the results and conclusions.
This part of the project is not currently under active development however this is
where the project started and is a good introduction to dierence spectroscopy.
2.1 Background and assumptions
The remote detection of water in structural materials is of importance to a range
of customers, from civil and structural engineers to home buyers and
do-it-yourself enthusiasts. There is also application in the agricultural sector
looking at the hydration of vegetation and the eciency of irrigation. This
project aims to show whether it is possible to create a device that this market
will support.
The primary driver for this project is the civil/structural engineering sector.
Their current methods of analysis typically measure resistance between two pads
or probes placed in contact with or inserted into the material under
investigation. This method is very dependant on the material in question and
requires direct physical access to the measurement site; this can be a particular
problem if the material is dicult to access for example the underside of a
motorway bridge. Using these techniques it requires a number of readings to
assess an area. To be able to assess larger areas in one go is a step change that
will make a signicant dierence in this eld. However it is thought that
(Dadachanji (2003 (personnal communication)) this market will not support high
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cost devices; preliminary investigations suggest a retail price of around $1000 -
this value has been taken as an upper limit for the project cost.
The key issues that need to be addressed are as follows;
 Analysis and understanding of how to remotely detect water.
 Knowledge of the theory and practical uses of various imaging technologies
including silicon CCD and CMOS imagers, other materials such as Indium
Gallium Arsenide (InGaAs) and any emerging technologies to select the
most suitable sensor for the application.
 Design and optimisation of the optical system, including detection methods.
 Image processing to extract the required information.
 Integration of the subsystems into a robust, cheap, easy to use device.
The detection method proposed is dierence spectroscopy which typically looks
for a particular feature of the IR spectrum by comparing absorption at that
feature with the absorption at an area nearby in the spectrum which does not
contain that feature. This technique is therefore relatively immune to absolute
intensities and does not require a library of sample spectra. Limitations of this
technique are that it gives information about a small area of the spectrum and
this area must typically selected prior to collection. The choice of spectral region
must be carefully made to be sensitive to the target at the exclusion of other
materials.
The absorption characteristic of water across the spectrum 200000{10cm 1 is
shown in gure 1.1; the fundamental vibrations are listed in table 2.1. Overtones
(harmonic excitation of a particular vibration above the frequency of the
fundamental) and combinations of these vibrations appear at frequencies right
up to visible frequencies (see Appendix A for detailed assignment of these
overtones). These overtone and combination bands are still detectable into the
Near Infrared (NIR) as shown in gure 2.1. The absorption in the visible region
is negligible for the depth of water this project is concerned with.
Type of absorption Location (cm 1) Location (m)
Asymmetric Stretch 3756 2.66
Symmetric Stretch 3657 2.73
Bend 1594 6.27
Table 2.1: Location of fundamental vibration modes of waterChapter 2 Low Cost Detection of Water 7
Figure 2.1: Measured absorption characteristic of 10mm of distilled water; horizontal
axis, wavelength (nm); vertical axis, absorption (%)
2.2 Design decisions and experimental strategy
For the proof of principle work the following decisions were made;
 Cheap o-the-shelf imaging sensors will be used instead of a single element
sensor scanned across an image. This is a cheaper and mechanically simpler
solution and it requires less time to capture an image. However a scanning
system may provide better sensitivity, resolution and dynamic range (given
the results in section 2.3 of the experiments it may be worthwhile revisiting
this decision).
 CCDs are better than CMOS for our purposes. CCDs have higher
sensitivity and greater ll factor both are key requirements. The
disadvantages of CCDs in regards to power consumption and speed of
readout are not critical factors in this application. For a more detailed
analysis of the merits of CMOS and CCD imagers see section 4.2.1
 Optical lters will be used to select the required absorption bands. This
decision impacts the choice of detector, the lter solution requires a highly
sensitive detector as much of the light will be absorbed (or reected) by the
lter.Chapter 2 Low Cost Detection of Water 8
 A supervised computer based processing system will be used to analyse the
images and provide usable output.
The system will use two lters chosen to relate to the spectrum of water, one (on
resonance) lter has been selected where water absorbs highly and one (o
resonance) where water does not absorb as signicantly. The light will be
collected and focused onto a camera which records the images and then
processed by a computer. The most simplistic processing would be to subtract
one image from the other. In reality a number of processing steps are required to
improve the signal to noise ratio in the image and to prepare it for display.
The experimental strategy was two-fold. Firstly to construct a series of low cost
prototypes and assess their capabilities against a series of targets. The targets
progressed from transmission measurements (where the distance travelled
through water is controlled and can be as much as a few centimetres) to
representative materials. Secondly experiments were conducted investigating the
spectra of construction materials with dierent water contents.
2.3 Experimental results
Three dierent prototype systems were constructed the conguration of these
can be found in table table 2.2.
The MK1 prototype was used to quickly gain an appreciation of the key
problems. This `quick and dirty' prototype used stock RG lters and produced
results within two weeks of the start of the project. The camera is a CMOS
webcam. The camera was modied by removal of the IR cut lter; it is a colour
device however the colour lters used on the CMOS chips are almost transparent
in the NIR region, as shown in gure 2.2. Quantum eciency (QE) is dened as
the ratio of output quanta to input quanta and in this case is the ratio of
photons at a given wavelength incident on a detector to the number of electrons
out of the detector. Therefore QE is a measure of the sensitivity of a detector at
a given wavelength. The overall decrease in eciency toward 1100nm is
fundamental to all silicon detectors and silicon starts transmitting light around
this point so has no sensitivity beyond that.
Figure 2.3 shows a plastic cup partially lled with water. The dierence between
the on resonance and the o resonance lter (or the `water signal') is highlighted
in red, note that the blue/red circular area in the upper right hand corner of the
images are collection artefacts due to reection of light from the lters. This
shows that it is possible to detect water where light is travelling through it.Chapter 2 Low Cost Detection of Water 9
MK1 Sweex web-
cam
MK1.1 Sweex we-
bcam (improved)
MK2 ExViewTM
camera
Camera Specications
Detector Speci-
cations
CMOS CMOS Sony ExViewTM
CCD with improved
sensitivity and opti-
mised NIR response
Resolution 352x288 (CIF) 352x288 (CIF) 640x480 (VGA)
Dynamic Range 6bits (eective) 6bits (eective) 8 bits
Interface USB1 USB1 Composite video and
capture card
Filter Specications
Filter Type Coloured glass lter Interference lter Interference lter
On Resonance RG1000 LWP, CWL = 970nm CWL = 970nm
50% transmission at
1000nm
FWHM = 10nm FWHM = 10nm
O Resonance
RG610 LWP CWL = 900nm CWL = 900nm
50% transmission at
610nm
FWHM = 10nm FWHM = 10nm
Total cost $8.97 $50 $90
Table 2.2: Conguration of prototype water detectors
However this is not a practical situation for detecting water in structural
materials. But it is an encouraging result for a $8.97 device.
The MK1.1 device used interference lters which are much better at isolating the
water signature. The Full Width Half Maximum (FWHM) or the bandwidth of
the interference lters is only 10nm so is much more selective than the long wave
pass of both the RG lters used in the MK1, gure 2.4 shows the respective
spectral transmission of these lters. Because of the selectivity of the interference
lters they are used in all the subsequent systems. Other ltering options
include; acousto optical tunable lters or liquid crystal lters both of these
devices provide electronically controllable wavelength selection however they are
currently expensive, have a limited tunable range and require the transmitted
light to be polarised, all of these factors make them unsuitable for this project.
Selectivity can be dened as the ability to distinguish between wanted and
unwanted signals. The selectivity to water of the optical lters used in the
prototypes is dependant on the spectral bandwidth of the lters and the
absorption of water in that bandwidth. So by decreasing the bandwidth of the
lters and ensuring that their spectral location is in the area where water
absorbs most strongly it is possible to maximise the amount of signal due to the
water absorption. However reducing the bandwidth means that less light is
incident on the detector making it more dicult to detect. The RG lters shownChapter 2 Low Cost Detection of Water 10
Figure 2.2: Typical colour sensitivity of a CMOS imaging sensor without IR blocking
lter (image taken from data-sheet for MT9V012 manufactured by Micron)
in gure 2.4 have a very wide bandwidth and so do not select the water band
well but allow a lot of light onto the detector. In contrast the interference lters
labelled I900 and I970 have a higher selectivity but block much of the incident
light requiring a more sensitive detector.
Figure 2.5 shows that the water signal is signicantly more obvious (it is again
highlighted in red) and the images have reduced artifacts. The darkness around
the edge of the images in due to vignetting - the small diameters of the lters
cutting o the edges of the image. One key problem with this prototype is that
the interference lters due to their selectivity cut out around 99% of the
available light. This means that the images collected are more limited by the
noise and the dynamic range of the detector. For this reason this prototype still
could not detect lms of water on test materials where the water signal is
signicantly smaller.
The MK2 device has a higher eective dynamic range (around 2 bits, a factor of
4, greater) than the previous two prototypes, lower noise gures and greater
sensitivity in the region of interest. It uses the same interference lters as MK1.1
so has the same selectivity advantage over the rst prototype. These advantagesChapter 2 Low Cost Detection of Water 11
(a) output of o resonance lter
(RG610)
(b) output of on resonance lter
(RG1000)
(c) processed output showing water content
Figure 2.3: Images showing the output of the MK1 prototype and the water content
of a cup of water
are shown by the ability of this device to detect water absorbed onto cardboard
as shown in 2.7 which the previous prototypes were unable to do. The image
sensor (a Sony ExViewTM sensor similar to the ICX258AL | the device was
destroyed in the Mountbatten re of 2005 and therefore impossible to give the
actual part number) is optimised for IR sensitivity and is logically a black and
white sensor | which also improves sensitivity. The spectral sensitivity is shown
in gure 2.6, this is normalised to the maximum response, in practice this is
typically higher than CMOS devices and is particularly apparent in comparisons
with the cheap CMOS webcam of the MK1 prototypes. The higher spectral
sensitivity is due in part to the size of the active area of the device. CMOS
sensors use an active pixel architecture which adds logic components to each
pixel hence reducing `ll factor' (the light sensitive area expressed as aChapter 2 Low Cost Detection of Water 12
Figure 2.4: Spectral characteristics of the lters used in the MK1 and MK2 pro-
totypes, showing both RG lters (RG610 and RG1000) and representations of the
interference lters used (I900 and I970) (source for RG lters www.schott.com).
percentage of the total incident area). For the CMOS sensor in the spectral
camera used in Chapter 4 this is 60% - which is considered high for a 1Megapixel
CMOS sensors without micro-lenses. A CCD sensor however can achieve 100%
ll factor, for example the Apogee camera used in Chapter 4 achieves this.
Figure 2.7 shows a piece of wet cardboard, it can be clearly seen an area of the
cardboard has been highlighted as containing a water signal. In gure 2.7(c) the
water is highlighted red, there is an obvious red area to the left of the cardboard,
this is due uneven illumination (the light source is above and to the right of the
image).
The Mk2 prototype shows that it is possible to identify areas of water in an
image. This prototype and the output image shown in gure 2.7(c) exploited the
technique of averaging a number of images to increase the eective dynamic
range. The increase in dynamic range scales with the square root of the number
of images averaged, the image in gure 2.7(c) was created by averaging 32
images together (giving an eective dynamic range of 11 bits and increased noise
immunity) and was calibrated for the conditions at the time. Even with these
algorithmic improvements there are only about 4 grey levels (2 bits) associated
with the water signal, suggesting that the signal is of the order of 1 in 500. To
achieve this level of dynamic range in something approaching real-time requires a
more sophisticated camera, these are much more expensive (10bit cameras
normally retail at over $1000). There are other techniques available to increase
the dynamic range by taking multiple exposures. These techniques are adequate
for recompressing the dynamic range to a limited format like a JPEG or Bitmap
however they provide a very non-linear response and so are unsuitable.Chapter 2 Low Cost Detection of Water 13
(a) output of o resonance lter (900nm) (b) output of on resonance lter (970nm)
(c) processed output showing water content
Figure 2.5: Images showing the output of the MK1.1 prototype and the water content
of a cup of water
The low signal suggested that light incident on the subject was travelling
through a very small amount of water before reaching the sensor. Figure 2.8
shows a number of interactions between light and matter, it is the third mode
from the top that gives rise to the water signal. This signal is small which is
intuitively reasonable as at 970nm the absorption coecient of water is around
3%mm 1 and the distance travelled through the water is short. Measurements
were taken on a Varian Spectrophotometer of various building materials to
better understand the absorption characteristics of dierent materials with
varying water content. The results of this suggested that the test case of wet
cardboard is representative and very low signal levels should be expected (less
than 0.1% in some cases). However these data were lost in the re and as this
part of the project is not under active development the measurements have notChapter 2 Low Cost Detection of Water 14
Figure 2.6: Spectral Sensitivity of the ExViewTMCCD
(a) output of o resonance lter (b) output of on resonance lter
(c) processed output showing wa-
ter content
Figure 2.7: Images from the mk 2 camera correctly identifying damp cardboardChapter 2 Low Cost Detection of Water 15
Figure 2.8: Modes of scattering and absorption, from top; Absorption, Scattering,
Water absorption and scattering, Specular reection
been repeated.
2.4 Conclusions
This part of the project set out to investigate the possibility of developing an
imaging device that can detect water in structural materials and that can be
produced for under $1000.
The prototypes developed have shown that it is possible to detect water by the
spectrum of the diusely reected light. However it is dicult and requires
imaging capabilities with a dynamic range of in excess of 11bits. The
practicalities of the imaging sensors at this level of sophistication are that they
are expensive and are in excess of the self imposed $1000 budget. Further work
may be undertaken to establish if this budget is realistic or whether the market
will support greater costs for such a device.
Further work may be done on using a single element sensor instead of a focal
plane array since this should provide higher dynamic range. Using a mirror toChapter 2 Low Cost Detection of Water 16
scan across the scene a resolution broadly similar to the prototype systems may
be achieved. It may also be engineered to provide a lighting solution that does
not rely on ambient light. This system would be more dicult to manufacture
and would be more sensitive in operation. The requirement to scan the scene
rather than capture in parallel would put practical resolution limits on this
technique.
This work has proved that it is possible to use lters to detect relatively small
changes in the spectrum of diusely reected light and infer from that properties
of that material. This may well have application in other areas.Chapter 3
Prion
In collaboration with the CNS Inammation Group in the School of Biomedical
Sciences this project has investigated the multispectral identication of early
stage prion disease in tissue samples. Prion diseases are fatal chronic
neurodegenerative diseases. They have gained notoriety due to the outbreaks of
Bovine Spongiform Encephalopathy (BSE) and the realisation that causative
agent of BSE can be transmitted to humans via the food chain and cause variant
Creutzfeldt-Jakob Disease (vCJD).
The CNS Inammation Group within the University is using a prion disease in
mice as a model for Alzheimer's Disease (AD) in humans. AD has many of the
same characteristics as a prion disease including; fatal chronic neurodegeneration
and aggregates of mis-folded protein. Over 26 million people worldwide are
estimated to have AD, and it aects around 417,000 people in the UK
(Brookmeyer et al. (2007); Alzheimer's Society (2009)) .
One characteristic common to all prion diseases and AD is the accumulation of
amyloid plaques containing mis-folded protein. These plaques are composed of
many protein molecules which occur naturally in the brain but for some reason
are mis-folded and become much more dicult to break down and are possibly
neurotoxic. In both AD and prion diseases the normal proteins are associated
with cell membranes and have a primarily -helical structure whereas the
mis-folded protein has a primarily -sheet structure. In pure protein samples
these dierent structures have unique spectral features which enable their
identication. This project seeks to identify these features in early and late stage
disease ex vivo.
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3.1 Background
This section seeks to establish the literature background to prion diseases in
general. It will give a primer on Fourier Transform Infrared (FTIR) spectroscopy
and literature background associated with the specic data processing techniques
generally known as \resolution enhancement". Finally it will briey consider the
synchrotron radiation source and why this is important.
3.1.1 Prion disease
Scrapie was the rst recognised Transmissible Spongiform Encephalopathy
(TSE). The earliest descriptions of this disease date from the mid 18th Century
(Aguzzi (2006)) although it was not known to be transmissible until 1936 when
Cuill e and Chelle demonstrated this by intra-ocular injection (Cuille and Chelle
(1936)). The demonstration of transmissibility between species followed in Cuille
and Chelle (1939) where Cuille demonstrated transmissibility from sheep to
goats. In the rst part of the 20th Century other TSEs were identied including;
the rst possible cases of Creutzfeldt-Jakob Disease (Creutzfeldt (1920); Jakob
(1921)) and Kuru in the Fore people of Papua New Guinea (Gajdusek and Zigas
(1957)). Transmissibility was demonstrated into more species such as scrapie
into mice (Chandler (1961)) and CJD into chimpazees (Gibbs et al. (1968)). It
wasn't until 1967 when the 'protein-only' hypothesis was proposed by Grith
that the current mechanism for transmission was described (Grith (1967)).
The term `prion' describing this `proteinaceous infectious particle' was coined by
Prusiner in 1982 (Prusiner (1982)) shortly after which the BSE crisis in the UK
brought prion diseases to the public attention.
TSEs are now dened by the transmission and involvement in neuropathogenesis
of abnormal forms of prion protein PrPc (Caughey and Baron (2006)) a list of
recognised TSEs can be found in table 3.1. PrPc is a glycoprotein which is
normally monomeric in structure, protease-sensitive and expressed at the cell
surface of neurons and glial cells. The purpose of PrPc is still not known but it is
highly conserved within species indicating that it does have an important role to
play. The high anity of PrPc to bind to Copper and Zinc presents one
possibility; that PrPc may be a sensor or a scavenger of these metals (and these
metals have been found near deposits of amyloid plaques in terminal disease,
Miller et al. (2006)). PrPc also appears to be involved in processes which
restructure cells whether during learning, cellular dierentiation or response to
injury and stresses, Caughey and Baron (2006). Mice bred without the PrP gene
have various abnormalities including interruption of circadian rhythms leadingChapter 3 Prion 19
to; the inherited prion disease fatal familial insomnia (Tobler et al. (1996)),
problems with synaptic function such as epileptiform activity (Collinge et al.
(1994)) and increased susceptibility to infection Watarai et al. (2003). It may be
the latter observation that provides the greatest insight that PrPc is associated
with the immune response as the brain is particularly intolerant of inammation.
PrPc is also expressed in lymphoid tissue associated with the immune system
(PrP is highly expressed in the human tonsils which may lead to a diagnostic
test Hill et al. (1997)) and challenges to the immune system have been shown to
increase progression of these diseases, Cunningham et al. (2005b).
Host Disease Cause
Animal
Sheep / Goats Scrapie Infection in genetically susceptible sheep; oral
transmission; sporadic
Cattle Bovine Spongiform En-
cephalopathy (BSE)
Infection with prion-contaminated food; pos-
sibly sporadic
Deer / Elk Chronic Wasting Disease Unclear, possibly similar to scrapie
Mink Transmissible Mink En-
cephalopathy
Infection with contaminated meat from sheep
and cattle
Cat Feline Spongiform En-
cephalopathy
Infection with contaminated bovine tissue and
food
Human
CJD Creutzfeldt-Jakob Disease
fCJD Familial CJD Inherited (mutation in the PrP gene)
sCJD Sporadic CJD Unknown possibly spontaneous conversion of
PrPC into PrPSc
iCJD Iatrogenic CJD Acquired from contaminated instruments,
dura mater grafts or growth hormone
vCJD Variant CJD Acquired (infected by bovine prions)
Kuru Limited to the Fore tribe of Papua New
Guinea, acquired through cannibalistic rituals
GSSS Gerstmann- Straussler-
Scheinker Syndrome
Inherited (mutation in the PrP gene)
FFI Fatal Familial Insomnia Inherited (mutation in the PrP gene)
Table 3.1: Overview of the human and animal TSEs (adapted from Kretlow et al.
(2006))
If prion disease is transmitted by transforming the host PrPc to a dierent
conformation (the `protein-only' hypothesis) then an individual devoid of PrPc
would be immune to the disease. This appears to be the case when tested with
mice bred without the PrP gene where inoculation with infected brain
homogenate does not induce disease of any kind (Bueler et al. (1993)). It would
also be expected that a small amount of PrPsc introduced into brain homogenate
in vitro would increase, this was demonstrated in Castilla et al. (2005). These
observations add weight to the `protein only' hypothesis however still do not
eliminate other mechanisms, for example an unidentied virus.
Although they are poorly dened structurally the abnormal PrP must be
consistent enough to allow inter species transmission. Abnormal PrP has been
given various names including; PrPtse, PrPd, PrPtox and PrPres, each of these
emphasise dierent characteristics of the abnormal prion such as disease state orChapter 3 Prion 20
protease resistance. This document will use PrPsc denoting the scrapie form of
the PrP protein. PrPsc forms structures ranging from non-brillar oligomers to
large amyloid plaques. These large amyloid plaques are apparent in late stage
disease and occur throughout the brain; however it is not known whether these
are neuroprotective, neurotoxic or simply the detritus of the neurodegeneration.
There is a general trend that small-to-intermediate oligomers, equivalent to
between 14 and 28 PrP molecules, are the most aective initiators and the more
toxic elements (Caughey and Lansbury (2003)) . However there are still
questions about the minimum infectious element, a mass greater than that of 5
PrP molecules has been presented by Silveira et al. (2005) however it is possible
that is not purely PrPsc. The mechanism which disables and kills neurons is still
unknown (Caughey and Baron (2006); Aguzzi (2003)).
PrPsc is not amenable to high resolution structural techniques such as X-ray
crystallography and NMR, Collinge (2005). It has however had its conformation
studied by FTIR and the major dierence being that PrPsc is predominantly
-sheet whereas PrPc is mainly -helix (Pan et al. (1993)). Some drugs can
break down the larger amyloid plaques however that may leave the smaller
oligomers which have been shown to be more infectious.
Transmissible is not the same as infectious; infectious implies that it is readily
communicated which is not the case in prion disease. Experimentally a number
of modes of transmission are used, including intra-cerebral injection and orally
administered infected brain homogenate. Iatrogenic disease has been transmitted
in humans from infected meningeal transplants and hormone products derived
from infected tissue. The most troubling mode of transmission reported is
through blood transfusion (amongst others, Peden et al. (2004)) intravenous
injection of infected brain homogenate has been shown to be as infectious as
intracerebral injection Lasmezas et al. (2001). However the transmission
reported here by Peden was of whole blood suggesting that contact with cerebral
materials is not required. This transmission occurred prior to the raft of
measures introduced in the late 90s to reduce the risk of transmission via
national blood banks, Wilson and Ricketts (2004). However the long incubation
times which are increased due to the so-called `species barrier' may mean that an
epidemic has not yet been avoided, Aguzzi (2006).
Initial transmission between species takes longer than transmission of native
prion material (Prusiner (1997)). Unlike the native disease where the progress is
notably consistent and all animals will succumb; primary interspecies
transmission is variable and not all of the animals will develop the disease,
Collinge (2005). For example mice inoculated intracerebrally with BSE brain
extracts required over a year to develop disease (Fraser et al. (1992)) whereasChapter 3 Prion 21
native prions take a consistent 140days (Cunningham et al. (2003)). The species
barrier only occurs only on the rst transmission, new prion created in the new
host is then identical to the native prion in that host | this adds considerable
weight to the 'protein only' hypothesis. The method of transmission also
inuences the incubation time and the species barrier, for instance pigs can be
infected by intra-cerebral injection of BSE but not orally, Lasmezas et al. (2001)
(an alternative interpretation is that the species barrier by this route is longer
than the lifetime of the host).
The species barrier is very much dependant on genotype and there also appears
to be a strain component, Lasmezas et al. (2001). For example; BSE only
transmits eciently to a range of species, transmission of sporadic CJD to mice
is very dicult with long incubation periods however mice expressing the human
PrP gene are highly susceptible and react as if it were a native prion. VCJD
transmits more readily to wild type mice than sporadic CJD and is relatively
more dicult to transmit into transgenic mice with human PrP Collinge (2005).
Most of the cases of vCJD to date (of which there have been 164 in the UK,
peaking in the year 2000, The National Creutzfeldt-Jakob Disease Surveillance
Unit (2009)) have been of a particularly susceptible genotype with short
incubation periods to BSE prions. It is possible therefore that these cases are a
genetic subpopulation and the vCJD outbreak is over or more pessimistically
that it has not yet started.
The mechanism of neurodegeneration is still under debate, Aguzzi (2006).
Evidence that PrPsc is toxic to cultured neuronal cells has been presented
(Forloni et al. (1993)) and not conrmed elsewhere (Kunz et al. (1999)).
Interestingly cells expressing PrPc are required for neurotoxicity, this was
demonstrated by a homozygous graft of brain over-expressing PrPc into a mice
devoid of the PrPc gene followed by an inoculation of infected homogenate.
Despite the mice having graft derived PrPsc throughout their brain and the graft
suering classic neurodegeneration the mice were still alive and well 16 months
after inoculation (Brandner et al. (1996)). It is therefore possible that it is the
conversion between PrPc and PrPsc that is neurotoxic, possibly due to some
intermediary or depletion of PrPc into the aggregates.
Alzheimer's disease is the most common form of dementia with clinical
symptoms of memory loss, disorientation in person, time and place, and cognitive
decline. Neuronal and synaptic loss, and the formation of amyloid plaques
typies the damage at a cellular level. This leads to cortical atrophy, narrow
gyri, widened sulci and enlarged ventricles at the level of gross anatomy. The
amyloid plaques share many of the same characteristics as the prion plaques seen
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primary component of the amyloid plaques of Alzheimer's disease is the 39-44
amino acid peptide Beta-amyloid. As with the prion diseases however the role of
these plaques in the neurodegeneration is still unknown, Choo et al. (1996).
Mutations in this beta-amyloid have been shown to relate to earlier onset and
more severe phenotype, Benzinger et al. (1998). Due to prion diseases presenting
many of the same morphological and pathophysiological features as AD except in
their transmissibility (Aguzzi (2003)) they make a good model for AD .
The prion model used in this project is the murine prion ME7. Clinical signs in
mice such as poor coat condition, hunched posture, urinary incontinence and
weight loss have an onset around 20 weeks post-inoculation. The animals are
normally euthanised around three weeks after the onset of clinical symptoms
otherwise the disease course would last for 35 weeks. At the onset of clinical
symptoms a signicant amount of brain damage has already occurred, maybe as
much as 50% of the neurons have been damaged Jerey et al. (2000). The
earliest this loss of neurons can be detected is at 14 weeks. MRI has also been
shown to be able to detect changes before onset of clinical symptoms Dubois
et al. (2003). Cunningham et al. (2005a) presents measurable behavioural traits
of prion infected mice. The rst of these in ME7 infected mice occur at 12 weeks.
Spontaneous behaviours such as glucose consumption, nesting, and burrowing
are aected rst, followed by increased open eld activity and cognitive
impairments measured in passive avoidance and T-maze spontaneous alternation
experiments. Motor impairments (balance, coordination, and strength) occur
toward the late stages of disease.
3.1.2 Fourier transform infrared spectroscopy
Infrared spectroscopy is a chemical analysis technique which detects the
vibrational characteristics of chemical bonds. As mentioned earlier chemical
bonds have dierent vibrational modes: stretching, bending and torsion. The
frequency of these vibrations principally depends on the mass of the atoms and
the strength of the bond; the environment is also important for example a C{H
bond has a dierent frequency depending on whether it is part of a CH2 or CH3
group.
Fourier Transform Infrared (FTIR) spectroscopy is a technique which encodes
the wavelength emission of a source in time, this light then interacts with a
sample (e.g. reection or transmission) and some of this light is absorbed. The
remaining light is detected in the time domain, it is then inverse Fourier
transformed in a computer. This provides the spectra of the source and sample
multiplied together, from which the source spectra (or background) can then beChapter 3 Prion 23
removed (by repeating the process without a sample). The wavelength encoding
is typically performed by a Michelson interferometer and it is the parameters of
the spectrometer that determine the fundamental resolution of the output
spectra.
In contrast with traditional dispersive techniques where the wavelength
information is encoded spatially (e.g. with a prism) and an aperture and detector
are scanned spatially to acquire the wavelength information. The Fourier
transform technique acquires all of the wavelengths at the same time (the
so-called multiplex or Fellgett's advantage). Also the aperture of the Michelson
interferometer does not determine the resolution as it does with a dispersive
instrument so a much higher intensity is found at the detector giving a greater
signal to noise (the throughput or Jacquinot advantage).
FTIR spectroscopy allows the collection of spectra with high resolution and high
signal to noise across a range of wavelengths in a reasonably short period of time.
A single scan typically takes of the order of a second to complete and scans are
normally averaged to improve signal to noise (typically of the order of 100 scans
are averaged). Most of the fundamental stretching and bending vibrations of
organic molecules are found in the 800{4000 wavenumber region, wavenumbers
are the inverse of wavelength in centimetres, denoted cm 1.
The absorption bands of the amide bond are of interest when investigating
proteins. The amide bond is part of the peptide backbone that links amino acids
together to form polypeptides and proteins. A list of the various amide bands,
their frequency and assignment are given in table 3.2. The amide I band is of
particular interest as it is sensitive to the hydrogen bonding in its local
environment. Therefore this bond changes frequency dependant on the
conformational structure of the protein. Interestingly in Raman spectroscopy the
amide III band is much stronger, it is also sensitive to conformation and so is
used in preference using this technique (Surewicz and Mantsch (1988)).
The amide I band is broader than many bands with typical bandwidth around
50cm 1. In puried simple proteins and polypeptides the predominant
conformation can be identied readily as there are distinct changes in the shape
of the band. In more complex proteins this is more dicult due to the line-width
of the components (gure 3.1 shows some example proteins). However in tissue
samples it is almost impossible to identify without further data processing due to
the overlapping nature of all of the amide I absorptions.Chapter 3 Prion 24
Designation Approximate description
frequency (cm 1)
Amide A 3300 NH stretching
Amide B 3100 NH stretching
Amide I 1600|1690 C=O stretching
Amide II 1480-1575 Out of phase CN stretching and
NH bending
Amide III 1229-1301 In phase CN stretching and NH
bending
Amide IV 625-767 OCN bending
Amide V 640-800 Out-of-plane NH bending
Amide VI 537-606 Out-of-plane C=O bending
Amide VII 200 Skeletal torsion
Table 3.2: Characteristic infrared bands of peptide linkage, adapted from Kong and
Yu (2007).
Figure 3.1: Image from Dong et al. (1992) demonstrating various amide I band shapes,
in each image the upper, middle and bottom trace represent absorption, Fourier self-
deconvolution and second derivative spectra. The primary component of each of the
proteins is as follows (X-ray crystallographic structural assignments) , Lysozyme { -
helix (45%), Cytochrome C { -helix (48%), -chymotrypsin { -sheet (50%), Trypsin
{ -sheet (56%), Ribonuclease A { -sheet, Alcohol dehydrogenase { -sheet (45%)Chapter 3 Prion 25
3.1.2.1 Data processing
FTIR spectroscopy is now a commodity technique even though the machines rst
became available in the 1970s. There was an interest in resolving the component
of the amide I band and given the signal to noise advantage over previous
techniques this appeared to be possible. Beginning in the 1980s a number of
techniques were developed, Fourier self-deconvolution and even-order derivatives
being the two most commonly used. These techniques have moved the precision
of FTIR spectroscopic determination of protein secondary structure to a point
between modelling and molecular coordinate approaches (Jackson and Mantsch
(1995)). FTIR also allows this determination in various conditions including in
solution and under changing temperature and pressure for example Meersman
et al. (2002).
Fourier self-deconvolution and the derivative techniques are generally called
`resolution enhancement'. This term is not strictly accurate, the fundamental
resolution is set by the machine at the time of data collection. These techniques
do not increase the resolution but increase the separation between features by
narrowing the line-width, thus allowing easier visualisation. The accuracy of the
location of these narrower features is still determined by the machine resolution.
The cost of narrower line-width is a decrease in signal to noise. A more accurate
term may be `contrast enhancement' and is the term that will be used in this
document.
Fourier self-deconvolution was presented by Kauppinen from the observation
that a major component of line-broadening had a consistent Lorentzian shape
and therefore can be removed (Kauppinen et al. (1981)). Before the Fourier
transform of the acquired spectra the intereferogram is divided by the Fourier
transform of a Lorentzian of a given width. The choice of parameters is
important and may aect how the results are interpreted Surewicz et al. (1993).
Details of this technique have been covered in much more detail elsewhere
Surewicz and Mantsch (1988); Susi et al. (1985); Byler and Susi (1986).
Even-order derivatives have also been shown to increase contrast as rst reported
in Susi and Byler (1983) and further in Susi and Byler (1986, 1987); Krimm and
Bandekar (1986). Derivatives of output spectra are calculated rather than
processing the interferogram. Any derivative will increase the contrast, the
advantage of even-orders is that the maximum intensity of component vibrations
will occur at the maxima rather than zero-crossings as would happen with
odd-order derivatives. Increasing order derivatives are more sensitive to noise,
second-order derivatives are most commonly used. Smoothing is routinely used
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These techniques are often presented together and provide very similar
information. The choice of which technique to use seems to depend on the end
user rather than technical merit. Cameron and Moatt (1987) demonstrates that
even-order derivatives yield higher signal to noise than convolution techniques.
However Fourier self-deconvolution does not change the integrated areas of the
dierent components making comparison with other techniques easier
Goormaghtigh et al. (1990).
X-ray crystallography is generally considered the gold standard for protein
structural analysis. However crystallographic data on a protein cannot easily be
extrapolated to protein properties in solution Kong and Yu (2007). Also not all
proteins form crystals, PrPsc appears particularly dicult to crystallise and
many membrane proteins present similar diculties. A question must be raised
regarding whether the conformation of a protein in a crystal is identical to that
of the protein in its native environment. This is not a problem for most proteins
however PrP seems to have two separate stable conformations. Another
technique for determination of secondary structure is nuclear magnetic resonance
spectroscopy, but the interpretation of nuclear magnetic resonance spectra of a
large protein is dicult.
Comparison between contrast enhanced FTIR determination of structural
components with X-ray crystallography has been made with many dierent
proteins Kong and Yu (2007); Prestrelski et al. (1991); Goormaghtigh et al.
(1990); Oberg and Fink (1998); Fabian et al. (1992); Lee et al. (1990). These
reports of components generally agree with crystallography to an accuracy of
between 4{7%. Computational models have also been compared with FTIR
structural analysis Torii and Tasumi (1992); Perez-Pons et al. (1995), as has
circular dichroism Gorga et al. (1988) and again forms a general consensus.
Although FTIR alone is not sucient to assign complete secondary structure
(Wilder et al. (1992)) and assumptions are made on the molar absorptivity of
components in the amide band (these have been shown not to be equal de Jongh
et al. (1996)) it is useful and generally compares well with other physical
techniques.
Spectral assignments are widely reported and while there is little contradiction
the exact assignment must be considered for each protein individually. One
structure which is rare but has a unique position in the band is the 310 helix
(Kennedy et al. (1991)), whereas others have been found not to have a unique
position for example the parallel -sheet (Khurana and Fink (2000)). A table
listing many of the assignments from various sources is presented in table 3.3 or
is adequately summarised in table 3.4.Chapter 3 Prion 27
Amide I
frequency
(cm 1)
Assignment Reference
1624 0.5 -sheet Dong et al. (1990)
1623 Antiparallel -sheet Susi and Byler (1987)
1626 Parallel -sheet Susi and Byler (1987)
1627 1.0 -sheet Dong et al. (1990)
1628 -sheet Susi and Byler (1987)
1631 Parallel -sheet Susi and Byler (1987)
1632 1.0 -sheet and extended chain Dong et al. (1990)
1632 Antiparallel -sheet Bandekar (1992)
1634 Antiparallel -sheet Susi and Byler (1987)
1635 -sheet Susi and Byler (1987)
1636 Parallel -sheet Susi and Byler (1987)
1638 1.0 -sheet Dong et al. (1990)
1639 Parallel -sheet Susi and Byler (1987)
1639 Antiparallel -sheet Susi and Byler (1987)
1642 1.0 -sheet Dong et al. (1990)
1645 Parallel -sheet Bandekar and Krimm (1988)
1648 2.0 unordered Kong and Yu (2007)
1650 1.0 unordered Dong et al. (1990)
1651 unordered and -helix Perez-Pons et al. (1995)
1652 1 -helix Susi and Byler (1987)
1654 4 -helix and loops Surewicz et al. (1993)
1656 2.0 -helix Dong et al. (1990)
1658 -helix Bandekar (1992)
1663 3.0 310-helix Kong and Yu (2007)
1666 1.0 -turn Dong et al. (1990)
1667 Rippled sheet Bandekar (1992)
1671 Antiparallel -sheet Susi and Byler (1987)
1672 1.0 -turn Dong et al. (1990)
1673 Parallel -sheet Susi and Byler (1987)
1675 Parallel -sheet Susi and Byler (1987)
1679 -sheet Susi and Byler (1987)
1680 1.0 -turn Dong et al. (1990)
1685 2.0 -turn Kong and Yu (2007)
1688 1.0 -turn Dong et al. (1990)
1691 2.0 -sheet Kong and Yu (2007)
1694 Parallel  sheet Bandekar (1992)
1696 2.0 -sheet Kong and Yu (2007)
Table 3.3: A list of amide I band assignments
FTIR analysis of both prion diseases and AD have been reported. Choo et al.
(1996) reported on a synchrotron study of AD samples taken from terminal cases.
Choo found extreme dierences in the spectra associated with the large amyloid
plaques found in these cases. The peak frequency found in this report is higher
than synthetic amyloid however the measurements are consistent with otherChapter 3 Prion 28
Structure Amide I frequency cm 1
aggregated strands 1610-1628
-sheet 1625-1640
unordered 1640-1648
-helix 1648-1660
310-helix 1660-1666
antiparallel -sheets or aggre-
gated strands
1675-1695
Table 3.4: Summary of structural assignments of frequencies in the amide I band.
proteins in the same spatial region of the sample. However it was already known
that there are large amyloid deposits in the terminal brain of both AD and prion.
Kneipp has demonstrated that is is possible to identify prion disease (263K
strain) in a hamster model Kneipp et al. (2000, 2002, 2004). However the
spectroscopic characteristics are markers of general disease or neuronal death
and not specically related to prion disease. The most signicant markers found
are located between 1000{1300cm 1, a region primarily associated with the
phosphate backbone of nucleic acids and not directly related to prion tissue.
Although these markers were found before the onset of clinical symptoms, this
mirrors disease progress identied elsewhere. In terminal disease of the same
model Kretlow et al. (2006) identies a prion specic marker relating to the
-sheet content of PrPsc however there is signicant overlap with the control
tissue indicating that there may be regions of more `normal' tissue within the
diseased samples. Normal tissue has a range of frequencies associated with it,
which follows intuitively given the diering constituents of the samples which
contain whole cells and have a number of resolution elements across them.
3.1.3 Synchrotrons
FTIR spectrometers use an infrared emitting source, standard bench top
instruments typically use a glo-bar which is similar to a lament light bulb
without the glass enclosure. The key parameter of the source is radiance which is
directly related to the overall throughput of the machine.
A synchrotron is a cyclic particle accelerator. As these particles (often electrons)
accelerate, as they do when they are bent around the ring, they emit radiation.
Due to the relativistic speeds these particles are travelling at this radiation is
emitted in a beam tightly conned in the plane of the ring. Various insertion
devices such as wigglers and undulators can control the spectral characteristics of
the output radiation. Synchrotrons are most commonly used in the shortChapter 3 Prion 29
Figure 3.2: Extract from Cunningham et al. (2003) showing the NBH mouse hip-
pocampus (D), and the CA1 region of NBH (E), early stage (F) and late stage (G).
Scale bars 200m D and 100m E{G
wavelength region where they are many orders of magnitude brighter than other
available sources. In the infrared region they are around 100 times brighter than
glo-bar sources used in FTIR instruments, Rener et al. (1995). The glo-bar
does provide more power but over a wider angle and is therefore the choice for
large apertures and focal-plane arrays, Miller and Smith (2005).
High spatial resolution spectra with reasonable spectral resolution are required
for investigating these prion diseases. As mentioned above the protein content is
integrated over an aperture including both diseased and normal proteins. To
maximise the chances of identifying a plaque of prion protein the spatial
resolution must therefore be maximised this was observed in Dubois et al. (2003).
3.2 Experimental setup
Despite the research into prion diseases there are still a number of questions yet
to be answered. This project is most interested in why the accumulation of the
abnormal PrPsc protein causes the neurodegeneration and mechanism by which
this occurs. By studying the earliest phase at a point when the earliest signs of
neurological decit occur, i.e. the rst behavioural eects, it may be possible to
dene the rst pathology. Using IR spectroscopy in the region of the brain
associated with these rst decits, the hypocampus, the project seeks to identify
relevant spectral markers associated with the deposition of PrPsc. In the late
stage of the disease these deposits are prevalent throughout the hippocampus, in
the early stage they are sparse and barely detectable by immunohistochemistry.
The immunohistochemistry detects aggregates large enough to bond with the
uorescent marker, IR spectroscopy may be able to detect the PrPsc in the
smaller oligomers.
Tissue from normal C57 mice and from animals infected with the ME7 mouse
prion agent was collected in accordance with UK Home Oce Licence. TissueChapter 3 Prion 30
was taken from mice inoculated with Normal Brain Homogenate (NBH) and
brain homogenate infected with ME7 at early (13wks) and late stages (18wks) of
the disease. The use of individuals inoculated with NBH ensures that any
features identied are not associated with surgical damage. Further details
regarding the animal husbandry can be found in Cunningham et al. (2003).
Images of the hippocampus and evidence of neurodegeneration are shown in
gure 3.2. Fresh frozen coronal sections were taken at the level of the dorsal
hippocampus, approximately 1.5mm caudal to bregma1. Fresh frozen sections
were chosen over formalin-xed parran embedded sections as these ensure that
any information in the lipid region of the spectrum is maintained. The sections
were mounted on Barium Fluoride slips which enabled the use of transmissive
mode spectroscopy. The spectral information collected was limited to above
850cm 1 due to the absorption of Barium Fluoride beyond this point, however
this retains the known important regions of the spectra.
The regions of interest (ROIs) to be sampled are illustrated in gure 3.3. A line
20um x 100m passing along the axis of the pyramidal cells in CA1 (3.3 i), an
area 70 x 70m located in the stratum radiatum of CA1 (3.3 ii), a line passing
across the dentate granule cells and the hilus of the dentate granule cells (3.3 iii).
The rationale for choosing each of these regions is as follows. ROI (i) contains
the cell body, dendrites and synaptic connections of the CA1 pyramidal cells
which are known to degenerate at late stages of disease. ROI (ii) contains a
relatively homogeneous eld of synaptic contacts from CA3 cells to the CA1 cells
and it is known that synaptic degeneration occurs early in this region in the
absence of immunohistochemically detectable PrPsc deposition. ROI (iii)
contains the cell bodies of dentate granule cell neurons which are not aected by
the disease but are surrounded by PrPsc at early and late stage disease.
Spectra were collected at the Daresbury Synchrotron facility on a Nicolet Nexus
FTIR spectrometer coupled to a Nicolet Continuum IR microscope. The spectra
were collected from a 10x10m region with a 10m pixel spacing. These spectra
had a spectral range of 850{4000cm 1, a spectral resolution of 1cm 1 with a zero
lling factor of about 2, yielding a data spacing of 0.12cm 1. The spectra were
calculated by an average of 128scans and normalised by background spectra
taken prior to collection of the image which was an average of 512scans, thus
improving the signal to noise by a factor of
‘
2. After collection, the images were
converted to a local format with equivalent dynamic range.
The data processing was conducted using the same image processing toolkit
developed for the medical imaging work detailed later in section 4.2.6. Specic
processing included using the Laplacian of Gaussian second derivative lter also
1a known standard reference pointChapter 3 Prion 31
Figure 3.3: Hippocampus of ME7 infected mouse at 22 weeks, showing data collection
areas.
known as the Marr-Hildreth operator which is common in image processing,
Marr and Hildreth (1980). This lter calculates the second order dierential and
also incorporates Gaussian smoothing.
A linear search algorithm was also implemented to automatically nd dierences
in the spectra that separate NBH from Late Stage (LS) individuals in a training
set. These spectral features were then compared with a test set including the
Early Stage (ES) individuals. This search algorithm compares dierent band
positions and widths to nd pairs of bands which separate the NBH and LS
groups in the training set. The metric used related the size of the group to the
distance between the centres of the groups. This process is computationally
expensive and so this application was threaded, using the pthread library, to
leverage the additional processing capacity of multiprocessor machines. Even so
on a quad-core AMD OpteronTM running at 2.4GHz a typical processing run
took a number of hours.
Due to the high cost of running synchrotron facilities, time is allocated via an
application and funding process. This project twice applied for time on the
beamline and was granted 5 days on each occasion. The rst of these periods
was rst rescheduled and then interrupted by machine failures and a further 2
days was allocated to make up this time. Thanks go to the Engineering and
Physical Sciences Research Council for the allocation. Acknowledgement must go
to the beamline scientist James Nicholson and other sta at CCLRC DaresburyChapter 3 Prion 32
Laboratory. Also thanks to all the neuroscientists from the CNS Inammation
Group and colleagues within the ORC who helped run the data acquisition
around the clock for a total of 10 days, who include; Ayodeji Asuni, Suzanne
Campion, Kathryn Hilton, Vincent O'Connor, Jack O'Sullivan, Hugh Perry,
Harvey Rutt, Zuzanna Siskova, Jedrzej (Andrew) Szelc and others.
3.3 Results
Spectra were collected in three collection sessions. These consisted of 9, 6 and 15
individuals respectively. Due to operational reasons the samples for the second
set (6 individuals) were not specically prepared for this project. These samples
were prepared some time previously and were not as high quality as those in the
rst and last set. That the preparation of samples is vitally important has been
reported elsewhere (Roggan et al. (1999)). Unfortunately these data proved not
to be good enough to make any quantitative deductions. The standard deviation
(calculated per wavelength) of one of these images 4.5 times greater than that of
the typical image from the other sets.
Sample spectra of control and late stage tissue are shown in gure 3.4. The noise
burst at around 2300cm 1 is due to poorly controlled CO2 bands in the purge
gas - this however is the only signicant aect of this problem as CO2 does not
absorb in the same spectral regions as amide I. It can be seen that these two
spectra are similar, indicating that there is no major change in the overall
composition of the tissue which is as expected.
Before further processing it is standard practice to normalise and baseline the
amide I band. This process allows consistent comparison between spectra
independent of source illumination intensity and in this case sample thickness
which will aect overall transmission. Normalisation was performed using the
peak of the amide I band and the minimum on the high wavenumber side
(typically around 1720cm 1). Baselining is particularly important when
comparing contrast enhanced spectra, the minima either side of the amide I band
are automatically found and the baseline removed, in line with literature Susi
and Byler (1986). Figure 3.5 shows an example baseline.
Figure 3.6 shows example second derivative spectra calculated with a Gaussian
smoothing =4cm 1. As discussed above there has been a signicant amount of
work done on the assignment of particular Amide I band frequencies to
structural conformations, this is summarised in table 3.5.Chapter 3 Prion 33
Figure 3.4: Transmission spectra of NBH and late stage individuals, vertical oset
added for clarity, horizontal scale in cm 1
Figure 3.5: Example amide I band showing baseline before further processing, hori-
zontal scale cm 1, vertical scale arbitrary
Initial processing on group 1 using the linear search algorithm to separate the
three groups (control, early and late) identied four spectral areas of signicance.
These areas are specied in table 3.6. This table shows a good correlation with
bands associated with -sheets assignments referenced above. Therefore these
factors identied are likely to be structurally relevant. Figure 3.7 shows how well
the groups separate, clearly demonstrating that the groups are generally
separable with a low number of structurally relevant factors. This graph showsChapter 3 Prion 34
Structure Amide I frequency cm 1
aggregated strands 1610-1628
-sheet 1625-1640
unordered 1640-1648
-helix 1648-1660
antiparallel -sheets or aggre-
gated strands
1675-1695
Table 3.5: Approximate structural assignment of amide I bands
Figure 3.6: Second derivative of the Amide I absorption spectra of NBH tissue cal-
culated by a LoG lter with =4cm 1.
Factor Region (cm 1) Processing done
1 1614{1623 Second Derivative (4cm 1)
2 1635{1643 Second Derivative (2cm 1)
3 1636{1644 Second Derivative (4cm 1)
4 1657{1669 Second Derivative (2cm 1)
Table 3.6: Amide I frequency regions identied as being helpful in the separation of
the groups
some overlap between the control and early tissue groups, this is entirely
expected as the disease process is continuous and not all the tissue particularly
in the ES group would be diseased. Also evident is some overlap between the
late stage and early stages again due to the continuous nature of the disease
progression this is to be expected.
The images in gure 3.8 show a false colour representation of the metricChapter 3 Prion 35
Figure 3.7: A plot of the clustering of the groups; horizontal axis is the product
factors 2 and 3, vertical axis the ratio of factors 4 and 1 from table 3.6, absolute values
are arbitrary
identied. This metric is calculated from the average of the spectra within the
regions specied in table 3.6, it is proportional to factors 2|4 and inversely
proportional to factor 1. Clearly showing that it is possible to identify the
dierences between the groups. This metric also shows interesting dierences
with the regions, gure 3.9 shows the ROI 3 of a late stage individual clearly
showing a dierence between the neurons and the synapses.
(a) Control (b) Early stage (c) Late stage
Figure 3.8: Region 2 demonstrating the dierence between control, early and late
stage tissues. Scale from blue to red proportional to factors 2, 3 and 4 and inversely
proportional to factor 1 from table 3.6.
Unfortunately due to the failure of set 2 to provide data of similar quality to set
1 (the training set used in the above). The predictions of the search algorithm
were unable to be tested until another set of data was collected. After collection
of set 3 these factors were not all found to correctly assign disease state except
one. The one factor that still had some power to predict the disease state of theChapter 3 Prion 36
Figure 3.9: Region 3 of a late stage individual demonstrating the dierences within
the CA3 region. Same scale and metric as gure 3.8.
test set this was the second derivative between 1635{1643cm 1. The training set
only contained a total of 6 NBH and LS individuals whereas the test set
contained 10 so the failure to accurately predict the larger test set is not
particularly surprising.
The search algorithm was rerun on a larger training set comprising at total of 12
NBH and LS individuals (6 from set 1 and 6 randomly from set 3), the test set
comprised the remaining 4 individuals from set 3. Only one band was identied
which was between 1639{1643 with contrast enhancement (=4cm 1); this bands
can be seen in gure 3.10 which shows the mean plus and minus the standard
deviation. In this gure this small band around 1640 is the only region which
shows the means greater than one standard deviation apart.
This band shows convincing separation of the test set as well as the training set,
the combined frequency graphs can be seen in gure 3.11. As expected the early
stage samples are also found between the NBH and late stage. This band is in a
spectral region recognised as -sheet and so must be considered structurally
relevant. Another metric which one would expect if there is a change in the ratio
of -sheet to -helix is that the location of the peak of the amide I. A decrease
in the frequency of the peak absorption indicates an increase in this ratio. This
has been observed elsewhere and also demonstrated here and shown in gure
3.12. This is a structurally relevant feature associated with a decrease in -helix
and increase in -sheet.Chapter 3 Prion 37
Figure 3.10: Average plus and minus one standard deviation of a contrast enhanced
(=4cm 1) averaged spectra of LS and NBH
Figure 3.11: Demonstrating the power of the 1640 band to assign disease progress,
horizontal scale arbitrary, vertical number of pixels.
The most interesting feature of the spectra of these groups is in the region
around 1740cm 1| the metric used is the average between 1735{1752 contrast
enhanced with =4cm 1. This is not associated with the amide I band and so
not a direct measure of PrPsc accumulation in tissue. In common with the amide
I band it is associated with the C=O stretch (carbonyl group) however not the
hydrogen bonded form found in the peptide backbone but that found in
carboxylic acids and saturated aldehydes. Of the 20 standard amino acids only
two contain a carbonyl groups on their side chains, glutamic acid and aspartic
acid and there are no aldehydes. Therefore this band is associated with proteins
with glutamic and aspartic acid side chains, any free amino acid and otherChapter 3 Prion 38
Figure 3.12: Demonstrating that the peak location of amide I is related to disease
progression, horizontal scale amide I position (cm 1), vertical number of pixels at a
given position
compounds with carbonyl groups (notably tricarboxylic acid (TCA) and lactic
acid). This band is twice as sensitive to free glutamic and aspartic acids as it is
to other amino acids. It is the association with amino acids which is most
interesting, for this absorption to be solely protein side-chains (of which glutamic
and aspartic acids will only account for of the order 10%) a massive change in
the amount of protein would be observed. This is not the case, overall protein
levels are reasonably consistent across the groups (demonstrated by little change
in the intensity of the amide absorptions relative to other bands, this is shown in
gure 3.13). Finally it is unlikely that the signal observed is associated with
TCA and lactic acid as in this ROI these will be primarily metabolised in
mitochondria of glial cells which increase in number as the disease progress (a
process called astrocytosis).
Notably glutamic acid is a neurotransmitter provided to neurons by astrocytes
and used in synapses. Glutamic acid is used in the vast majority of fast excitory
synapses in the brain, gamma aminobutyric acid (also with a carbonyl group) is
the next most prevalent neurotransmitter and is used in the vast majority of fast
inhibitory synapses. Glutamic acid is produced in synapses from glutamine, it is
then stored in vesicles near the synaptic terminal. On activation the synapse
releases this glutamic acid activating receptors of the post-synaptic density.
Some of this glutamic acid escapes into extracellular space where if it was not
removed would kill the synapse (a process called excitotoxicity). In healthy tissue
astrocytes would collect all of the glutamic acid, convert it back to glutamine
and pass it back to the neuron. Kleene et al. (2007) has associated depletion of
PrP with decreased transport of these amino acids by astrocytes . As shown inChapter 3 Prion 39
Figure 3.13: Transmission spectra of LS and NBH overlaid, normalisation to maxi-
mum value, horizontal scale cm 1, vertical scale arbitrary.
Figure 3.14: The average plus and minus one standard deviation of the absorption
spectra of LS, ES and NBH tissue is shown (red green and blue respectively) in the
carbonyl region, horizontal scale in cm 1, vertical scale arbitrary.
the background section 3.1.1 many of the neurons are already damaged before
the onset of clinical symptoms, the synapses of these neurons are damaged rst
with 40% fewer synapses found at 12 weeks relative to NBH (Perry (2009)).
The average and standard deviation of this band are shown in gure 3.14, the
spectra presented here were normalised to the maximum of the amide I band and
baselined as described. Even with this minimal processing of the spectra it can
be seen that these bands will separate. Contrast enhancement makes this marker
easier to identify. With contrast enhancement this marker separates the NBH
and LS groups by almost 3 standard deviations, and NBH and ES by over 2, thisChapter 3 Prion 40
Figure 3.15: Frequency plot of the intensity in the carbonyl region, horizontal scale
is measure of the intensity, vertical scale is number of pixels
is shown in gure 3.15. The similarity in shape and mean suggests that the rst
evidence of this feature occurs far earlier in the disease progress than the
structural features identied associated with PrPsc deposition. If this can be
shown to be correlated with the neurotransmitter glutamic acid this signal could
used as an indicator of synapse loss in the earliest stages of the disease.
Finally separation of the groups is possible using the metrics identied. Figure
3.16 shows the grouping of the three groups using two of the metrics identied
(the average of the bands 1735{1752cm 1 and 1636{1643cm 1 contrast enhanced
with =4cm 1). As can be seen the NBH and LS groups have good separation
with the ES group between them as expected.Chapter 3 Prion 41
Figure 3.16: Separation of the three groups using two metrics, horizontally the av-
erage between 1735{1752cm 1, vertically the average between 1636{1643cm 1, both
bands contrast enhanced with =4cm 1Chapter 4
Intraoperative imaging of human
brain
The possibility of optically imaging the human brain intraoperatively to assist
surgeons identify diseased tissue arose out of a meeting with Prof. Liam Gray of
the Southampton General Hospital and the University School of Medicine. He
presented that even experienced neurosurgeons are unable to visually distinguish
between many brain tumours and normal tissue. Tissue also moves during
surgery reducing the accuracy of the registration with images taken before the
operation. This makes it more dicult to balance greater removal of tumour
with higher risk of post-operative decit.
This project approaches this problem in two ways; rstly to identify the
boundaries between tumours and normal tissue, and secondly to delineate
functionally useful areas. This project will attempt to nd dierences in the
spectra of normal and tumour tissues and develop a system able to identify these
dierences. It will also attempt to identify the time varying characteristics which
are associated with the use of brain tissue.
This chapter will begin by detailing the relevant literature regarding the medical
background of this project. This section considers in some depth the debate
about how much tumour should be removed and whether this correlates with
increased survival. This issue is key to this project as if there is no medical
benet in removing more tumour then surgery should only be performed for
palliative reasons. The background will continue by looking into current and
developing imaging systems.
Then the details of the systems and software developed will be presented. This
will be followed results from these systems demonstrating that it is possible to
both delineate tumour and areas of functional tissue intraoperatively.
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4.1 Background
The background to this project will be considered in three sections; a medical
review and a review of current and developmental systems. The medical review
will establish the need for intraoperative imaging to delineate both tumour and
function. The following sections will discuss imaging technologies that are
currently available and those that are still in development.
4.1.1 Medical review
This section seeks to establish the medical need for this work. There is a large
amount of literature in the eld, this section will review the most relevant of this
literature. The treatment of tumours particularly in the brain is a contentious
issue where there is signicant debate; this thesis attempts to represent both
sides but also presents the authors opinion. What follows is a brief overview
before going into more depth in the following sections.
Currently about 1 in 4 people in the UK will die of cancer. Four types of
tumour; lung, bowel, breast and prostate account for approximately 50% of these
deaths. These are principally in older people; 74% of cases are diagnosed in
patients over 60 years of age, a group which accounts for only about 22% of the
UK population. Primary tumours of the brain and CNS are rare, they account
for only 2% of new cases in the UK (approximately 4500 people per year)
however they are responsible for 7% of the cancer deaths in patients under 70
years of age. The rate of incidence has remained uniform for about 20 years but
critically the survival rates have not changed either. These survival rates are low.
One year survival is currently around 30%, 5 year around 10% and these rates
correlate strongly with age with older patients having very low survival.
(Statistics from Cancer Research UK (2009))
In contrast breast cancer has seen a consistent increase in survival with 1 year
survival currently over 90% and 20 year survival at over 60%. There are a
number of reasons why the survival rates of tumours of the brain and CNS are so
low;
1. Tumours of the brain and CNS typically present late in the disease
progress. A number of factors including the plasticity of the human brain
allow the tumour to grow without symptoms for a signicant period of
time. Presenting symptoms commonly include seizures, headaches and focal
decits - these are `mass aects' due to the growing tumour.Chapter 4 Intraoperative imaging of human brain 44
2. Brain tumours inltrate surrounding normal brain. Recurrence often occurs
near the original tumour site. For this reason surgery is in the vast
majority of cases not a cure.
3. The blood brain barrier limits chemotherapy options.
Survival may be the most important metric in tumour treatment, although it is
not without limitations. For example progression or disease-free survival may be
more useful for patients seeking to understand how long before a tumour comes
back. There are a number of neurological performance metrics and quality of life
metrics which can be used to measure `quality time' before further treatment.
All of these metrics have a common problem that earlier detection equates to
longer survival times. At diagnosis a brain tumour patient may have been living
with a slowly growing tumour for many years before the tumour mutates and
starts causing symptoms. These symptoms are typically caused by an increase in
growth thus increasing cerebral pressure leading to diagnosis. A patient may
only live for a few months after diagnosis but may have lived with this tumour
for 20 years. However there is of course no other time point from which to start
measuring survival. Within this survival gap exists a lack of understanding of
tumour growth. This presents a diculty in treatment particularly of low grade
tumours - will they all mutate into higher grade tumours, and how does surgery
aect this outcome?
Current opinion is that in all but the lowest grade of tumour (grade I) the
tumour will return. Grade II tumours may take 10 years to do so, the most
malignant (grade IV) may take less than 6months. For these tumours, surgery
falls short of a cure but is the primary method of treatment. However during
surgery the tumour resembles healthy tissue so closely to be indistinguishable by
even the most experienced surgeons (Albert et al. (1994)).
Even with the most sophisticated pre-surgical imaging and careful planning of
surgical treatment there are two key problems limiting the eectiveness of the
surgery;
1. Movement of the brain tissue reduces the registration accuracy with the
pre-operative imaging. Movements as large as 10mm have been observed
with the average being reported as 5.6mm (Maurer et al. (1998)), gure 4.1
shows an example of this imaged by iMRI. This movement is seen as soon
as the dura is opened and is a result of the internal pressure put on the
brain by the growing tumour. The reverse is also true as during surgery the
tissue dehydrates and relaxes and deforms as resection continues. TheseChapter 4 Intraoperative imaging of human brain 45
factors seriously degrade the registration between the guidance system and
the tissue.
2. Functional tissue in the region of the resection must be avoided to prevent
neurological decit after surgery. The current protocol for assessing this is
described later (4.1.1.6) but has poor spatial resolution and takes time to
perform.
Figure 4.1: Images taken by an intraoperative MRI during craniotomy showing move-
ment of brain tissue (images taken from Morton (2005))
4.1.1.1 Inltrating nature
Bernsen et al. (2005) documented a case of gliomatosis cerebri1 which although
rare does highlight the extent to which a tumour can inltrate normal tissue.
The patient presented as a 68-year-old man with cognitive dysfunction with
sudden onset. CT showed a large hypointense region in the left hemisphere, MRI
showed a similar hypointense region which did not enhance with Gd contrast.
CT images taken 4months later showed increased hypodensity in both
hemispheres, these images are shown in gure 4.2. The patient died days after
the second set of imaging of an unrelated cause, autopsy showed a highly diuse
tumour in both hemispheres. This highlights the fact that angiogenesis is not
always associated with tumour growth, this lack is associated with the lack of
MR-imaging contrast. This also poses a problem for therapy as this tumour or
non-enhancing portions of other diuse inltrating tumours are likely to be
unresponsive to antiangiogenic treatment.
80 years ago Dandy (1928) described the hemispherectomy (removal of half the
brain) | possibly the most extreme treatment for malignant glioma. The few
patients that survived this extreme treatment died of recurrent disease. Dandy
noted that the tumour tissue invaded deep into the midline of the brain and
1Gliomatosis is a rare neoplasm, dened by the WHO-2000 classication of tumors of the nervous
system as a diuse glial tumor inltrating the brain extensively, involving more than two lobes, frequently
bilaterally, and often extending to infratentorial structures.Chapter 4 Intraoperative imaging of human brain 46
Figure 4.2: Figure from Bernsen et al. (2005) indicating the extent of inltrating
margins, a; CT image with large hypointense region indicated taken at rst admission,
b and c; T1 and T2 MRI with Gadolinium enhancement indicates large hypointense
area that is non-enhancing with contrast, d; CT obtained 4 months later demonstrating
hypodensity in both hemispheres.
inltrated the overlying dura so these cases were extreme. However visible
tumour was found well away from the primary site demonstrating in the early
part of the 20th Century that glioma had no discrete margin and also that
surgery was not a cure. Over 50 years later Burger et al. (1983) demonstrated
with modern neuroimaging that glioma inltrates diusely centimetres from the
primary site and even into the other hemisphere.
4.1.1.2 Assessment of extent of resection
Before commencing the discussion of how much tumour should be removed
during surgery it must be noted how the assessment technique used inuences
the outcome of the studies. As noted earlier brain tumours are visually
indistinguishable from normal tissue and their inltrative properties make
achievement of complete removal dicult. This is also the case for assessment of
the extent of resection.
The estimation of extent of resection by the operating surgeon has been shown to
be a poor predictor of resection assessed by either intraoperative MR or early
post-operative MRI or CT. Martin et al. (2000) demonstrated that using an
iMRI system increased the extent of resection in 57% of the 30 patients studied
and assisted in avoiding critical vessels in 4 (13%) of the remaining cases.
Schneider et al. (2005) stated that the extent of resection was increased in 29%
of the 31 patients. These 31 patients were operated on using current techniques
until the resection was judged complete, MR imaging was then used to assess the
extent of resection and surgery continued as necessary.
Early post operative imaging is the most important technique for identifying the
extent of resection and understanding the pattern of regrowth. Forsting et al.Chapter 4 Intraoperative imaging of human brain 47
(1991, 1993) demonstrated that scans must be collected within the rst four days
after surgery, beyond this point surgically induced enhancement prevents clear
visualisation of residual tumour. Forsting also observed a much higher incidence
of progressive disease, 75% in those with residual tumour immediately
post-operatively compared with only 36% in those without. Forsting went on to
work with Albert to further quantify the importance of early post-operative MRI
(Albert et al. (1994)), particularly with Gadolinium enhancement. Gadolinium
enhancement within 72hrs identies any remaining tumour better than either CT
(with or without contrast) or surgeons estimation. This timing continues to avoid
visualisation of surgically induced enhancement and minimises interpretation
diculties. In his study Albert also found that the majority of tumour regrowth
initiates from the same location as post-operative MRI enhancement.
Later work (Ryska et al. (2005)) has conrmed this and also investigated the
aect of methemoglobin, a product of haemoglobin degradation, which presents
as hyperintensity on T1 MRI and could be mistaken for residual tumour. Albert
and Forsting (2003) commenting on Lacroix et al. (2001), demonstrated the
importance of an appropriate post-operative MR imaging protocol that images
within the rst 72 hours. Emphasis was also given to conducting this imaging
using Gadolinium contrast enhancement. This method is a valuable tool in
determining extent of resection and should be the standard for assessment of
residual tumour, this unfortunately is not always the case.
4.1.1.3 Aims of resection
The optimum amount of tumour removed (or alternatively the amount of
tumour left behind) is currently the subject of some debate and has been so for
some time. Intuitively one would think that greater resection increases the risk
of post-surgical neurological decit, less resection decreases the progression-free
survival. The presented data has not always backed this up. This section will
look at the reasons for surgical intervention, the next two sections will consider
the debate for both high grade and low grade tumours.
The rst surgical resection of a primary brain tumour has been attributed to
Bennet and Godlee in 1888 (Pang et al. (2007)). Although this was over 130
years ago there still remains considerable controversy and discussion about the
surgical treatment of primary brain tumours. Patient survival was reported in
the 1930's as less than 2 years, today's situation is not much dierent, Pang
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There are a number of aims of surgical intervention that cannot be ignored.
These have been enumerated in a number places including Pang et al. (2007) and
Nazzaro and Neuwelt (1990)
1. Symptomatic relief - relief from mass eect and obstructed cerebrospinal
uid circulation are clear benets. Distortion of the brain and compression
of the local structures contribute to both general symptoms and focal
decits which are likely to show some improvement with resection.
2. Neurological improvement - global symptoms such as headache, nausea,
vomiting and general malaise often show dramatic improvement following
surgery. This may be due to the reduction in intracranial pressure or may
be due to a reduced tumour burden.
3. Oncological reduction to augment adjuvant therapy - reducing the tumour
load increases the ecacy of adjuvant therapy such as radio and
chemotherapies and reduces the number of tumour cells available for
proliferation.
4. More accurate diagnosis - the accuracy of the diagnosis is dependant on the
size of the tissue sample particularly where the mass is heterogeneous.
However the possibility of achieving long-term survival for malignant tumours is
remote even with multi-modal therapy.
So where should the line be drawn between resection and minimal damage? The
fact that such a fundamental question is still unanswered is remarkable. A large
number of authors have attempted to draw together conclusions from the extant
literature for example Ryken et al. (2008); Claes et al. (2007); Jacobs et al.
(2005); Keles et al. (2001); Whittle (2004). To accomplish this is dicult as
there are signicant dierences in classication criteria, distributions of
co-variants, patient selection bias, and various methodological dierences.
It has been observed that the level of published evidence regarding the extent of
resection is not high. Proescholdt states that there are no studies with a high
level of evidence, Proescholdt et al. (2005). This may be primarily due to the
lack of randomised trials and the moral diculties in setting up such a trial.
One of the few randomised trials Vuorinen et al. (2003) presents a small study of
23 elderly patients with malignant glioma. Vuorinen did not nd a signicant
relationship between the extent of resection and survival however this study was
particularly small and only considered patients over 65 years and so this may
limit interpretation. Stummer et al. (2006) describe a randomised study of theChapter 4 Intraoperative imaging of human brain 49
extent of resection and it's eect on survival using 5-aminolevulinic acid (a
uorescence inducing agent). This study is probably the most signicant to date
and states that a complete resection (dened by post-operative MRI) is
correlated with increased survival in glioblastoma multiforme. However this trail
was critically awed in that it excluded neuronavigation in the control group, it
is also questionable whether the selection bias was too signicant. Both of these
factors will be discussed below.
The current standard for surgery is using neuronavigation. Neuronavigation
exploits pre-operative imaging to aid the surgeon resect as much tumour as
possible. Preoperative imaging has limitations as described earlier on page 44
however neuronavigation has been shown to increase the chances of gross total
resection (as assessed by early post-operative MRI) in approximately 26% and
12% of cases Kurimoto et al. (2004); Wirtz et al. (2000) respectively. Stummers'
2006 study and the additional work presented in 2008 which further adjusted for
bias in the study are critically awed as they excluded neuronavigation in their
control group (Stummer et al. (2006, 2008)). Neuronavigation was only
permitted in planning and initial tumour localisation and by implication not
during resection. Stummer achieved an increase in the chance of GTR in 29% of
patients. This increase does not appear to be much larger than that achieved by
neuronavigation alone.
The study was also highly selective regarding both the position of the tumour
away from hard to resect areas and eloquent tissue and the observation of the
tumour on preoperative MRI where a ring of enhancement and indication of
necrosis was required. This selectivity is probably due to the limitations of the
5-aminolevulinic acid induced porphyrin uorescence used. There is some debate
as to whether 5ALA can cross the blood brain barrier or whether this technique
depends on the compromised blood brain barrier in high grade tumours. Studies
such as Terr and Weiner (1983) suggest that it only crosses into the brain where
the barrier is compromised; others like McGillion et al. (1975) that it will cross
(although the techniques of the latter have been questioned, Hebeda et al.
(1998)). The conclusions may be drawn that a compromised blood brain barrier
is the primary means for 5ALA to enter the brain but not the sole method
(Novotny and Stummer (2003)) so to quote Hebeda;
Probably Astrocytoma will behave dierently form oligodendroglioma,
and grade II tumours could be completely incomparable to grade III
or IV tumours
This would pose a serious problem where the tumour is not homogeneous. This
is conrmed by Utsuki et al. (2006) where non-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demonstrably inltrating tumour. In summary Stummer's work on the extent of
resection guided by 5ALA induced porphyrin uorescence performs similarly to
neuronavigation in a subset of the highest grade of malignant glioma.
The achievable extent of resection has been greatly improved by better
intraoperative imaging. Intraoperative Magnetic Resonance imaging has been
particularly useful, Knauth et al. (1999) demonstrated that iMRI signicantly
increases the rate of complete tumour resection. In their study of 41 operations
(not a large number but probably sucient for the conclusions drawn) they rst
conducted the surgery with a normal neuronavigation and when judged complete
imaged intraoperatively before continuing where appropriate; over 50% of the
cases judged complete by the surgeon showed residual tumour on the iMRI.
IMRI in this case increased the complete resection of enhancing tumour by
36.6% (judged by early post-operative MRI), this result was statistically
signicant. However this paper also serves to highlight the fact that in this iMRI
setup the time taken to perform each MR examination was about an hour.
The risks of surgery are not inconsiderable North et al. (1990) in a retrospective
study of 77 patients noted that one adult was left moribund a further two died
within 3 weeks of surgery and 9 of the 18 children had cognitive impairment (IQ
70). Sawaya et al. (1998) reported major post-surgical morbidity as 8.5% in his
study of 400 craniotomies (327 patients). Greater morbidity was present in
patients with tumours in or near eloquent tissue, 13% of patients with tumour in
an eloquent region suered major neurological complications even though these
patients were less likely to have a gross total resection. Other factors which
correlate with morbidity include age and low KPS.
4.1.1.4 Extent of resection of high grade tumours
This section will consider the literature background regarding the resection of
high grade tumours. There is still a signicant amount of debate in this subject.
Some of the factors hindering the assessment of literature in this area are the
assessment criteria, eligibility criteria and the denition of GTR.
Table 4.1 shows the increasing weight of recent studies favouring gross total
resection for high grade (WHO grades III and IV - typically anaplastic
astrocytoma (AA) and glioblastoma multiforme (GBM)). This demonstration
that recent studies have shown an increase in the amount of literature favouring
GTR is probably indicative of better post-surgical imaging protocols. This
report will now go on to select some of the more interesting papers to review in
more detail.Chapter 4 Intraoperative imaging of human brain 51
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In Albert et al. (1994), a prospective study of 60 patients all eligible for gross
total resection, it was found that GTR assessed by Gadolinium enhanced early
post-operative MRI was the most predictive factor in patient survival, larger
than both performance status and age. Using this imaging technique patients
with residual tumour had a median progression free interval and median survival
of 2 and 9months respectively. Whereas the patients without residual tumour
were disease free for 14 and median survival was 16months (a conservative
estimate as 4 patients from this group were still alive at publication). This was
one of the key papers establishing early-post operative MRI for the assessment of
residual tumour.
Even before post-operative MRI became the method of choice for determining
the extent of resection there was some evidence that total resection improved
prognosis. Ammirati et al. (1987a) demonstrated that the performance rating
and extent of resection were the most important factors for life expectancy in
patients undergoing repeated surgery for high grade glioma.
In a retrospective study looking at 416 patients between 1993 and 1999 Lacroix
et al. (2001) investigates the aect of age, Karnofskey performance scale, extent
of resection and degree of necrosis on pre-operative MR. The extent of resection
was assessed by early post-operative MRI. Resection of greater than 98%
demonstrated a signicant (p<0.0001) increase of median survival of 4months
(median survival time of 13months, compared with 8.8months for resections less
than 98%). The extent of resection was found to be more signicant than any
other factor and confer the most advantage to those patients whose other
predictive factors are favorable.
Kowalczuk et al. (1997) uses post-operative CT for the assessment of extent of
resection but only collects this within 10days of surgery in their retrospective
study of 77 (23 Anaplastic astrocytoma, 52 Glioblastoma multiforme).
Post-operative CT within that time period would show surgically induced
enhancement, therefore this was assessed using two criteria; where enhancement
was nodular and in a `probable location of residual tumour' is was assigned as
residual tumour. This work did not nd that extent of resection was a signicant
prognostic factor.
Nitta and Sato (1995) observes in his retrospective study of 101 patients that
there is no signicant dierence between `subtotal' and `partial' resections (here
dened as between 100% and 75% and less than 75% respectively). He
demonstrates that patients with a gross total resection (resection equal to 100%)
have a signicantly longer survival. Results that subtotal resection performs
similarly to biopsy have been reported elsewhere.Chapter 4 Intraoperative imaging of human brain 53
Other prognostic factors have been suggested, for instance; Hammoud et al.
(1996) found necrosis, oedema, and degree of enhancement to be signicant.
Martinez et al. (2008) correlates two neurological functional tests; the
Neurological Performance Scale and the Sawaya Functional Grade (as used in
Sawaya et al. (1998)). These functional factors were shown to predict disease-free
time and survival whereas extent of resection only correlated with survival. They
performed better than all other factors in predicting survival and disease-free
progression. These factors assess how much functional tissue is involved in the
tumour and this may aect the extent of resection. The association of extent of
resection and other clinical variables (such as age, clinical location and clinical
status) has been demonstrated in Mineo et al. (2007), the functional parameters
proposed by Martinez may be measures of these variables. Andreou et al. (1983)
demonstrates using postoperative CT that where greater resection is possible
prognosis is better, age was also found to be a signicant factor.
In Burger and Green (1987) histological factors aecting survival of Glioblastoma
Multiforme (GBM) are presented. This study did not consider extent of resection
to be a prognostic factor. Burger found a strong negative correlation between
increasing age and length of post-operative survival. Other factors were related
to age; the presence of necrosis, extent of vascularisation, smaller cell size,
however these factors did not oer a full explanation of the observed age eect.
Given the very short life expectancies after diagnosis of older people and
probable extant conditions which make surgery more complicated and recovery
times longer, many oncologists may recommend limited cytoreductive surgery
and palliative care. For these reasons older people are typically excluded from
analysis. Mangiola et al. (2006) attempts to put forward the view of equal
treatment options for patients over 65 years of age. Mangiola looked particularly
at the role of radiotherapy, chemotherapy and surgery in this group of 34
patients. All patients underwent resection, 79% received a gross total resection,
the remainder a partial resection. The tumour location was not analysed, it has
been shown elsewhere that tumours in functional areas and those in more
inaccessible areas are more dicult to resect completely. 10 patients did not
receive any adjuvant therapy due to `treatment refusal or particularly poor
conditions', this will prejudice any survival metrics which consider this group.
This paper while advocating non-discrimination based on age (which has been
consistently been shown to be a predictor of poor prognosis) does not analyse
their results suciently accurately to draw any signicant conclusions. It has
been shown that non-surgical treatment options also inuence outcome, the
inuence of radiotherapy on survival performed better than age and KPS in
Mineo's study of 340 GBM patients reported in Mineo et al. (2007).Chapter 4 Intraoperative imaging of human brain 54
There is still much debate within the literature; Barker and Chang (2006)
questions the scientic basis for GTR stating that patients where GTR has been
performed typically have other favourable factors. This criticism may be valid
and may correlate with the function performance scales that also seem to be
indicative of prognosis. However Barker seems to ignore the evidence presented
by papers which only select patients where GTR would be appropriate. Barker
makes the following statement; \the survival benet of complete removal of
enhancing tumour is modest at best". Any demonstrable improvement is likely
to be benecial and an increase in survival of up to 70% (reported by Albert
et al. (1994)) is unlikely to be referred to as modest so a question must be raised
as to what Barker is basing this statement on.
Anderson et al. (1983) is often cited as a criticism of the analysis of GTR, this
paper outlines the shortcomings of a simplistic analysis of chemotherapy data
particularly in assignment of signicance to these data. This paper observes two
problems in the traditional analysis of medical intervention;
1. Patients must survive long enough to be identied as responding to
treatment whereas any patients who die before this point are identied as
non-responders
2. It is very dicult (or impossible) to dierentiate between cases where
response prolongs survival or simply acts as a marker for patients with a
favourable prognosis.
In respect to item 1 Anderson observes that survival curves for non-responders
and responders can still be useful in the clinical management of patients where a
patient with a poor prognosis may be treated dierently than those with a
favourable prognosis. This criticism is less relevant to surgical intervention than
medical, Anderson identies that where \most patients who respond do so early
and very few patients die in this early period ...the results of the incorrect
methods [come] close to those of the correct methods." Surgical intervention can
be considered to be the extreme where patients respond immediately (or not at
all) and no patient dies before this point (surgical mortality is invariably
discounted from any prognostic analysis).
Anderson's criticism is however relevant to some literature; one example is
Mangiola et al. (2006) where they analysed a group of 34 patients aged over 65
years for prognostic factors in the treatment of glioblastoma multiforme.
Mangiola considers the eect of a second surgical intervention and determines
that this is of statistical signicance, although the time points where the second
intervention took place are not stated the implication is that it is not immediate.Chapter 4 Intraoperative imaging of human brain 55
Operating after any post-operative MRI enhancement has dissipated would mean
that the delay would be at least three months at which the survival has already
dropped to 70%. This eect, particularly when combined with the small group
size, means that these results have to be seriously questioned.
The problem dened in 2 could be restated that \Gross total resection is only
possible in patients with a favourable prognosis". This is increasingly being
recognised in the literature;
tumour resectablity may be a surrogate factor for tumour behaviour.
Molecular cytogenetic proles may be dierent for multifocal, deep
tumours located in eloquent areas of the brain, compared with those
lesions located near the cortical surface in noneloquent areas. Laws
et al. (2003)
Study of how these tumours develop and an understanding of the features which
make them more aggressive may help mitigate this problem.
Even where all patients are eligible for GTR and the extent of resection is
accurately assessed Anderson's criticism may still be valid. Eligibility criteria
can be set up to attempt to ensure that all patients are equally likely to have a
GTR. This can be done by excluding from the study certain tumours including
those dicult to reach (basal ganglia, brain stem, corpus callosum etc.) and
those adjacent to functional areas (sensorimotor cortex, speech region etc.).
Accurate measurement of residual tumour is required and is possible with early
post-operative MRI. The only way to resolve this criticism is to randomly assign
gross total or partial resection to a population of patients and pursue gross total
resection at whatever expense. However this would be totally unethical and
against the oath which all surgeons undertake (Hippocrates (ca. 400BC)). One of
the closest to this is Albert et al. (1994) which dates from before neuronavigation
became standard practice, this paper looks at assessing both surgeon's
estimation of resection extent and the survival advantage conferred by GTR. The
surgeon's estimation was therefore the only method to intraoperatively assess the
extent of resection. Albert used early post-operative MRI for assessment of
residual tumour and had reasonable exclusion criteria for dicult tumours.
Surgeon's estimation was shown to be a poor assessment of the extent of
resection (this is supported elsewhere, Nazzaro and Neuwelt (1990); Keles et al.
(2001)). Also the extent of resection was shown to be a strong predictor of
survival, however even without neuronavigation and depending on surgeon's
estimation which means that the extent of resection may be more likely to be
randomly distributed there is no way to prove this.Chapter 4 Intraoperative imaging of human brain 56
By similar reasoning papers such as Claus et al. (2005) where the aim is to
achieve GTR (in this case using iMRI) and only accept partial resection when
functional tissue is involved is critically awed in that the ability to perform
GTR could be a prognostic indicator rather than the treatment.
Selection bias can be a particular problem, for example high risk patients are
more likely to have a biopsy than undergo the more aggressive total resection,
this tends to distort the statistics in favour of resection. Attempts have been
made to mitigate selection bias, for example Laws et al. (2003) states in their
retrospective study of outcome data from 788 patients that the biopsy group
were considered to have negative risk factors (age >60 years, KPS <70, presence
of multifocal tumours). Therefore to accurately assess whether patients
undergoing biopsy actually have a poorer outcome or if it is simply associated
with their existing high-risk factors some adjustment must be made. Laws
mitigates this bias by removing the \poor-risk" patients from analysis. Although
this reduces the size of the data-set it increases the validity of the data. Laws
observes an increase in the signicance of extent of resection with successive
attempts to analyse only the \good-risk" patients from both resection and biopsy
groups for both GBM and AA.
Care must be taken in analysis of the existing literature as there seems to be a
large amount of comment but little new data and some of the data presented
needs to be carefully considered. For example Hess (1999) continues the debate
but does not add signicantly to it. This paper, published in 1999, considers
data collected in the early 90s, the latest data point is from 1996. The
publication of this paper appears to lag the collection of the data by an
unacceptable margin even though the data relates to higher grade tumours where
the prognosis is poor and so not requiring particularly long follow-up periods.
Similarly Jeremic et al. (2003) uses data collected before 1993 considers a cohort
of 175 patients with GBM of whom the maximum survival was 60months. A
large number of factors were considered in this work and most found to be of
some relevance, the extent of resection the greatest of these factors however the
assessment protocol was not stated. One might assume given the publication
date that a post-surgical imaging technique would be used however the patient
cohort dates from before this saw wide adoption.
Dierences in the denition of the extent of resection present interpretation
diculties. The results of Ammirati et al. (1987a) must be called into question
based on the measurement of the extent of resection, that GTR is not possible in
all patients and that almost certainly that GTR would indicate those with a
favourable prognosisChapter 4 Intraoperative imaging of human brain 57
4.1.1.5 Low-grade tumours
Low grade gliomas are the most benign of the primary brain tumours. The
World Heath Organisation classies these as grade I and II. The more common
grade I tumours are pilocytic astrocytoma, dysembryoblastic neuro-epithelial
tumours, pleomorphic xantho-astrocytoma, neurocytoma and ganglioglioma. The
more common grade II tumours include astrocytoma, oligodendroglioma and
mixed oligostrocytoma Whittle (2004). These denitions are important as grade
I tumours can generally be cured by surgical excision Luyken et al. (2003).
Whereas grade II are tumours generally incurable but have long median survival
times of >5 years. Equally oligodendrogliomas typically have a better prognosis
than astrocytomas partially due to gene deletions which make them particularly
susceptible to chemotherapy, Shaw et al. (2002).
Low-grade gliomas commonly present with seizure disorders and are dicult to
classify even with the best MRI so rst an accurate diagnosis must be obtained.
After diagnosis a number of management options other than surgery present
themselves; a \watch and wait" policy may be most appropriate for patients who
are asymptomatic or whose symptoms can be controlled medically (e.g. with
anticonvulsants); radiotherapy and chemotherapy have been shown to improve
prognosis, Karim et al. (2002). However the timing is still debatable as Olson
et al. (2000) has shown that there is little dierence between post-operative or
delayed radio/chemotherapy. Surgery is complicated by the large number of
these low-grade gliomas which are diusely inltrating, gure 4.3 demonstrates
the diculty, this patient underwent a sub-total resection and which completely
stopped her seizures. However a complete resection in this patient even using
awake craniotomy would almost certainly be followed by major neurological
disabilities.
Whether the extent of resection is associated with longer survival times is still a
subject of some debate. Claus et al. (2005) investigates this question but the
condence intervals presented in this paper are too large for any signicant
conclusions to be drawn from it. Hall (2004) documents a long-term study
correlating extent of resection with survival in 65 patients with low-grade glioma
(29 oligodendrogliomas and 36 astrocytomas). Lo et al. (2002) found that the
only signicant prognostic factors in their study of 65 patients with low-grade
glioma were extent of resection and whether the tumour was enhancing on
preoperative imaging. In this study little dierence was observed between those
patients with subtotal resection and those who only underwent a biopsy. This
study has not attempted to adjust for the inherent selection bias in the
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Figure 4.3: A T2-weighted MRI scan of 28 year old woman with complex partial
seizures but no focal decit. The lesion did not contrast enhance and radiologically ts
the classical appearance of low-grade glioma (from Whittle (2004))
Similarly to the high grade tumours there are a number of prognostic factors
associated with survival. Nicolato et al. (1995) retrospectively analysed 76
patients diagnosed with low-grade astrocytoma in the CT-era and found a large
number of signicant prognostic factors listed in table 4.2. A number of these
factors are likely to be inter-dependant, for example the shape and the edge
denition are likely to be correlated. This study has a relatively small number of
cases so it is inappropriate to over-emphasise this study however it does highlight
the same factors as other papers. Age, size, KPS and histology are recognised in
Pignatti et al. (2002) as signicant in one of the rare larger randomised studies -
the specic aim of this study however was to investigate the eect of
postoperative radiotherapy and although not randomised with respect to the
extent of resection its conclusions are still interesting.Chapter 4 Intraoperative imaging of human brain 59
Signicant factors by p Value
univariate analysis
Extent of surgery 0.0001
Preoperative KPS Score 0.0001
Age (50 years) 0.0006
Well dened edge 0.002
Regular shape 0.003
Tumour diameter (CT) 0.004
Presence of cyst 0.01
Postoperative KPS Score 0.02
Table 4.2: Univariate prognostic factors in low-grade glioma from Nicolato et al.
(1995)
Authors and Year (no. patients astrocytoma/oligoden-
droglioma or mixed)
2000 2000-2008
statistics favour more extensive resections
North et al. (1990) Lo et al. (2002)(65)
Nicolato et al. (1995)(76) Pignatti et al. (2002)(395/215)
Miralbell et al. (1993)(67) Yeh et al. (2005)(46/47)
Hall (2004)(36/29)
Shaw and Wiso (2003)1(1600)
statistics do not favour extensive resection
Lote et al. (1997)(379) Shaw et al. (2002)(64/139)
Table 4.3: A historical summary of literature either favouring or not gross
total resection for low grade glioma
1 Review of 5 prospective clinical trials
Selection bias seems to be more evident regarding patients with low-grade glioma.
Every neurosurgeon has seen patients with low-grade astrocytomas
who are fully functional, have no neurological decit, and who survive
for long periods of time without any form of treatment Laws (2001).
Laws suggests that these patients are very unlikely to be entered into a trial of
any sort. There has not been any signicant attempt to mitigate this selection
bias.
In spite of the various problems within the literature, including; selection bias,
diering de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to achieve gross total resection in high grade tumours improves patient prognosis.
The weight of recent literature using post-operative MRI indicates an increasing
trend towards this same conclusion. Low grade tumours pose more of a problem
particularly if their symptoms can be controlled with medication and ultimately
it probably depends on the patient. The author does not entirely agree with the
statement below from Laws (2001). If the patient is asymptomatic or adequately
controlled then a `watch and wait' policy may well be the best option; however if
resection is chosen then this author advocates maximal safe resection.
this strategy of recommending radical resection of gliomas of the brain
is probably a sound one, based on what we currently believe to be the
pathogenetic mechanisms associated with gliomas. Clearly, the more
cells at risk, the more likely a tumour is to undergo the series of
genetic events that ultimately leads to a more aggressive or malignant
glioma. For that reason, the traditional oncological principle of
cytoreduction must be considered appropriate until proven otherwise.
Laws (2001)
If Anderson is correct in his statement that it is the ability to perform total
resection rather than the resection itself that is prognostic then attempt the
resection and remove any doubt. Whatever happens the tumour seems likely to
return, and a better understanding of the prognosis is likely to assist the patient
even if this prognosis is not favourable. If this author were the patient, whether
the tumour was a low or high grade, he would opt for maximal resection
4.1.1.6 Function
Neurosurgeons seek to minimise post-operative neurological decit which means
that they do not operate solely on anatomy but also on physiology. There are a
number of techniques to assess the function of tissue both preoperatively and
during surgery. There is more information about these methods in 4.1.2.
Duau et al. (2008) demonstrates the amazing potential for the brain to
reorganise function or `plasticity'. He studied 77 consecutive patients undergoing
surgery for Low-Grade Glioma in principle functional areas including the
sensorimotor cortex and temporal language areas. 92% of these tumours were
extensively or totally resected and all patients had immediate post-operative
decit. However all but 5% of cases suered no long-term morbidity. This
plasticity shows how it is possible that all of the patients studied presented
without functional decit despite signicant tumour masses within typicallyChapter 4 Intraoperative imaging of human brain 61
eloquent areas. Also that these decits experienced immediately post-operatively
were due to resection of tumour inltrated regions which are associated but not
essential to function. This decreases the risk of post-surgical morbidity. It
presents an opportunity to surgeons to increase the extent of resection into
eloquent areas but leaves the dicult question of knowing what functionality can
be compensated for.
The gold standard for localizing functional areas is direct electrocortical
stimulation (DECS). At the beginning of the procedure, after the brain has been
exposed the surgeon stimulates the cortex with bipolar probe. This probe
consists of two metal contacts about 2mm in diameter separated by
approximately 7mm. This is applied to the exposed cortex and current pulses are
injected. The awake patient is able to communicate and perform tasks, where
the probe is applied to eloquent tissue it will inhibit function in this tissue hence
stopping the task. As the surgeon does not stimulate into the sulci this could be
considered an incomplete map also stimulation cannot always be performed for
clinical reasons. Therefore new ways of assessing the location of eloquent tissue
are of interest.
Functional MRI has the potential to be of some use in identifying functional
tissue however the correlation between fMRI and electrocortical stimulation has
yet to be proven. Xie et al. (2001) calls into question the validity of all
measurements by BOLD-fMRI by suggesting that a change in
deoxy-haemoglobin does not always accompany neuronal activation. Pouratian
et al. (2003a) questions the correlation between perfusion-related imaging (such
as optical intrinsic imaging and fMRI) and activity. Pouratian notes that the
signal often seems to \spread" possibly due to; subthreshold activity in adjacent
tissue, super threshold activity of non-essential tissue, or the non-exact
colocalisation of activity and perfusion. Larsen et al. (2007) quanties the
correlation of DECS and fMRI in a single case study, Larsen demonstrates that
stimulation nds a subset of the areas dened by fMRI. This may be due to
active tissue in the sulcus or could be the activation of tissue that is associated
with but not critical for a given activity. Krings et al. (2001) has correlated
fMRI with Transcranial Magnetic Stimulation (TMS), DECS and PET. Krings
presents that fMRI correlates with both the electrophysiological methods (TMS
and DECS) and the metabolically based method (PET) however the limited
spatial resolution of these techniques and Krings' denition of a miss as >2cm
raises questions. Krings also uses a dierent technique for DECS | a monopolar
(presumably a return is located elsewhere on the patient) stimulator on
anesthetized patients to elicit muscular movement (monopolar stimulation is
broadly similar to bipolar stimulation Kombos et al. (1997)). Hill et al. (2000)Chapter 4 Intraoperative imaging of human brain 62
which denes signicant errors as >10mm in their comparison of fMRI and
stimulation and determines that fMRI is not suitable for functional delineation
for surgical use. Hill cites brain deformation during surgery and motion artifacts
during imaging at the primary causes of error.
There is some interest in integrating fMRI systems with other imaging or point
measurement modalities. Gore et al. (2006) investigates the integration of fMRI,
and event-related potentials, and recognises that there could be considerable
advantages in integration of the varied techniques for functional imaging.
However the cost in additional complexity seems to make this sort of integration
somewhat unlikely.
Michael Haglund currently at Duke university has pioneered the optical imaging
of function in humans. His work built on that of Grinvald working in the
Weizmann Institute of Science in Israel, Grinvald developed this technique in
mammals both awake and anesthetized (publications include Grinvald et al.
(1986, 1991)). Although there was some question as to the origin of the signal,
optical imaging of function was demonstrated in the sensorimotor cortex by
activity and stimulation by Haglund and colleagues in 1992 (Haglund et al.
(1992)). Haglund has continued working in this eld and has expanded it to
observe spontaneous epileptic seizures, Haglund and Hochman (2004). Haglund
typically uses wavelengths between 650 and 700nm.
The sources of the intrinsic signal include reectance changes from several
optically active processes which correlate indirectly with neuronal ring. The
main parameters that aect this signal are summarised by Zepeda et al. (2004)
as;
1. Changes in the blood volume
2. Chromophore redox, including the oxy/deoxy haemoglobin ratio,
intracellular cytochrome oxidase and electron carriers
3. Light scattering
The rst two factors are simply dependant on the metabolic rate of the cerebral
tissue and thanks to the autoregulation of blood ow in the brain these signals
are very localised. Neuronal activity uses oxygen which is initially supplied by
the local capillaries and a highly localised dip in the oxy/deoxy ratio (initially
evidence to support this was lacking however it was demonstrated in Vanzetta
and Grinvald (1999) and subsequently conrmed elsewhere). During brain
activation regional cerebral blood ow greatly increases ( 30%) within 1{2
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in healthy volunteers using PET, Fox and Raichle (1986); Fox et al. (1988). This
decoupled response means that during neuronal activity deoxyhaemoglobin
concentrations decrease while oxyhaemoglobin increases. It is this increase in
oxygen delivery which is observed in fMRI and referred to as the \Blood Oxygen
Level Dependant" (BOLD) signal and can be interrogated optically.
The third factor was rst reported in Hill and Keynes (1949) from the scattering
of a crab leg nerve. Although this is undoubtedly present and potentially yields
information with a higher temporal and spatial correlation, particularly as this
eect does not expand to surrounding areas. It dominates the other aects in the
near-infrared 850|700nm region. However it does not seem to have signicant
interest in the current literature possibly due to its low value relative to the
scatter of the surrounding tissue.
Building on work rst reported by this group in 2002 (Sato et al. (2002); Nariai
et al. (2002)) Sato and colleagues use Xenon illumination and a lter of 605
5nm to correspond with the maximum dierence between the oxy/deoxy
haemoglobin spectra. Work presented in Sato et al. (2005) and Nariai et al.
(2005) observed the somatosensory cortex of 14 patients undergoing a
craniotomy and stimulated either the digits of one hand or the maxillary nerve.
Their patients were anesthetized so they correlated their results with
somatosensory-evoked potentials. In this study even though brain surface was
stabilized with a glass plate some movement artifacts were reported. The size of
the craniotomy in the gures presented is somewhat larger than one would
expect even given the requirement for functional mapping of the cortex near the
tumour. Acquiring a map required 8 blocks of 3 stimulation/control cycles
taking in total about 10 minutes, another 5 minutes was required for initial
processing. Areas of functional activation corresponded with stimulation. These
areas were slightly overlapped but generally well separated.
Cannestra et al. (2001) presents work establishing the co-localisation of fMRI,
Optical intrinsic signal and evoked potentials. This paper strengthens the spatial
correlation between fMRI and optical imaging of function. It also highlights the
dierence in temporal location with fMRI lagging optical imaging by
approximately 2{3seconds. The same group previously reported (Cannestra
et al. (2000)) that optical imaging and electrocortical stimulation were
colocalised in the regions associated with speech and language. This paper also
presents dierences in the temporal prole of the optical signal relating to
sensory and motor cortices which may add additional information to the
analysis. Further work from the same group was presented in Pouratian et al.
(2002) highlights the fact that fMRI is a volumetric tool instead of the 2-D
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Epileptic events are of particular interest to optical imaging due to the high
temporal and spatial resolution possible with intraoperative optical imaging.
Schwartz (2003) describes imaging of simulated seizures in the ferret visual
cortex and exploits the ability to map function in the vicinity. Suh et al. (2005)
investigated the eect of epileptiform events and observed in an animal model
that these events unlike normal physiology increase the metabolic rate beyond
the capabilities of the brain to supply it. If this event is short then the increase
in local blood ow will eventually supply enough and an increase will be
observed. They observed the dip in oxyhaemoglobin in human patients with
electrocortical stimulation (which is not unlike an epileptic event).
Intraoperative optical imaging is invasive and optical means are being sought to
determine function through the skull. Schroeter et al. (2005) demonstrates that
an intracranial functional Near Infrared Spectroscopy (fNIRS) system is capable
of assessing functional response in tissue as deep as 1cm into the cortex. He
correlated this with fMRI and continued recording until the relative haemoglobin
levels returned to pre-stimulation values which took approximately 30s.
Various techniques to improve the signal to noise in optical functional maps exist
including Schiessl et al. (2008). There also attempts to increase the functionality
of such a optical system, Dunn et al. (2002) integrates functional imaging with
laser doppler to add sensitivity to blood ow to the total haemoglobin
concentration and oxygenation in mice.
Imaging of the haemodynamic response is not the only optical technique that
may be relevant to delineation of function. Husson et al. (2007) presents a
technique sensitive to avoprotein autouorescence which derives from proteins
involved in the mitochontrial electron transport chain and is therefore a more
direct measurement of function than the haemodynamic response. They have
shown that this signal is present in both cats and rodents and follows activation
but precedes the BOLD signal. This paper acknowledges some of the limitations
of this technique, that it requires a large amount of illumination and long
integration times to capture sucient uorescence for mapping, the amount of
background uorescence is not mentioned but is likely to limit the signal to noise
ratio.
4.1.2 Current Imaging methods
A number of imaging technologies are in current oncological use. Many of these
have been mentioned in Section 4.1.1 this section will provide a brief
introduction into these methods. This section will focus specically on the use ofChapter 4 Intraoperative imaging of human brain 65
Category Imaging Method
Structural
X-ray Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Magnetic resonance angiography
Functional
Noninvasive
Positron-emission tomography (PET)
Single photon-emission computed tomography (SPECT)
Functional Magnetic Resonance Imaging (fMRI)
Electroencephalography (EEG)
Magnetoencephalography (MEG)
Transcranial Magentic Stimulation (TMS)
Invasive
Electrocortiography
Depth electrodes
Cortical Stimulation
Optical signal imaging
Table 4.4: A summary description of imaging methods.
these technologies for diagnosis and will provide some of the pros and cons of
these methods. These techniques either give information about the tissue
structure (anatomy) or the tissue function (physiology) the advantages of this
will also be highlighted. Table 4.4 shows broadly what techniques can be used
for anatomical and physiological delineation. Figure 4.4 summarises graphically
the spatial and temporal resolution of some of these techniques.
4.1.2.1 Radiological
Most people are familiar with radiology for diagnostic purposes and it is the
primary means of anatomical imaging (with the exception of in the brain). The
simplest form of which is the diagnostic X-ray which involves directing radiation
upon a specic part of the body and collecting radiation that has passes through.
Increasingly digital sensors are replacing the traditional cassette and
photographic lm. X-rays passing through the body are more absorbed or
scattered by dense tissues (bones, tumours etc.) and relatively less absorbed
through less dense tissue (muscle, fat etc.). These radiological techniques are
primarily an anatomical technique as tissue density varies with tissue type and
not function. Tumour tissue is typically more dense than non-malignant tissue
and in addition more advanced tumours can show calcication which can be
detected.
Computed Tomography (CT or commonly as \cat") uses an X-ray generating
source opposite a detector (normally an array of detecting elements). This sourceChapter 4 Intraoperative imaging of human brain 66
Figure 4.4: Spatial and temporal comparision of functional human brain mapping
techniques (image from Pouratian et al. (2003b))
detector pair are then rotated axially around the patient and a computer is used
to reconstruct this information into a three dimensional model and generate
cross-sectional images. Intravenous contrast agents can be used to enhance the
appearance of arteries and veins in CT scans which enables the anatomy of
these, otherwise low contrast, vessels to be viewed.
With the introduction of spiral CT systems in the mid 1990s a new technique
called perfusion CT was made possible. A small amount of reasonably innocuous
contrast agent is administered intravenously and then frequent scans give the
perfusion of tissue under investigation. This is primarily used in strokes and
oncology. Perfusion CT use in strokes can identify areas of brain which are being
deprived of oxygen prior to surgical intervention i.e. areas where the blood ow
is below a threshold. In oncology perfusion CT can identify the relative increase
in blood ow due to the angiogenesis (or neovascularisation) of the tumour bed.
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poor contrast of cerebral anatomy when compared with MRI, it certainly has it's
uses (for more information Miles and Griths (2003) is an interesting review and
two cases studies can be found in Teksam et al. (2005)).
Intraoperative CT although demonstrated in the early 80's has not achieved a
signicant role in neurosurgical practice. Mobile CT has improved the situation
in certain elds, for example in intensive care units where moving the patient
would be detrimental to their welfare. This has made intraoperative CT more
practical. However CT uses ionizing radiation, has limitations on plane
orientation and has poorer contrast than MRI (Martin et al. (2000)). For these
reasons and the development of iMRI in the mid 90's intraoperative CT has not
made a signicant impact.
Fluoroscopy is another radiological technique that has signicant impact in the
eld. Fluoroscopy should not to be confused with uorescence techniques using
intrinsic or extrinsic uorophores and optical excitation. This technique uses a
constant stream of X-rays onto a uorescent screen or image capture device.
This is often used intraoperatively to aid guidance during procedures however is
not a tomographic technique so has limited utility.
Radiological techniques are minimally invasive. All patients will receive a
radiation dose. Currently it is assumed that all radiation doses present risk to
the individual however small the dose. The contrast agents used in CT scans
present some risk to patients particularly those with kidney impairment. The
scan takes some time, maybe as much as 30 minutes, through which the patient
should be as still as possible. The CT is enclosed in a ring and so the
environment is relatively open and so is not as intimidating as MRI, and is also
suitable for patients with metal implants (e.g. cochlear implants, aneurysm clips,
pacemakers, replacement joints).
4.1.2.2 Nuclear medicine
Nuclear medicine involves the use of radioactive isotopes to diagnose disease.
Radioisotopes (`tracers') are integrated into radiopharmaceuticals with a known
behaviour and administered intravenously or inhaled by the subject. These
radiopharmaceuticals act characteristically in the body therefore these isotopes
collect in specic tissues or organs giving a measure of function (or physiology)
not anatomy.
Positron Emission Tomography (PET) was developed in the mid 1970's although
was not in clinical until the late 1980's (Mazziotta (1994)). PET uses positron
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travelling in opposite directions, detecting these gamma rays allows tomographic
images to be produced. Typical uses include uorine-18 labeled
uoro-L-thymidine and uorodeoxyglucose for monitoring glucose consumption
and DNA synthesis respectively, amino acid transport can be monitored using
carbon-11 methionine and oxygen-15 can be used to monitor oxygen metabolism.
The short (about 2mins for 15O up to 110mins for 18F) half-lives of these isotopes
require local production in a cyclotron which makes this technique particularly
expensive. PET can provide information about cerebral metabolism, blood ow
and volume, oxygen use, neurotransmitter synthesis and receptor binding.
Single Photon Emmision Computed Tomography (SPECT) is very similar to
PET, the key dierence being that the tracer emits a gamma photon rather than
a positron. SPECT instruments were developed in the 1950-60s and immediately
applied to cerebral function. Typical tracers used include xenon 133, iodine 123,
technetium 99. SPECT can provide generally similar information to PET
including cerebral perfusion, blood volumes, and receptor distribution. It is also
used in applications such as thyroid function assessment and bone imaging.
Although it has lower spatial resolution than PET the longer half-lives of the
radioisotopes mean that local production is not necessary.
Similar to radiological techniques all patients receive a radiation dose generally
about the same as a diagnostic X-ray. These techniques are minimally invasive
typically requiring no more than an intravenous injection. They do take a
signicant amount of time, following the injection of the radionuclide a patient
may have to wait a number of hours for the tracer to reach it's destination. The
scan itself takes some time (maybe as much as 30 minutes) during which
movement of the patient is detrimental to the image.
4.1.2.3 Magnetic resonance imaging
Magnetic Resonance Imaging (MRI) has it's origins in the chemistry technique
Nuclear Magnetic Resonance, a spectroscopic technique that is used to provide
microscopic chemical and physical information about molecules. MRI was
introduced clinically in the 1980s. It is particularly useful in neurooncology due
to the excellent spatial resolution and high contrast between gray and white
matter.
MRI uses a large, often superconducting, electromagnet (commercial clinical
devices range from 0.1Tesla up to about 3T) to align the nuclei of atoms that
exhibit spin, one such nuclei is hydrogen. Once aligned the atoms are then
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Hydrogen in a 1T machine this is 42.58MHz). The excitation is then removed
causing the excited atoms to relax and emit radiation at the same frequency
which can be detected.
The contrast of MRI images can be tuned to a number of dierent tissue
properties (unlike radiological methods whose only contrast mechanism is the
optical properties of tissue in the X-ray region). There are three main
parameters that are used; Spin-Lattice Relaxation time (T1), Spin-Spin
Relaxation time (T2) and Spin Density (). These parameters vary with tissue
type, some pathology has the T1 value similar to that of normal tissue whereas
the T2 values may dier - some relaxation times and density values for tissues
found in the human head are shown in 4.5. The details of how the MRI is tuned
to these values are not pertinent to this document and are explained better
elsewhere (for example http://www.cis.rit.edu/htbooks/mri/index.html).
Kelly et al. (1987) demonstrates that T2-weighted MRI imaging reveals greater
tumour volumes than contrast enhancement and low-attenuation boundaries on
CT. Biopsy of 195 samples revealed that contrast enhancement indicated
tumour; hypodensity related to normal tissue inltrated with tumour cells or in
some instances low-grade glioma or oedema; and isolated tumour cell inltration
extended at least as far as T2 enhancement on MR images. MRI is very sensitive
to high grade tumours particularly with the use of contrast enhancement,
however this contrast agent exploits a compromised blood brain barrier which is
not present in low grade tumours. Due to this lack of contrast agent, the
presentation as hypodensity and presence beyond the T2 enhancement MRI is
not particularly sensitive to these low grade tumours.
Tissue T1 (s) T2 (ms) ?
CSF 0.8 { 20 110 { 2000 70 { 230
White 0.76 { 1.08 61 { 100 70 { 90
Gray 1.09 { 2.15 61 { 109 85 { 125
Meninges 0.5 { 2.2 50 { 165 5 { 44
Muscle 0.95 { 1.82 20 { 67 24 { 90
Adipose 0.2 { 0.75 53 { 94 50 { 100
?Based on  =111 for 12mM aqueous NiCl2
Table 4.5: shows the range of values T1 T2 and  found in magnetic resonance images
of the human head Fletcher et al. (1993)
MRI is mainly used as an anatomical technique but also has the ability to detect
functional characteristics of the brain by detecting the BOLD signal. The Blood
Oxygen Level Dependant (BOLD) signal is a function of the activity of a section
of brain tissue. Using the BOLD signal MRI is able to establish where an area is
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This technique is called functional MRI (fMRI). In common with other
functional techniques the patient must be conscious and able to perform the
tasks required. FMRI has the advantage over radiological techniques (e.g.
SPECT), which can detect similar signals, in that it does not expose the patient
to ionising radiation. FMRI does not have the temporal resolution of
Electroencephalography (EEG) but has better anatomical sensitivity.
MRI takes some time to capture an image but it does not expose patients to
ionising radiation like radiological or nuclear techniques. Due to the tremendous
magnetic elds present in the MRI there are limitations placed on the local
environment including medical instrumentation. There is an infamous case of a
6year old boy killed when struck by an oxygen cylinder which was attracted by
an MRI. This also limits patients with metal implants such as cochlear implants,
aneurysm clips, pacemakers, hip replacements etc. as even small amounts could
present a hazard and will distort the image. A contrast enhancing agent is often
administered intravenously, a Gadolinium compound is common in
neurooncology; normally this is tolerated exceptionally well but may not be
advisable in patients with poor renal function. As with all the tomographic
techniques the patient must stay as still as possible during the scan although the
images collected by MRI can be registered post acquisition to reduce motion
artefacts. The patient will be totally enclosed during the scan which may
preclude its use for those with claustrophobia and scans can be very noisy
particularly with older instruments.
4.1.2.4 Intraoperative MRI
Intraoperative MRI (iMRI) is a developing technique that has signicant
potential in the eld of neuro oncological surgery. The possible impact of this
technology is such that it deserves individual attention. Current image guidance
systems rely on images taken pre-operatively and so as tissue is resected and
anatomical structures move these systems become increasingly inaccurate. These
systems cannot provide the surgeon with any new information. Intraoperative
MRI however can provide real-time information similar to uoroscopy, however
iMRI is a tomographic technique and does not use ionising radiation with the
added benet of better resolution. This enables the surgeon to establish the
extent of resection and provide image guidance on the current anatomical state
of the tissue. However there are signicant limitations on these systems not least
the extent that the surgical routine is aected. The region around the MRI and
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instrumentation and even instruments that are non-ferrous may be repelled or
attracted by the strong magnet or cause artefacts in the images.
The intraoperative MRI was developed in a collaboration between the Brigham
and Women's Hospital and General Electric starting in 1990. The prototype
system was deployed into an operating theatre in 1994 the development was
documented in Black et al. (1997). The development of this system included
signicant testing of which instruments can safely be used within the vicinity of
the imager. This imager has a split coil with a 54cm gap, allowing the surgeon
and assistant to access the patient between the vertically oriented rings (see
gure 4.5). This allows images to be collected while the surgery is in progress.
The 0.5T eld does not provide the resolution of more powerful diagnostic
imagers (typically 1.5T) but is described as `sucient for intraoperative
guidance' (Martin et al. (1998)). Similar split rings are available such as that
demonstrated in Germany by Schneider et al. (2005). The split coil does have
disadvantages, the gap between the coils is small and limits access to at most 2
people, may limit the positions that the patient can orientated, all the
instrumentation used must be MRI compatible. Even though the smaller imagers
yield lower resolution images they do provide real-time imaging.
Figure 4.5: Image of split coil MRI note the size of the gap between the rings (image
from Martin et al. (1998))
Intraoperative MRI systems come in a number of dierent shapes and sizes. In
Martin et al. (2000) an iMRI system is described that consists of a 1.5T high
eld unit with a operating table that can slide in and out both sides of the ring.
The theatre has an area of high-eld where only MR compatible equipment can
enter, outside this area normal equipment can be used. The ring is not split so
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imager within the high eld region using MR compatible equipment, or in a more
traditional theatre environment in the low-eld region (see gure 4.6). Imaging
typically takes 10{15 minutes and the imager provides similar capabilities, in
terms of both resolution and range of imaging, to a diagnostic imager. The
imaging performance of this system is superior to typical split ring congurations
due to the higher eld, it also allows use of normal instrumentation (although
care and correct procedures must be implemented). It does however require a
larger operating theatre than split ring iMRI congurations and has the
disadvantage of additional time required to move the patient to the imager.
These disadvantages must be weighed against the improved contrast and other
functionality of the higher power imager such as fMRI and FLAIR. These high
eld imagers do seem to be becoming more common, Nimsky et al. (2004)
demonstrates a 1.5T short bore MRI and an increase in resection of up to 39%.
Figure 4.6: An iMRI suite showing the short-bore 1.5T MRI towards the left, the
arrow indicates 4 MRI-compatible screens, the bed can slide between the MRI and a
pedestal on the right surrounded by conventional instrumentation (image from Martin
et al. (2000))
One option where a full iMRI system may be unaordable or there are other
constraints is to position the operating theatre adjacent to a full diagnostic MRI
system. This can allow the patient to be transfered to this system for imaging,
this may take up to 40 minutes but provide important information. This system
suggests that a full-time MRI system is not required but does introduce other
problems such as maintaining the sterility of this system. This system is in use
and recognises that an MRI is not required throughout the whole procedure andChapter 4 Intraoperative imaging of human brain 73
so potentially one MRI system could be shared between a number of operating
theatres.
IMRI shares the same limitations as diagnostic MRI however there are also
concerns that iMRI can increase the amount of post-operative morbidity as total
resections are pursued at the expense of functional areas. Muragaki et al. (2005)
presents a signicant correlation between the rst 46 patients operated under
iMRI and the previous 50 patients operated using traditional techniques.
Although this paper does observe a signicant increase in post-operative
morbidity the rate of permanent morbidity did not dier signicantly. This
paper also observes a signicantly reduced amount of residual tumour. Others,
for instance Schneider et al. (2005), have not reported any increase in morbidity.
4.1.2.5 Developing MR techniques
Magnetic resonance imaging techniques are still under active development. There
are two emerging techniques of particular interest; the rst is MR Spectroscopy;
the second is Diusion Weighted MRI.
Magnetic Resonance Spectroscopy exploits the fact that the resonant frequency
of a 'MR visible' nuclei (for example 13C, 23Na, 19F) is dependant on it's local
chemical environment. The change is small, of the order of 10 6, so a known
reference must be used. Because MRS is dependant on frequency shifts another
method of excitation is required to enable tomographic data collection, this can
be achieved by use of phase encoding the dimensions of interest. Specic
chemical signatures can then be extracted which can be used to assign tissue
properties or characteristic tissue types Urenjak et al. (1993). The image shown
in gure 4.7 shows on the left healthy brain tissue displaying the normal high
N-Acetyl-Aspartate peak (NAA). The right is a spectrum of brain appearing
normal on MRI (without Gadolinium contrast enhancement). This spectrum
however shows an absence of NAA indicating a loss of viable tissue and an
increase in choline indicating high cell proliferation often found in tumours Liney
(2009).
The contrast mechanism in diusion weighted MRI is based on endogenous
contrast using a technique discovered by Stejskal and Tanner (Stejskal and
Tanner (1965)). This technique applies two eld gradients with equal amplitude
and opposite polarity over a given time interval. Stationary nuclei will be equally
phased and dephased however nuclei that have moved will suer a net phasing
and therefore enable detection. By using elds of suciently high amplitude
microscopic levels of motion can be detected. Full 3D di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Figure 4.7: Example of a single voxel proton MRS in normal and malignant brain
tissue (image from Liney (2009))
can be made and require 13 scans with dierent settings. The major advantage
of this imaging technique is the ability to visualise movement due to the
preferential diusion along structures and bres such as white-matter tracts.
Figure 4.8 shows an image courtesy of Liney (2009) showing the possibilities of
diusion weighted MRI to identify white matter tracts. This technique could
reduce post-surgical neurological decit in neuronocological surgery but to date
the major clinical use is to identify areas of ischemia (lack of oxygen) due to a
stroke, diusion weighted imaging can identify this earlier than any other
diagnostic technique. However Smith et al. (2005) reports that post-operative
diusion weighted MRI should be handled with care but could be useful in long
term monitoring.
4.1.2.6 Ultrasound
Diagnostic sonography is a well established technology in certain elds, obstetric
care is the typical example particularly prenatal scans. However ultrasound can
also be used to image almost any soft-tissue in the body; cardiac, muscular,
tendons, renal and liver it even has opthalmic uses. Ultrasound has seen little
exploitation in the neurological eld mainly due to the poor signal to noise ratio
of transcranial ultrasound. There are niche applications for example neonatal
ultrasound can be key in identifying and monitoring various conditions. There is
some indication that ultrasound may be helpful in diagnosing Parkinson's disease
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Figure 4.8: Example of white-matter tracts in a normal subject imaged by diusion
weighted MRI. Image from Liney (2009)
.
Intraoperative ultrasound can be dicult to correlate with preoperative imaging
as almost all preoperative imaging is conducted with CT or MRI which have
dierent contrast mechanisms (Martin et al. (2000)). A group in Norway
(Unsgaard et al. (2002)) has demonstrated a three-dimensional ultrasound
imager with a neuronavigation system utilising pre-operative imaging although
this technique hasn't seen signicant adoption many of the problems limiting
earlier systems seem to be solved.
4.1.2.7 Electroencephalography and magnetoencephalography
Electroencephalography (EEG) was developed and used clinically in the early
part of the 20th Century. It measures the weak electrical potentials created by
neuronal activity. Averaging and statistical analysis of components of the EEG
signal have signicantly improved the signal to noise and EEG currently has a
wide range of uses. Measurements can be taken on the surface of the head, the
surface of the cortex or by use of `depth electrodes' into the sulci. The later two
are obviously limited to patients undergoing a surgical procedure but provide
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by the skull. The temporal resolution is uniformly excellent and of the order of
neuronal events (milliseconds). Intraoperative measurement of evoked potentials
is a very similar technique.
Magnetoencephalography (MEG) has been in development since the 1960s and
works by measuring the induced magnetic elds created by the weak electrical
currents created by neuronal activity. The extremely low magnitude of these
signals makes this dicult requiring supercooled devices and a shielded
environment. Unlike the electrical elds measured in EEG magnetic elds are
not distorted by the intervening matter Mazziotta (1994). MEG has exquisite
temporal resolution which is comparable to neuronal events. The spatial
resolution is continuously improving as the signicant technical challenges are
overcome.
4.1.2.8 Intra-cranial near infrared spectroscopy
In this context Intra-cranial Near Infrared Spectroscopy (INIRS) will be a term
used to describe intracranial measurement of tissue parameters by using infrared
spectroscopy, fNIRS is a functional implementation of this method. This
technique suers from three major problems;
1. Partial volume eect | due to the dierence between the volume sampled
and the volume exhibiting a change in properties (i.e. activation) INIRS
therefore underestimates the concentration changes. Correction factors can
be used to help account for this, factors of the order of 10 have been
reported Strangman et al. (2002).
2. Cross talk | the path length in tissue is wavelength dependant, if this is
not adequately determined changes in oxyhaemoglobin concentration can
mimic those of deoxyhaemoglobin. This can be reduced to a few percent
when using optimal wavelength combinations Steinbrink et al. (2005).
3. Extracellular blood volume changes | to sample the brain the scalp and
skull must be traversed hence any changes in the blood volume in these
tissues will also be detected. Using multiple detector/source pairs and
methodological techniques (i.e. avoid systemic responses to stimulation)
help reduce this eect.
Typically INIRS systems use light emitting diodes as sources, these are available
in a suciently wide range of wavelengths and powers. Laser systems have been
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demonstrates a non-contact system tested against a phantom. By using
time-gating in the hundred picosecond region this system is able to to detect
objects buried up to 20mm in a scattering medium. However this system is
currently impractical for clinical measurements, two Ti-Sapphire lasers were used
with pulses in the 15ps region with a time-resolved intensier operating with a
600ps time gate which is a physically large, complex and costly system. The
signal to noise was generally poor, spatial resolution was approximately equal to
the depth of the object. The dependence of this system on backscatter requires
the time-gating system, whereas separated source-detector systems do not collect
backscatter. Coupling into the head will be a particular problem for this system,
hair will scatter or absorb almost all of the signal and limit this technique to
hairless portions of the head.
fNIRS has struggled to consistently measure the decrease in deoxyhaemoglobin
concentrations, for example Boas et al. (2000). It has also been noted that
patients with brain disorders may have a dierent response from healthy adults
Xie et al. (2001). It has been suggested that an increase in cerebral blood ow
will not necessarily remove the deoxyhaemoglobin from the vessels or that a
sucient increase in oxygen use may compensate for the change in blood ow.
Both of these possibilities would have aects on fMRI which can only measure
activation by changes in the deoxyhaemoglobin concentration. During activation
region blood ow increases by up to 50% however the oxygen consumption
increases by no more than 5% therefore neuronal activity leads to a decrease in
the extracted fraction of oxygen. Deoxygenated haemoglobin concentrations
decrease in the cerebral vessels, including capillaries and veins, while oxygenated
blood concentrations increase Xie et al. (2001).
4.1.3 Systems and techniques in development
This section will discuss the systems and techniques in current and recent
literature.
4.1.3.1 Fluorescence
Fluorescence is an established technique in all sorts of histopathological and in
vitro biological applications. This section will focus on the in vivo applications
and it's use in oncology in which uorescence is a developing technique with
limited commercial exploitation. There are some surgical procedures that
already use uorescence techniques for example uorescence angiography NICE
(2004) and NICE (2006). Labelled antigens have been developed for certainChapter 4 Intraoperative imaging of human brain 78
cancers (prostate cancer and adenocarcinoma for example) and for specic
detection of many proteins (see section 3 for another example).
Fluorescence occurs when a molecule absorbs a photon of high energy light
(often ultraviolet) promoting the molecule into a higher energy state which then
relaxes into a lower energy state emitting a photon of a lower energy (longer
wavelength). The dierence in energy of the high and low energy states is taken
up by other changes of state within the molecule, for example vibrational or
electronic states. There are two types of uorophores in use, extrinsic (or
exogenous) uorophores and intrinsic (endogenous or autouorescence). The use
of extrinsic uorophores requires the introduction of labelled drugs, proteins,
antibodies or other entity into the patient or tissue sample. Intrinsic uorescent
systems exploit the natural uorescence of the material or part of the material
under investigation. Systems are in development that exploit both of these types
of uorophores, some only one, others integrate this information with other
sources to enable diagnosis.
Xillix Technologies Corp (2007) have developed a number of systems based on
their `LIFE' core, where LIFE stands for Light Induced Fluorescence Endoscopy.
Their LIFE-Lung system has completed it's clinical trials (in the US) and has
been released commercially. They also have a Gastro-Intestinal (GI) and an Ear
Nose and Throat system in development. These systems are all used in addition
to white-light endoscopy and consist of an intensied CCD with red and green
lters and a blue light source. They have shown that changes in the red/green
ratio are related to tissue abnormality. The endoscopes used for these systems
are bre-bundles and so are considerably larger than top of the range endoscopes
which typically have an imager on the patient end of the endoscope and only
electrical signals pass down the body of the endoscope. The results have been
published by the US Food and Drug Administration (the regulating body for
medical instruments in the US) and showed an increase in per patient sensitivity
from 0.37 to 0.75 (sensitivity is the probability of positively identifying tissue)
but a decrease of specicity from 0.78 to 0.42 (specicity is the probability of a
negative test of normal tissue) meaning a increase in overall detection but also
an increase in false positives. A number of papers have been written
documenting the testing these devices (including Kusunoki et al. (2000); Sokolov
et al. (2002)) although in 2007 the LIFE core was sold on to Novadaq (Novadaq
(2009)) after Xillix entered receivership. Novadaq has been exploiting
uorescence for the assessment of coronary angiography since 2002 Canada
(2002) and markets the LIFE-lung system as Pinpoint.
Other groups are also targeting lung tissue, Zeng et al. (2004) have used a bre
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optical bre have coupled a spectrometer to the centre of the image. They
demonstrate the use of the camera for white light endoscopy and uorescence
imaging and the spectrometer for point measurements of tissue. This system is
using a bre bundle endoscope these are physically larger and have a limited
range of movement when compared with more modern endoscopes which place a
camera at the end of the endoscope. A number of groups have investigated
inserting a bre down the instrument channel of a standard endoscope for point
measurement. This is likely to result in a much more exible and clinically useful
device than Zeng et al. suggest.
Epithelial tissues (surface tissues) are an obvious target for all oncological
instruments due to the ease of access and the majority of tumours start in these
tissues. Skin is the most accessible of these and a device that can detect skin
cancer under the name of Dermlite (2009) is already on the market based on
polarised illumination. In other areas Tumlinson et al. (2003) shows the
development of a endoscopic system for the colon, however no human tests have
been completed to date. This probe | unlike the LIFE system | is small
enough to go down the instrumentation channel of most endoscopes (typically
greater than 2.8mm diameter for colonoscopy and GI, smaller for the lungs down
to about 2mm diameter, source Olympus KeyMed Group (2009)). A complete
endoscopic system with integrated white light and uorescence imaging has been
demonstrated by Wang et al. (1999).
Fluorescence laser scanning confocal microscopy has been demonstrated (Astner
et al. (2008) building on work in Meyer et al. (2006)) to be useful for in vivo
histological diagnosis of actinic keratosis (a premalignant skin condition) and
bassal cell carcinoma (the most common skin cancer). This investigation uses an
exogenous uorophore, in this case sodium uorescein which is an organic dye
and used for various purposes in medicine but with repeated exposure will illicit
an immune response. The use of this uorophore which has an excitation maxima
at 450nm (longer than most avins and porphyrins) enables uorescence confocal
microscopy by providing better contrast than the endogenous uorophores.
Gastro-intestinal epithelial tissues are another target for uorescence
investigation, Chwirot et al. (1997) demonstrates ex vivo that there are
diagnostic dierences between normal, malignant and pre-malignant tissue
samples. Renal tissue has also been investigated; Parekh et al. (2005) uses both
uorescence and diuse reectance to distinguish between normal and tumorous
renal tissue with a high sensitivity and selectivity (both >90%).
Cervical and ovarian tissues are subject to a lot of interest as ovarian cancer
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6% of female cancer deaths (source Cancer Research UK (2009)). Brewer et al.
(2001) shows that uorescence may have the ability to dierentiate between
malignant and normal excised tissues of the ovary using an exogenous uorescent
agent. Later work by the same group (Brewer et al. (2004)) showed that there
were diagnostic dierences dependant upon excitation frequency. They presented
a confocal uorescence imaging device with 270 and 340nm excitation which can
be inserted down the instrumentation channel of a normal endoscope. This group
is continuing with this programme and in Kanter et al. (2006) published results
using the same technique on a rat model of ovarian cancer showing statistically
signicant (p <0.05) changes in the uorescence signal for neoplastic tissue.
A uorescence and white light colposcope (a device to aid the examination of
vaginal and cervical epithelia) for detecting cervical cancer has been
demonstrated in Benavides et al. (2003). This device uses a normal 8bit colour
CCD camera and either white light or specic excitation frequencies for the
uorescence. This device does not require measurements to be taken in the dark
nor does it require a signicant deviation from normal practice and does not
require the administration of exogenous uorophores. The sensitivity and
specicity are reasonably high (greater than 0.6). This device appears to be an
excellent example of this technique in operation and is highly exploitable. The
aim of this device is to assist the physician and with further development may
help reduce the requirement for biopsy. Brookner et al. (2003) looks at
improving the diagnostic accuracy of uorescence diagnosis of cervical tissue by
analysing other biological factors eecting the uorescence emission of this
tissue. A device exploiting the dierences in uorescence and diuse reectance
spectra of normal and neoplastic cervical tissue has been presented in
Schomacker et al. (2006). The device demonstrated here is near clinical use and
can identify grades 2 and 3 dysplasia.
Fluorescence techniques have also been applied in neurosurgery. Bottiroli et al.
(1998) uses intrinsic uorescence to attempt to identify tumour margins
intraoperatively with a point measurement technique, this paper does identify a
need for a solution to this problem. Croce et al. (2003) present dierences in
both the spectral shape and signal amplitude between neoplastic and normal
(both white and grey) brain tissue. Croce present point measurement or
discrimination techniques and nds signicant dierences between normal,
marginal and tumour tissue in a small study of high grade tumours. Toms et al.
(2005) presents a point measurement dual modality uorescence and diuse
reectance spectroscopic system which has sensitivity and specicity of 0.94 and
0.93. This device must be held in contact with the patient, each sample taking
about 30seconds to complete and must be conducted in complete darkness. YangChapter 4 Intraoperative imaging of human brain 81
et al. (2003) takes this a step further developing an imaging system comparing
ve dierent uorescent bands to identify malignant tissue and ITM during brain
surgery. Tests were done with only six patients and an extrinsic uorescent
agent, however some correlation was found, the system was also able to
determine absolute uorescence levels with a 10:1 signal-to-background ratio.
With the exception of Bottiroli, all of these techniques use extrinsic contrast
enhancing agents.
Butte et al. (2005) show with high sensitivity and specicity (>0.89 and 1
respectively) a method of diagnosing meningioma by uorescence. Meningioma
are typically slow growing, low grade, fairly benign tumours of the meninges
which is the system of membranes which surrounds and protects the brain.
Surgery, in contrast to most other primary brain tumours, is often a cure for
meningioma. Therefore although this research is interesting and meningioma is
one of the most common primary brain tumours it is not particularly useful in a
diagnostic setting as this tumour is currently being successfully treated.
Fluorescence when combined with diuse reectance has shown power to
discriminate between normal and tumorous tissue by Lin et al. (2000).
Fluorescence intensity is not the only factor which could be diagnostically useful.
Marcu et al. (2004) demonstrated that uorescence lifetime also varied with
disease state in ex vivo human brain tissue, and might therefore be useful for
diagnosis but requires more sophisticated measurement equipment. Marcu did
not however specically consider tumour margins.
5ALA induced protoporphyrin uorescence guided surgery in a high grade
tumour rabbit model has been demonstrated to greater resection than white
light alone, Bogaards et al. (2004a). Although there are questions regarding the
validity of tumour models in small mammals they do allow histological analysis
of the residual tumour to be conducted. Bogaards observes a signicant increase
in extent of resection however this conclusion would be more relevant if
conducted in a human cohort which is possible for example by intraoperative
MRI. Bogaards has extended the use of 5ALA in relation to photodynamic
therapy where protoporphyrin can be used as a light induced toxic element
Bogaards et al. (2004b).
Fluorescence guided resection of high grade glioma is becoming an established
technology principally developed by Walter Stummer, Stummer et al. (2000,
2006, 2008, 1998) although others have also published in this eld including
(Sugawara et al. (2003)). This technique uses 5ALA induced porphyrin as a
uorophore and can identify high grade glioma tissue, this has been extensively
reviewed above, in section 4.1.1.3. In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be non-uorescing (Utsuki et al. (2006)) and therefore this technique is likely to
leave residual tumour.
There are some papers which give the idea that uorescence has the ability to
image tumours through large amounts of scattering tissue. While it is possible
for uorescence to identify specic molecular markers present in for example
DNA, it is not practical to do this through more than a few mm of tissue.
Ntziachristos et al. (2002) uses a number of animal models and specic
uorescent agents to image tumours using systems that look at the whole
animal. All the models used are mice where the tumour site is not far from the
surface and acquisition times of minutes are used with bright illumination.
There are still a number of problems with uorescence spectroscopy in vivo that
limit application. The rst is detection of the small uorescence signal,
approaches to this are two fold; increase the excitation power and use intensied
imagers (often ICCDs). Both of these approaches are limited by the background
autouorescence of tissue under investigation. The second problem is selection of
the uorophores specic to the application and the greater challenge of
understanding the biochemical basis of uorescence spectroscopy and the other
factors that inuence the uorescence signal. Despite signicant work in this
eld there is still no mathematical model of how uorophores are modulated by
the disease process.
Mahmood et al. (1996) observes that nonspecic exogenous uorescent agents
often accentuate non-specic dierences such as permeablity or perfusion. This
results in relatively low target to background ratios (usually <4:1). Mahmood
goes on to develop near-infrared uorescence probes which are only uorescent
after interaction with specic enzymes.
4.1.3.2 Spectroscopic techniques
In 2003 the opportunities and limitations of optical intrinsic signal imaging
relating to function were eloquently established by Pouratian et al. (2003b).
Pouratian's comparison of the temporal and spatial resolution of various
techniques is shown in 4.4. This technique has helped dene the relationship
between the electrophysiology and perfusion related signals and dene the
plasticity of sensory and language cortices. The limitations listed include image
registration issues (minimisation of registration during collection and post
registration) correlation between diering modalities and sensitivity. Although
only a year earlier Pouratian recognises that this technique was solely in the
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will be useful in the near future with improving CCDs and image processing
techniques.
Infrared, Raman and Near IR Spectroscopy are used extensively in the physics
and chemistry elds to identify what materials are present in samples. Chapter 3
has a more detailed example of a specic use of this IR spectroscopy. These
technique are of great potential use in the medical eld and spectra of dierent
tissue types have been reported. For example Torricelli et al. (2001) reports the
NIR spectrum of skin tissue samples from various parts of the body.
The specic details of spectral dierences in the long wave region in specic
cancers are reported in a number of places in the literature. Using the Colon as
investigated by Jianqiu et al. (2001) in the 1300|900cm 1 waveband using
exfoliated cells, the following dierences were found;
 Changes in the Phosphodiester group is probably associated with changes
in the phosphate backbone of nucleic acids and destruction of hydrogen
bonds. The peak of the symmetric stretch (VsPO
 
2 ) normally located
1082cm 1 shifted 3cm 1 to high frequency and the asymmetric stretch
(VasPO
 
2 ), normally 1241cm 1, was shifted by 2cm 1 to low frequency.
This brings the peaks of the VsPO
 
2 and VasPO
 
2 closer together in
cancerous cells compared to normal tissue.
 Changes were identied in the region 1150{1180cm 1, particularly the ratio
of the peaks at 1174cm 1 and 1155cm 1. This change can be attributed to
a change in the number of C{O bonds stretching vibrations and a change in
the amount of hydrogen bonding in the C{OH groups.
 Descreases in the C{OH bond of glycogen indicating lower levels in
cancerous cells (although not statistically signicant). Observed by a
weaker glycogen band at 1025cm 1.
 Additional band peaks. An additional peak presented at 970cm 1 in the
cancerous tissue.
The same conclusions are found elsewhere and in dierent tissues for example
Salman et al. (2001) and Rigas et al. (1990) both in the colon, Wood et al.
(1995) gives the glycogen more weight and also uses the C|O whereas
Mordechai et al. (2004) uses the glucose/phosphate and a RNA/DNA ratios
(1121/1020cm 1) for their respective diagnostic tools in cervical cancer. Yano
et al. (2000) also gives glycogen more weight and introduces cholesterol for
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grouping and the asCH3 and sC(CH3)2 bending vibration in gastric tissue.
Eckel et al. (2001) in addition to some of the previous metrics observes a
dierence in the secondary structure of proteins in breast tissue using the Amide
I band. The spectra of brain tissue has been reported in Krat et al. (2004,
2006) and Steiner et al. (2003) both of whom nd diagnostic dierences. FTIR
techniques have successfully distinguished between normal and malignant gastric,
colon, cervical, breast, lung and brain tissues (amongst others) using these
metrics. Mordechai suggests that not all of these measures are found in all tissue
but that some metrics may be more generic than others for example the ratio of
nucleic acids calculated using wavenumbers 1121cm 1 and 1020cm 1.
Infrared spectra have been used for grading of tumour tissue; this is a useful
application but does have it's limitations. Andrus and Strickland (1997) have
shown that the DNA/RNA ratio (1121/1020 cm 1) and the presence of a
distinct peak at 1121cm 1 is correlated with the grade of lymphoid tumours.
Morris et al. (1995) have shown that there is a progression of spectral features
with grade in cervical specimens. Jackson et al. (1999) have shown through
multiple regression analysis changes in spectra correlated with grade in breast
tissue. These methods are not however perfect, the accuracy of the reported
grading is at best 90% and shows evidence of classifying high grade tissue as low
or non-malignant tissue, therefore it should not currently be used in isolation.
Near Infrared spectroscopy is in some ways more interesting as the technology
becomes cheaper and traditional materials can be used for the optics (`normal'
glass is opaque on the low wavenumber side of 3000cm 1). The NIR
spectroscopic characteristics of human brain tissue have been investigated by a
group in Vanderbilt University. Their work is of particular interest to this
project as they are operating using similar methodology. Using a combination of
uorescence and diuse reectance on fresh frozen samples with blood removed
Lin et al. (2000) achieved a sensitivity and specicity of .96 and .93 respectively
on a total number of 127 sites from 20 patients (in 4 of which the primary cancer
was located elsewhere in the body so not relevant as these are easy to distinguish
from brain tissue). Removal of the blood means that this technique requires some
development before it is becomes a useful technique. Some of this work was done
in Lin et al. (2001a) which reduces the eect of supercial blood contamination
for the combination of uorescence and diuse reectance. The trial presented in
Lin et al. (2001b) investigated another 120 sites in 34 patients (again, 7 of which
did not have primary brain cancer) and concluded that using a combination of
diuse reectance and autouorescence it is possible to distinguish normal tissue
from inltrating tumour margins. This work was continued in a larger study in
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for distinguishing solid tumour from normal tissue and as high as .94 and .93 for
normal tissue and ITM. There is report that there has been a follow-up pilot
study Toms et al. (in preparation) but is yet to be published. The key problem
and limitation in all the work from this group is the point measurement nature
of their measurement technique. This would imply that the surgeon either has to
probe every cut surface (in a number of places) or have an idea about where the
tumour has not been completely resected. An imaging technique would remove
this limitation but would be more dicult to implement.
Visible and very near IR spectroscopy (including diuse reectance spectroscopy)
has been used. Cervical tissue has been investigated by Collier et al. (2003) who
found that there is a dierence in diuse reectance between normal,
precancerous and malignant tissues. Ali et al. (2004) observes diagnostically
signicant dierences in the water content of normal and malignant prostate
tissue. Ali also observes a dierence in the polarisation of light reected from
these tissues, this polarisation signal is independent of the absorption of the
tissue and relates more to the physical construction of this tissue. The malignant
tissue was less ordered than the normal and was identied by a drop in the
polarisation signal. This may also be present in the brain where the tissue is
highly structured, however no investigations into this have been published.
Raman spectroscopy is a complimentary technique to FTIR. In Infrared
spectroscopy a sample is illuminated with infrared light, dierent bonds absorb
this light at dierent frequencies and, some of, the remaining light is collected to
form a spectrum. In Raman spectroscopy the sample is illuminated with a laser
so the light is monochromatic. This brings the energy levels in the molecules to a
virtual high energy state from which the molecules relax back down to
vibrational energy level with the emission of a photon (see Figure 4.9). Normally
the photon has a lower frequency than the laser (Stokes Raman scattering)
sometimes it is higher (Anti-stokes Raman scattering) but in practice only
Stokes scattering is normally measured. The dierence between the frequency of
the laser and the scattered photon is called the Raman shift and it is this that
corresponds to structural features of the molecule. Even though these techniques
both involve molecular vibrations they do not provide the same information. IR
spectroscopy probes vibrations during which an electrical dipole moment
changes, Raman spectroscopy detects those where the electrical polarisability
changes. Taking CO2 as an example the asymmetric stretch is IR active as there
is a change in dipole (and little change in the polarisability) and the symmetric
stretch is Raman active as there is a change is polarisability (and no change in
the dipole). Although in larger molecules the vast majority of bonds are both IR
and Raman active although the intensity can vary greatly.Chapter 4 Intraoperative imaging of human brain 86
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Figure 4.9: A diagram showing Rayleigh, Stokes and Anti-Stokes scattering
Raman spectroscopy has it's advantages, for microspectroscopy the achievable
spot size is signicantly smaller than FTIR. Water which dominates the IR
spectrum shows a very weak signal in Raman spectroscopy and so Raman can
penetrate some tissues deeper than IR spectroscopy. However Raman
spectroscopy also has it's limitations, and they are severe, about only 1 in
10,000,000 photons will produce a Raman shift whereas all the other photons are
either absorbed, transmitted or reected. This means that much more
illumination or time are required. One key factor that inuences the Raman
signal is the choice of excitation frequency, there has been some work done in this
area including by Utzinger et al. (2001); Huang et al. (2003); Min et al. (2004).
A short summary of the characteristics of each technique are given in table 4.6.
IR spectroscopy Raman spectroscopy
Spatial resolution >10m >1m
Signal-to-noise High Low
Eect of Fluorescence None High
Sensitivity to;
Water Strong Weak
Amides Strong Medium/Weak
Phosphates Strong Medium
C{C, C=O, CO Medium/Weak Strong
O{H Strong Weak
Table 4.6: General features of Raman Spectroscopy and Infrared Spectroscopy
Raman spectroscopy has been used in neurology to identify glioblastoma and
necrotic tissue, the technique presented by Koljenovic et al. (2002) shows
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can be distinguished. Identifying necrotic tissue is of particular interest for
follow-up surgery after radiotherapy. Koljenovic used a 100mW laser for
excitation and took 10seconds to collect each pixel of the maps (the maps
presented include between 1000|5000 pixels equating to between 3 and 15 hours
for collection). More work has been done in the area of lung cancers, Huang et al.
(2003); Kaminaka et al. (2002); Min et al. (2004) all present work on the Raman
spectrum of normal and malignant lung tissue. The conclusion of these papers is
that it is possible to distinguish between normal and malignant lung tissue using
a point measurement endoscopic technique. Utzinger et al. (2001) presents work
on the Raman spectroscopy of cervical pre-cancer cells showing that there are
signicant dierences in the spectra and suggests that it may be possible to use
this method for grading. Min et al. (2004) reported the NIR Raman spectra of
normal and cancerous fresh lung tissue concluding that it is possible to
discriminate these tissues with 1060nm NIR multi channel Raman spectroscopy.
These are all point measurement techniques and so are limited in application.
4.1.3.3 Optical mammography
Due to the number of publications in this area it deserves some consideration.
This area has seen signicant investment, breast cancer is the highest incidence
of all cancer in the UK, 16% of all cancer cases are breast cancer (Cancer
Research UK (2009)). X-ray mammography is currently used as a screening test
and can help with diagnostics. The case against X-ray mammography is that it
does expose the individual to ionising radiation and that it is not as eective at
testing the denser breast tissue of the under 50s. However the radiation dose is
typically 0.7mSv (or 70mrem) which is less than the average person would pick
up in 3 months from background radiation and secondly the incidence and
mortality of people under 50 is signicantly lower than that of the over 50s
(although the rate drops even more under 40).
There are papers that have investigated the optical properties of breast tissue;
Cerussi et al. (2000); Peters et al. (1990); Grosenick et al. (2005) to name three.
These broadly agree on the magnitude of the absorbance and scattering
coecients, taking as an example Cerussi et al. quote the absorption coecient
(a) as .05mm 1 and the scattering coecient (s) as 1mm 1 at about 700nm.
This leads to the question of the probability of a single photon a second being
transmitted without scattering (T) through length (l) of breast tissue is as
follows;
T = e
 al  e
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Then the probability of a single photon getting through 5cm of tissue is of the
order of 10 22 which means that to stand an even chance of having a single
undiverted photon a second through the tissue it would need to be irradiated
with about 100W. Which is clearly impractical and would certainly cause
thermal damage.
The example above is emphasising the case against and it is not really as bad as
this case would suggest. Techniques such as time gating can select photons which
have travelled the shortest distance through the tissue. However the
break-through was the development of Diuse Optical Tomography by a group in
University College London. Diuse propagation through bulk tissue is
complicated, the light will spread out through the tissue in a highly non-linear
way depending on the optical properties of the tissue. By using multiple sources
and detectors it is possible to solve the `inverse problem' and calculate the
optical properties of the tissue (Le et al. (2008) is a recent review). However the
spatial resolution of this technique is still not suciently good for an oncological
diagnostic technique and is in the authors opinion unlikely to be in the
foreseeable future. van der Mark et al. (2008) presented an optical tomographic
technique which used spectroscopic and uorescence and was supported by
Philips, technically the system was very impressive however the inability to
achieve the required spatial resolution led to the programs discontinuation.
Diuse Optical Tomography does have applications that are potentially very
useful and dicult to achieve in other ways. These applications do not have such
stringent spatial resolution requirements. One example is monitoring cerebral
perfusion of neonates which could provide non-invasive bedside monitoring for a
number of life-threatening complications of premature babies.
4.2 Systems developed
The problem that this project has attempted to address can be summarised as
follows;
To develop an imaging system that;
1. Is non-contact
2. Provides real-time imaging of the whole eld at a resolution equal to or
better than the precision of the surgeon's cut
3. Will automatically identify the required tissue/features with minimal
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4. Will have minimal impact on the surgical environment
5. Does not have prohibitive cost or infrastructure requirements
Initially this project only set out to identify tumour and tumour margins however
it became apparent that it would also be possible to investigate functional
activation. The key to this work was a collaboration between the Prof. William
Gray and Diederik Bulters both of the Southampton University Hospitals NHS
trust and the author and his supervisor Prof. Harvey Rutt both of the University
of Southampton Optoelectronics Reasearch Centre. All the collecting of images
was done with informed consent and under appropriate ethical approval.
This work developed two separate system, rst one which was designed to be
sensitive to tumour and then one sensitive to functional activation. These two
systems will be presented separately.
4.2.1 Development strategy - tumour systems
To obtain the required spatial (dened by Prof Gray as 0.25mm) and temporal
resolution (towards real-time) the technique must be an optical system. The
visible and near infrared has been shown to contain diagnostically relevant
dierences between normal, malignant and marginal tissue shown in gure 4.10.
This region is also the most cost-eective spectral range as silicon imagers can be
used and no exotic optical materials are required.
There are other features which may make it possible to detect malignant tissue
in vivo. These tissues have a higher metabolic rate than surrounding normal
tissue and therefore use more oxygen and have a higher vascularisation. This
vascularisation is disordered and often leads to hypoxia and can result in necrosis
of the centre in high grade tumours. This hypoxia may be detectable (Dachs and
Tozer (2000)) as the spectral characteristics of haemoglobin are well known and
shown in gure 4.11. Tumour hypoxia is a secondary eect and does not directly
identify the tumour. This technique is very similar to the contrast mechanism in
fMRI and this led to the work presented later in 4.3.2 investigating functional
activation.
One other feature which may be diagnostically useful is a change in polarisation.
In general nerve tissue is highly ordered, this order combined with structures
which are long and thin indicate that there may be some anisotropic behaviour
relative to polarisation. This is speculative, there is some evidence from other
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Figure 4.10: Diuse reectance spectra of dierent brain tissues collected by bre-
coupled spectrometer intraoperatively reproduced from Toms et al. (2005)
shown that the polarisation signal is independent from any spectral
characteristics.
Visible light has a very shallow penetration depth in tissue which is primarily
due to the high scattering of tissue which dominates absorption. Given that
scattering is much larger than absorption (s >> a) the reduced scattering
coecient (0
s) is normally used which allows for anisotropic scattering.
Coecients of absorption and scattering can be found in the literature (Gebhart
et al. (2005) amongst others) where a typical value for the reduced scattering
coecient of white matter at 700nm is found to be 4mm 1. While this is related
to the wavelength this typical value is a reasonable estimate across the
wavelength range and diering tissues. The inverse of this factor gives the
`reduced mean free path' and is a measure of the depth of penetration of this
wavelength of light. Therefore at 700nm the systems developed will only be
sensitive to the rst 250m of tissue, or about 6 cells. Moving towards longer
wavelengths will increase this, also the use of polarised illumination and aChapter 4 Intraoperative imaging of human brain 91
Figure 4.11: The visible and near infrared spectra of haemoglobin taken from Prahl
(2001)
polarised lter in the camera will preferentially select photons which have been
multiply scattered, therefore increasing the average depth.
The requirement to have minimal impact on the operating theatre environment
means that the camera system should operate under normal theatre illumination,
should be as automatic as practical should take a minimum amount of time to
set-up and operate. To minimise registration issues resulting from the camera
moving it requires a stable platform to operate from. This platform should have
a minimal impact on the theatre and provide sucient range of movement for
the camera.
The signal level of the diusely reected signal is small, variously reported as
approximately 1 in 1000. This requires a imaging device which has sucient
signal to noise.
There are two types of visible/NIR imagers in widespread use, these are the
Charge Coupled Device (CCD) and Complimentary Metal Oxide Semiconductor
imagers (CMOS - this name actually refers to a device fabrication technology
and not specically an imaging device however it is common usage and is
unambiguously used in this report to refer to an imaging device). Visible/NIR
CCD and CMOS imagers both share the same basic operation, they capture
photons of light converting these photons to a charge; this charge is then
measured and assigned a digital value. They are both band-gap devices made
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photons with less energy will not be able to excite an electron across this gap
and therefore will not be absorbed or detected. For silicon this cut o is around
1.1m.
There are some key dierences between the two types of imager which aect the
performance. CCDs are constructed with only a photodiode making up each
pixel, the electrons produced by absorbed photons (or the dark current
associated with the photodiode | a noise source) are collected in potential wells.
These potential wells are then read out one row at a time into a shift register
where each well is then transfered out of the sensor into a single charge-to-voltage
converter. CMOS imagers have what are called 'Active Pixels', in each pixel in
addition to a photodiode there is clear and readout circuitry typically consisting
of 3 transistors. The charge-to-voltage conversion occurs in each pixel.
Feature CMOS CCD
Responsivity
X
More on chip gain gives CMOS the marginal lead
Noise
X
Less on chip circuitry and common charge-to-voltage circuitry give
CCDs far noise performance
Uniformity
X
The CMOS onboard ampliers improve sensitivity but greatly
increase non-uniformity
Dynamic range
X
Far superior in CCDs due to lower noise
Global shutter
X
Shuttering is superior in CCDs than CMOS while maintaining pixel
size. The most sensitive imagers use external shutters
Windowing
X
Random access allows dynamic changing of window parameters
Speed (frame-rate)
X
More on chip circuitry allow shorter propagation delays and faster
readout
Power consumption
X
CCDs consume several times more power than CMOS
Cost
X
While not achieving the very low costs promised by using standard
CMOS production facilities CMOS still has the marginal edge
Table 4.7: A comparison of the features of CCD and CMOS imagers
Some of the features of CMOS and CCD imagers are compared in table 4.7. The
key parameters for this application are the noise and dynamic range which are
closely related and are determined by the physical parameters of the imager
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current and read-out noise; all of these factors are better in CCDs than CMOS
imagers. Dynamic range is dened as the ratio between the smallest and the
largest possible values. CMOS imagers have the advantage in speed and power
consumption, where the additional on-chip circuitry makes signicant dierences.
CMOS sensors typically use a rolling shutter; the exposure time is dened as the
time between the clearing and the readout of each row and the rows are cleared
in sequence. This means that the rst row is exposed before the last row, a
global shutter exposes all the rows at the same time. The problem with a rolling
shutter occurs where there are changing features in the scene. At their
conception CMOS imagers were expected to be signicantly cheaper than CCD
imagers due to the similarity of their manufacture with volume products such as
RAM, however this has not become reality and the manufacture of these devices
require short production runs with dedicated equipment. For these reasons CCD
imagers are used throughout the camera systems in this project, specic
selection of a given imager will be detailed where appropriate.
4.2.2 Tumour camera system 1
A prototype imaging system has been developed to investigate the spectral
signatures intraoperatively. Our medical partners have applied for and the
project has been awarded ethical approval a process which took a considerable
amount of time (almost 12months) and eort. The table given in 4.8 gives
details of the specication of the components of this system. To avoid confusion
the terms `Apogee camera' will refer to the imaging camera, `spectral camera'
will refer to the Specim spectral camera and `camera system' will refer to the
whole prototype.
The Apogee CCD camera is designed specically for astronomy and so has
particularly low dark noise (assisted by the Peltier cooler) and
readout/digitisation noise. The full well size is up to 500,000 electrons so the
dynamic range is limited by noise at 14 bits or 1:16384. As the digitisation level
is greater than this level the achievable dynamic range can be increased by
averaging a series of images. These parameters are constantly improving and
now a similar priced camera can deliver 2-3 times better noise performance.
The Spectral camera consists of a grating and an imaging device. The grating
separates the spectral components of a line across the scene onto the imager.
This camera was purchased as a single device specied to provide the spatial and
spectral resolution given in table 4.8 however the device did not perform as
specied. This camera collects the light from a small area of the scene separates
that light spectrally onto a imager, naturally the amount of light falling on eachChapter 4 Intraoperative imaging of human brain 94
Imaging Camera
Model Apogee U260 camera
Sensor Kodak KAF-0261E CCD
Sensor format 1inch
Cooling 3 stage peltier cooled -40C
Resolution 512x512pixels
Pixel Dimensions 20x20m
Digitisation range 16 bits (65536 levels)
Lens focal length 70mm
Lens minimum working distance 50cm from front of system
Dark noise 1e /pixel/sec
Readout noise 15e 
Spectral Camera
Model Specim V10E Spectral Camera
Sensor CMOS
Resolution 1280(Spatial) x 1024(spectral)
Dynamic Range 12 bits (4096 levels)
Wavelength Range 400-1000nm
Spectral Resolution 2.8nm
Mounting
Tripod Vinten 3796-3 Aluminium tripod and dolly
Max Height 200cm
Head Vinten Vision 8
Max Weight 25Kg
Table 4.8: Specication of the rst prototype tumour imaging camera
pixel is small. Therefore the integration times for this device are large | seconds
or even higher. One would expect therefore that the imager would be specied
for a low dark current suitable for such low light imaging | this however was
not the case and the images from this device were too poor to be of use even
with the bright theatre illumination. The spectral camera has subsequently been
used by Jack O'Sullivan tted with a more appropriate CCD imager from the
Prosilica range.
The prototype camera system was designed to ensure that both cameras had a
co-axial view by the use of a ipping mirror, the lters and polarisers were
mounted in separate lter wheels in front of the imaging camera and polarisers
were mounted in front of the spectral camera. All of the lter wheels were
motorised and the electronics would also control the mirror and a pair of class I
lasers to assist in alignment. These electronics had a software interface into the
software running on the controlling computer.
Software interfacing to both cameras and the control electronics was written to
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acquisition time was set at ve minutes and included moving, aligning and
focussing the camera and collecting a complete set of images. The software
includes a user interface displaying the captured image to allow focusing, it
auto-exposes the camera (algorithm based on Farrell (2004)) for each lter using
previous values and records each image with the appropriate information about
the camera status.
Although this camera did produce interesting results which have not been
reported elsewhere it did have some shortcomings;
 The Apogee camera although providing excellent noise performance and
dynamic range was slow to readout providing a maximum frame-rate of
approximately 2 fps. When one considers the requirement to auto-expose
each image and time to change lters the frame-rate decreases further to as
low as 0.3 fps.
 The Apogee camera is a large format sensor requiring large lenses, large
lter diameters and large lter wheels.
 Both the Apogee and the spectral camera are physically quite large devices
(the Apogee 150x150x62.5mm and the spectral camera 60x60x235mm) and
when combined with the lter wheels and associated electronics result in a
large camera system.
 The tripod posed problems, although relatively easy to move around it was
large and this restricted the angle the camera can achieve to the patient
limiting imaging options.
 This camera system did not integrate well with the sterile drapes used in
theatre as this was not considered a priority in initial discussions. It was
therefore limited in how close to the patient it could approach.
4.2.3 Tumour camera system 2
The second camera was designed to overcome many of the limitations of the rst
camera. The physical size of the rst camera system was the greatest limitation
and associated with that was the inability of that camera to collect images
looking directly down, which was a requirement developed through the use of the
rst camera. Therefore the second camera system was based around a much
smaller imager described in table 4.9.
Due to the smaller format of the imager (the format is associated with the
dimensions of the imager and is given as the diameter of the equivalent vidiconChapter 4 Intraoperative imaging of human brain 96
Camera
Model Prosilica GC1290
Sensor Sony ICX440 ExView CCD
Sensor format 1/3 inch
Resolution 1280x960pixels
Pixel Dimensions 3.75x3.75m
Maximum frame-rate (full frame) 32 fps
Physical dimensions 46x33x60mm
Lens focal length 15mm
Lens minimum working distance 12cm
Table 4.9: Specication of the rst prototype tumour imaging camera
tube | a type of cathode ray tube used as an imaging device in video cameras
until the 1980s) which relates to area where the image is formed; the lens
required for this camera is physically much smaller (25mm diameter in contrast
to the 60mm diameter of the Apogee). This means smaller lters can be used,
smaller lter wheels are easier to move meaning smaller electronics. The
complete camera system is now only 200x100x100mm. The requirement for
vertical imaging has been met by using an old microscope base with the camera
mounted on an adjustable arm. Photographs of the camera and microscope base
can be found in gure 4.12.
The proximity electronics for this camera are necessarily more complicated than
the rst camera. As space was at a premium, smaller geared motors were used in
place of the larger stepper motors that were used in the rst system. This means
that the lter-wheels required indexing, and the maintenance of the state of
these wheels was o-loaded to the camera. A further requirement to
mechanically adjust the focus was introduced due to the draping requirements of
working in an operating theatre. An AVR microprocessor was used for the
control the hardware and interface to the image acquisition software.
The speed issue was also addressed in this second camera system. Using the
microscope base signicantly reduces the amount of setup time required. The
full-frame readout speed of the prosilica camera is 32 fps (frames per second)
which can be increased by binning the image however this reduces resolution.
The practical frame-rate was limited by the data acquisition system to a
continuous 12 fps or a burst of approximately 200 frames at full speed. Smaller
lter-wheels allow the time to change lters to be reduced to around 200ms.
Overall the frame-rate to collect a set of images is around 1 fps. This camera has
also been designed with the requirements for draping and so is easy to drape
with standard equipment used in theatre.Chapter 4 Intraoperative imaging of human brain 97
(a) Front view without enclosure (b) Rear view without enclosure
(c) Front view with enclosure (d) Microscope base
Figure 4.12: Photographs showing dierent views of the camera system and the
microscope base (before removal of microscope)
4.2.4 BOLD imaging system
The early results of the rst tumour camera raised the possibility of optically
identifying functional activation of tissue intraoperatively. FMRI already
exploits changes in the oxygenated/deoxygenated haemoglobin ratio to infer
function as described in section 4.1.1.6. While fMRI uses a change in the
magnetic properties to assess the concentration of deoxygenated haemoglobin
there is also a change in the optical properties. A number of people have
investigated this eect but despite over 15 years since Haglund demonstrated
intraoperative imaging of activity in the human brain (Haglund et al. (1992))
there is still no clinical use of this technology. This project aims to categorically
demonstrate this technology working alongside the current gold standard for
intraoperative functional delineation.
The visible and NIR spectra of haemoglobin changes dependant on it's
oxygenation state as shown in gure 4.11. These data can be presented to
highlight the contribution of each oxygenation state to the absolute absorptionChapter 4 Intraoperative imaging of human brain 98
Figure 4.13: Visible and NIR spectra of total absorption of haemoglobin (left axis)
and percentage contribution to this absorption from deoxyhaemoglobin, vertical line
denotes 610nm (data from Prahl (2001))
as shown in gure 4.13. As can be seen there is a region between 600{700nm
where deoxygenated haemoglobin dominates the absorption.
There is only a requirement to measure one wavelength; functional activation
will be detected as a change of the signal over time. Otherwise the requirements
are similar to that of the tumour cameras; high dynamic range, low noise etc.
Framerate is more important as temporal resolution better than twice the heart
rate removes the requirement to synchronise image acquisition with the heart
rate. The single wavelength means that there are no moving parts and hence a
much simpler camera. This camera uses an adapter to a standard Zeiss
neurosurgical microscope which is already in use in theatres in Southampton
General Hospital. The imaging device is the same model as that used in the
second tumour imaging camera. The whole system makes minimal impact on the
theatre environment and on surgical procedure.
4.2.5 Image capture
The requirements for the image capture system were that it be portable, has
sucient interface and storage bandwidth and that it has a suitable user
interface including visual display. A laptop computer is used to meet this
requirement as a common image acquisition system. All of the cameras
communicate via USB2 or gigabit ethernet (GigE or 1000base-T). USB2 is used
by the Apogee and the original spectral camera posed some problems due to the
limited cable lengths of only 5m between hubs/boosters. Ten metre cables haveChapter 4 Intraoperative imaging of human brain 99
been used with all the cameras therefore these cameras requiring a commercial
signal booster making the use of the camera system more cumbersome. GigE is
used on the prosilica cameras and has a 100m maximum cable length.
All of the image data is stored on the laptop prior to permanent storage on
university owned computers. The frame-rate limit mentioned in section 4.2.4 is
due to the maximum sustained bandwidth of the hard disk which is approaching
30MB/s, to achieve the maximum stated frame-rate a bandwidth of 80MB/s
would be required. These bandwidths have been achievable for some time in
desktop devices and more recently in laptops mainly in the very high end devices
aimed at high performance gaming.
A custom application has been developed to control each of the camera systems.
These have used the manufacturer's software development kit (SDK) to interface
to the camera and provide the maximum automation at the user level. SDKs are
provided by manufacturers to provide access to camera functions, typically these
are very low level interfaces some down to the level of bytes and bits. These
interfaces have been wrapped to provide an object with high level functionality
such as; auto-exposure, initialisation, image capture. This object can then be
fully tested before it is used in a programme to capture a complete set of data.
This is good software engineering practice has been followed throughout this
project. Just the interface to the cameras without any of the controlling software
contains 4500 Source Lines of Code (SLOC).
The control applications use conguration les to ensure consistent settings
across each data acquisition session. These applications allow full control over
the camera hardware at a high level. They provide the operator a visual display
of the images as they are acquired. This allows the operator to ensure that the
camera is set up correctly and that high quality images are being collected.
Due to the dierent requirements of each of the camera systems a custom
application was written for each system. These applications build on the camera
abstraction layer and the same imaging framework. This framework will be
described in more detail in section 4.2.6.
The tumour cameras' acquisition software interfaces with the hardware
controllers on the cameras. The software then presents a live image to allow the
camera to be targeted at the required region. It then auto-exposes and collects
and image using each of a sequence of lters/polariser combinations which had
been previously dened by the user.
The software for the functional imaging camera unlike the tumour cameras only
interfaces with the camera. However this application has been optimised toChapter 4 Intraoperative imaging of human brain 100
Figure 4.14: A sample view of the application used with the functional camera
obtain the maximum bandwidth from the camera as well as providing real-time
display to the operator of the region of interest. This optimisation has required
using multiple threads in both the top level application and at the camera level
to maximise the image-capture bandwidth. Multi-threading allows a single
program to conduct multiple tasks at the same time as if these tasks are running
in parallel (processors use time-division multiplexing and the context switching is
suciently fast that it can be conducted during high latency operations such as
reading from memory). This application also allows the user to record
information about how cortical stimulation was performed and what the outcome
of this stimulation; i.e. a given site was stimulated and whether this site was
determined to be eloquent or not. This ability to record information alongside
the images makes correlation of these separate data sources much more simple,
gure 4.14 shows a sample view of this application.
4.2.6 Image processing
The image processing requirement of the data collected should allow statistical
analysis of the data and should visually enhance the collected images such that
one can appropriately identify areas of interest. Visual enhancement is required
for two reasons; the dynamic range of standard display devices does not match
that of the image acquisition devices used in this project; secondly that the
human vision system would not be able to identify those dierences even if
displayed. Although a large 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human visual system is essential in designing the image display system. Some
examples of these limitations include the following;
The bottom row of the image to the right
has 8 evenly spaced levels of grey, the next
level up shows 16 levels .... Typically the
human eye cannot distinguish between more
than about 32 levels or the third level up.
This can be represented by only 5 bits, the
Apogee camera can capture 14 bits, or over
500times more. (Note that this image is well
within the colour gamut of most printing
and display devices.)
Figure 4.15: Demonstra-
tion of the limited dynamic
range of the human eye
The gure on the right shows three pairs of
boxes with the same absolute intensity on
dierent intensity backgrounds. The boxes
on the lighter background appear darker
than those on the darker background. This
gure demonstrates how the relative con-
trast aects how the absolute value is in-
terpreted.
Figure 4.16: Demonstra-
tion that observed intensity is
contrast dependant
The pattern on the right is stationary (de-
nitely so if printed) yet it is often perceived
to expand, particularly if one is not looking
directly at it, e.g. reading this text. This is
one of the many variants of the \snake il-
lusion" made famous by Akiyoshi Kitaoka.
This image demonstrates that even move-
ment can be simulated in a stationary im-
age.
Figure 4.17: A variant
on the \snake illusion" by
Akiyoshi KitaokaChapter 4 Intraoperative imaging of human brain 102
Figure 4.18: Conical representation of the HSV colour space. (Reproduced under the
GNU Free Document Licence version 1.2, original author; moongateclimber)
An image processing toolkit has been constructed specically for this project.
This toolkit makes up a third of the total amount of software written for this
project (approximately 9000lines). All of the camera systems use the same image
format which is capable of storing an arbitrarily large image or stack of images.
An image stack is a commonly used concept in multispectral imaging which
collects all the images in a single le. This concept is not dissimilar to the
concept of storing red green and blue images to create a colour image. A video
processing toolkit has also been developed using a similar format to the still
image work and can exploit all of the functions in the still image toolkit.
The primary aim of the image processing is to highlight the dierences between a
pair of images and present that dierence in a way that the user can identify it.
The dierences between images are calculated by the equation shown in equation
4.1, due to the small dierences typical in the images used a gain G is added as
in equation 4.2. In these equations R and D are images, R(x;y) is the pixel at
row x, column y of image R. These equations can trivially be extended to work
with more than one image pair.
D =
R
R
(4.1)
D(x;y) = 2G
R1(x;y)   R2(x;y)
R1(x;y) + R2(x;y)
(4.2)
For display this dierence information is typically converted into an 8bit
representation and mapped into the Hue, Saturation and Value (HSV) colour
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The collection of images takes time, ranging from tens of seconds in the case of
the tumour systems (section 4.3.1) up to several minutes of video in the BOLD
system (section 4.2.4). Any movement of the tissue relative to the camera over
this period of time will produce registration inaccuracies between the images. As
the primary algorithm for identifying dierences in tissue is sensitive to changes
in pixel intensity these registration inaccuracies must be minimised. To
accomplish this one image from a sequence is chosen as a `key frame' and all
other images are registered to that image. This provides a dataset where a single
pixel position relates to the same piece of anatomy in each image. The data from
the tumour systems often does not require registration as the patients are
normally asleep and the head is held in a stereotaxic frame. The data from the
BOLD system typically requires registration due to movement of the patient, in
this case the rst frame is normally chosen as the key frame. The BOLD data is
also particularly sensitive to the amount of time taken for each registration as
there are often many thousands of frames to register.
There are a number of transformations which can occur due to movement of the
camera or of objects in the scene. Some of these are ane transforms that
comprises of a linear transformation and then a translation. The properties of an
ane transform are that collinearity is maintained (i.e. three points in a line
before the transformation will still be on a line afterwards) and that the ratios of
the distances between these points will stay the same. These transforms are
illustrated in gure 4.19, they are typically associated with camera | scene
movement for example translation occurs when the scene moves laterally, scale
where the camera move towards or away from the scene. Transforms 4.19(g) {
4.19(i) are associated with movement of objects within a scene or a surface
changing shape as occurs intraoperatively. Barrel distortion is often associated
with sh-eye lenses but also occurs due to a distortion of the surface of the scene,
this occurs during surgery as the cortical surface swells and contracts with each
heartbeat. Object movement occurs due to a portion of the scene or an object
within the scene moving, this occurs frequently intraoperatively as objects are
introduced and subsequently removed from the operating eld. With object
movement there is also often occlusion where part of the scene is hidden from
view.
One of the key capabilities of the imaging toolkit and as mentioned above is
particularly important for the video processing required by the functional
imaging camera is image registration. The task of image registration is to
translate a pair of images taken at dierent times or from dierent relative
positions into the same coordinate system. This is fundamental in image
processing. Image registration is a problem which humans excel at but is aChapter 4 Intraoperative imaging of human brain 104
(a) Original image (b) Translation (c) Rotation
(d) Scaling (e) Shear (f) Perspective
(g) Barrel distortion (h) Object movement (i) Warping
Figure 4.19: Representations of dierent types of transform, gures 4.19(b){4.19(f)
are ane transforms, gures 4.19(g){4.19(i) are not ane transforms
subject of current research interest, currently there is no one optimised set of
algorithms which satisfy the requirements. Image registration methods can
loosely be broken up into the following categories;
1. Methods that use the pixel values directly, e.g. cross-correlation methods.
Benhimane and Malis (2004)
2. Algorithms which use the frequency domain, e.g. Fourier transform based
methods, phase correlation. Including De Castro and Morandi (1987); Chen
et al. (1994); Reddy and Chatterji (1996); Averbuch and Keller (2001,
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3. Feature based methods that use low-level features such as edges and
corners. Bajura and Neumann (1995); Bentoutou et al. (2005)
4. Feature based methods that use high-level features such as objects or the
relationships between features. Wong and Clausi (2007)
These methods have dierent characteristics; the frequency domain methods (2)
are typically illumination and noise resistant (Wang et al. (2007)) but can only
recover a limited class of transformations | currently translation, rotation and
scale. Methods directly using pixel values (1) have problems with noise and are
illumination sensitive and computationally expensive (although reducing the
computational expense is also being researched Chen et al. (2005)). Both of the
feature detection methods depend heavily on the consistent identication of
features which can be problematic. For a more comprehensive review of image
registration techniques see Brown (1992) and more recently Zitova and Flusser
(2003).
This project has investigated both image registration by Cross-correlation which
uses pixel values directly and a frequency domain technique based of the
Fourier-Mellin Transform. The cross-correlation equation as dened by Garhart
et al. (1999) is;
r(m;n) =
￿
x
￿
y
 
w(x;y)   ￿ w(x;y)
 
t(x   m;y   n)    t

￿
x
￿
y
 
w(x;y)   ￿ w(x;y)
2=
￿
x
￿
y
 
t(x   m;y   n)    t
2 1
2
(4.3)
Where r is the result matrix,  t is the average of value of the template, ￿ w(x;y) is
the average value of the portion of the window match image currently coincident
with the template t(x;y). The template is dened as the original image and the
match image which requires registration to the template. This searches a window
(x;y) over an area (m + x;n + y) and generates an array r containing the
correlation values. The computational expense of this technique is correlated
with the size of the search area mn and the size of the window xy. The
maximum value of the result array should be the translation of the matching
image to the template, this maximum should satisfy various statistical tests e.g.
should be greater than any other local maximum by 1
4 (where  is the standard
deviation). This algorithm was found to be unreliable for nding a match even
with feature enhanced images such as edge detection. Cross-Correlation scales as
O(k2n2) where k is the search space and n is the size of the image. Therefore
large translations require large search spaces and increase computational
expense. Scale and rotation introduce further complexity and require a much
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large number of registrations required for the functional work. However
cross-correlation can in principle recover most of the transforms presented, even
barrel distortion and warping, however object movement and occlusion can not
be recovered and must be excluded by the statistical tests.
A frequency domain technique based on the Fourier-Mellin invariant descriptor
was found to successfully register a pair of images. The Fourier transform of an
innite image is translationally invariant, i.e. it does not matter where the
`origin' of the image is. A nite image which has been appropriately windowed to
reduce edge eects can exploit this property to extract the amount of translation.
The method is as follows (the rst and second images are denoted a and b;
1. Calculate the Fourier transform of a and b let these be A and B
2. Generate a third image from A multiplied by the complex conjugate of B
3. Inverse Fourier transform the result
This algorithm results in a delta function at the location that correlates with the
translation of both images and approximately zero elsewhere. The Mellin
transform introduces a conversion from Cartesian to log-polar coordinates for
both A and B before repeating the process from step 1. This gives an output
which is a delta function at a location which correlates to the rotation and scale.
The log-polar transformation conceptually converts both scale and rotation into
linear factors which are mutually perpendicular and can be extracted in a similar
way to translation. For more information about the log-polar conversion consult
Young (2000). The Fourier Mellin transform was presented in Chen et al. (1994)
however the author found Reddy and Chatterji (1996) more accessible.
The Fourier Mellin transform scales as O(nlogn) due to the Fourier transforms
of which at least 3 transforms are required and 2 reverse transforms. There are
other operations required but all scale better than the Fourier transforms so that
these dominate. This image registration algorithm has been demonstrated to be
highly resistant to noise, illumination changes and object occlusion. The major
criticism of these techniques is the limit on the class of transform which can be
recovered, however the transforms that can be recovered are the most likely to
occur in the specic imaging scenario under investigation.
In total over 28,000 source lines of code have been written for this project. Jack
O'Sullivan has written approximately 1500 of these lines. For comparison this is
about twice as large as this thesis. All of the code is on the CD enclosed.Chapter 4 Intraoperative imaging of human brain 107
Centre Filter Set
Wavelength 1 2 3 4 5
410nm X
440nm X
470nm X X
580nm X X X
610nm X X X X
630nm X X X
700nm X X
750nm X
800nm X
900nm X X X X
970nm X X X X
Patients 1 6 4 1 3
Table 4.10: The dierent lter sets used in the tumour imaging cameras and the
number of patients investigated with each
4.3 Results and discussion
This section will discuss some of the results from the dierent camera systems.
Where appropriate it will also highlight some of the processing involved. It will
start by considering the tumour systems and move on to look at the results from
the functional systems.
4.3.1 Tumour systems
There have been a number of dierent lter sets used on the tumour imaging
systems. These can be found in table 4.10, all of the lters have a 10nm full
width half maximum, or bandwidth, these lters typically have a 60% maximum
transmission and have of the order 0.01% transmission out of band. In addition
to these lters the cameras have a 'clear' lter which has a transmission of 1%
this low transmission value is comparable to the overall transmission through the
coloured lters when integrated over the entire sensitivity of the CCD. There are
also polarisers in the each of the cameras, the rst camera had polarisers
covering the 400{700nm range the second camera has polarisers covering the
complete 400-1000nm range. The selection of lters has evolved and is
continuing to do so. The initial lter set was quickly changed to accommodate
900/970 combination that are sensitive to water, this required the removal of the
410nm and 470nm lters which were giving the poorest imaging of the set and
presented little contrast with 580nm. The addition of more 600-800nm lters is
due to the research presented in Toms et al. (2005).Chapter 4 Intraoperative imaging of human brain 108
(a) Clear image (b) 610{580nm (c) 970{900nm
Figure 4.20: Images captured using the rst tumour imaging system and lter set 2
in patient 2283840. 4.20(a) shows the tumour margin in magenta
This project has been awarded grant funding to continue work by the National
Institute for Health Research (NIHR). The NIHR is part of the NHS and this
project will be funded under the New and Emerging Applications of Technology
programme (NEAT). The main aim of this fund is to address the funding gap for
translational research and development in new and innovative technology. It only
funds projects aligned with a clinical need and so provides more evidence that
there is a wider acknowledgement that this is an important area of study. The
application submitted for this funding can be found in Appendix B.
The data presented here is from a low number of cases. With the wide range of
neuropathological condition which require surgery there is little coherence across
the data set and little duplication of tissue types. This project is not in the
position to be able to state that there are `X' spectral characteristics which
relate to `Y' tumours as yet. In fact correlation with tissue type is an extant
problem with all of the data presented here. Pre-operative imaging poorly
dierentiates inltrating tumour margins and there is currently a problem
registering preoperative data with the images collected by the camera systems. It
is possible to project tumour extents based on pre-operative images into the eld
of an operating microscope, however this equipment is not currently available at
the hospital (allowance has been made for it within the grant funding). The
problem of poor diagnostic imaging of inltrating tumour margins presents more
dicultly in correlation. The only solution to this is extensive sampling and
diagnosis by pathology which requires agreed assessment criteria for these
specimens and a strong relationship with the pathology department. For
consistency this may require a single pathologist to analyse these cases as there
has been shown to be some variation between pathologists. The pathological
assessment of these cases is in the process of being established.Chapter 4 Intraoperative imaging of human brain 109
(a) Clear image (b) 610-580nm (c) 970-900nm
Figure 4.21: Three images of a normal brain from patient 4700075 these have under-
gone identical processing to those in gure 4.20
The images shown in gure 4.20 are from patient number 22838402. This is a
grade III tumour and as is clear in Figure 4.20(a) is visually indistinct from the
surrounding normal tissue. Figure 4.20(a) shows the clear image without a
colour lter, the magenta outline denes the tumour as seen by pre-operative
imaging. The centre panel shows the dierence between 610 and 580nm lters,
the panel on the right shows the dierence between 970 and 900nm. The
dierences in these images have been presented in a false colour,
blue{cyan{green{yellow{red (this colour mapping will be used consistently
throughout this report). Artifacts can be seen in some of these images; 4.20(a)
shows reections as bright white areas where the camera pixels were saturated -
there is a loss of information in these regions. Figures 4.20(b) and 4.20(c) show
artifacts around particularly high contrast regions such as vasculature, again
these artifacts are not considered to contain information.
Figure 4.20(b) shows the dierence between two bands associated with the
rapidly changing absorption of haemoglobin as seen in gure 4.11. Therefore the
contrast in this image can be attributed to changes in the vasculature and
neovascularisation due to tumour growth. The extent of the contrast is
somewhat larger than that from pre-operative imaging particularly to the top of
the image between two vascular structures. Vasculature in the brain is generated
as needed and so highlighting a larger area of changing vascularisation is not
unreasonable but may also indicate tumour margin however angiogenesis is not
always associated with tumour growth, Bernsen et al. (2005). The dierences in
the 970-900 region are shown in gure 4.20(c) this has a higher correlation with
the preoperative margin, the area that is highlighted in the green-red colours
again however there is some indication in the top and bottom of the image that
the same spectral characteristics can be found elsewhere.
For comparison with the images presented in gure 4.20 the images shown in
gure 4.21 show unquestionably normal tissue. This patient was undergoing
2The rst six patients were anonymised by assignment of unique 7 digit random numbers, this proved
to be cumbersome and subsequent patients were sequentially numbered from 1, the pre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(a) Clear image (b) 970-610
(c) Threshold 50% (d) Automatically generated con-
tours
(e) Threshold 70%
Figure 4.22: A selection of images from PT1. 4.22(a) shows the clear image with
the resection extent marked in magenta; 4.22(b) shows the dierence between 970 and
610nm; 4.22(c){4.22(e) shows a series of threshold values applied to 4.22(b)
surgery for epilepsy, which involved small resection deep inside the brain. There
was no involvement of the brain surface with this condition. The image
processing conducted in both gures 4.21 and 4.20 is identical | including the
gain as specied in equation 4.2. Processing includes a normalisation step to
remove global changes which makes the system insensitive to factors such as the
spectrum of illumination and camera sensitivity. The at green seen in gure
4.21 is indicative of no contrast in these wavelengths, this is not stating that the
reectivity of the tissue is equal at each wavelength but that there is no change
across the eld. Consistent reectivity changes across the entire eld will be
removed by the normalisation. The consistency seen in these is maintained even
at much higher gain settings.
Patient 1 had a left frontal oligodendroglioma grade II. Figure 4.22 shows a
series of images from Patient 1 the outline in 4.22(a) indicates the resection
extent, this was generated using pre-operative imaging. There is clearly contrastChapter 4 Intraoperative imaging of human brain 111
(a) Clear image (b) 610-580nm
Figure 4.23: Images from PT1, 4.23(a) shows the clear image with surgical margin
shown; 4.23(b) shows the dierence between 610 and 580nm
in the dierence between 970 and 610 bands this correlates with the surgical
extent. Thresholding the dierences can visually enhance the results, gures
4.22(c){4.22(e) show only the dierences above a given value. Figure 4.22(d)
shows automatically generated contours after median ltering of the dierence
image in 4.22(b), while the processing conducted on this image is still fairly basic
it does show one possible method of visualisation during surgery giving
condence levels (in this case the green represents 65%, orange 75% and the Red
85%). Note that gure 4.22(e) demonstrates a high correlation with the surgical
margin (shown in 4.22(a)).
The images shown in gure 4.23 are shown for comparison with similar images in
4.20(b). The images from Patient 1 show little contrast associated with the
surgical margin, this may be due to a lack of angiogenesis associated with this
tumour or alternatively the angiogenesis extends outside of the surgical margin
as in 4.20(b) to the point where we are unable to resolve the boundaries. As
mentioned above the current system of camera and processing is not powered to
resolve global dierences and so is not able to compare these on an intra patient
basis however the possibility that the edges of the inltrating tumour margin
have not been reached exist.
Filter sets 1 and 2 perform particularly badly where there is an excess of blood
in the eld. This is often the case with high grade glioma due to the breakdown
of the blood brain barrier. It is also the case in reoperation, even for low grade
tumours.Chapter 4 Intraoperative imaging of human brain 112
(a) Clear image
(b) 610-580nm (c) 900-580nm
(d) 970-630nm (e) 970-900nm
Figure 4.24: Images from PT4 highlighting the blood contamination in high grade
glioma; 4.24(a) shows the clear image with resection contour in magenta the very dark
areas are blood contamination; 4.24(b) shows the diculty of imaging vascularisation in
this region; 4.24(c) shows that the longer wavelengths are less sensitive to blood contam-
ination; 4.24(d) shows much better contrast achieved with a pair of longer wavelengths;
4.24(e) with a threshold applied highlights what may be normal tissue.
Figure 4.24 shows how a damaged blood brain barrier can aect the imaging.
The longer wavelengths are relatively less aected by the blood due to the lower,
and spectrally atter, absorption of haemoglobin in this region (Zijlstra et al.
(1991)). The images shown in 4.24(d) and 4.24(e) demonstrate that it is possible
to obtain relevant contrast in the presence of blood.
Tissue movement during surgery was highlighted as an issue in the background
section (page 44) where reports detailing average movements of around 5.6mm
were described. It is this author's experience is that is a real issue, after
performing the craniotomy on patient 2283840 (of which some images are
presented in 4.20) the surface of the brain moved to be almost level with the
skin. This displacement would be of the order of 10mm but was not measured.
Figure 4.25 demonstrates graphically how much these tissues move during
surgery. This gure shows two images (4.25(a) and 4.25(b)) from before and
after resection, the lower two images are the same images with areas coloured to
allow discussion of these areas. The green and blue areas correlate in the two
images, it can clearly be seen that these areas change shape and position during
resection. Additionally the magenta area in the before resection images
disappears from the after resection images as this tissue has moved out of the
surgical eld. These three regions highlight the diculty of registering the tissue
with pre-operative data as resection progresses. Finally the yellow area in the
after resection image indicates a surgical instrument used to temporarily hold
tissue out of the eld, this is an example of occlusion mentioned in section 4.2.6.Chapter 4 Intraoperative imaging of human brain 113
(a) PT4 before resection (b) PT4 after resection
(c) PT4 before resection (d) PT4 after resection
Figure 4.25: This gure demonstrates the amount of tissue movement during resec-
tion. The top two images (4.25(a) and 4.25(b)) are black and white visible images taken
before and after resection. The bottom two images (4.25(c) and 4.25(d)) are the same
images with certain areas highlighted; the green and blue hatched areas correspond to
the same piece of tissue but has been moved and deformed, the magenta area in 4.25(c)
is a section of tissue that was not removed during surgery but is not visible in the
post-resection image, the yellow hatched area in 4.25(d) shows a surgical instrument (a
retractor) holding the tissue in place (an example of occlusion as seen in gure 4.19
Some of the potential utility of this technique during surgery is demonstrated in
gure 4.26. Imaging of the bottom of the resection cavity may indicate the
extent of resection and could be sensitive to low grade and inltrating tumour
which other techniques are not sensitive to. Also this will not require registration
with preoperative imaging. Figure 4.26 shows a detectable dierence the tissue
at the bottom of the resection cavity indicated by the blue colours in 4.26(b).
There is also an area which shown in gure 4.26(c) which shows a particularly
strong signal in the dierence between the 610 and 970nm bands which has been
shown above to correlate with resection margin (gure 4.22). However without
the associated pathology assessment this is currently impossible to assess
whether the bottom of the cavity contained inltrating tumour.Chapter 4 Intraoperative imaging of human brain 114
(a) Clear image
(b) 610-580nm
(c) 970-610
Figure 4.26: Images take after resection in PT4 show some contrast; 4.26(a) shows
the clear image for reference; 4.26(b) shows some contrast between the cortical surface
and the resection cavity in the dierence between 610 and 580 nm | blues at the
bottom of the resection cavity and yellows at the cortical surface; 4.26(c) shows an area
of distinct contrast (this image has been threshold ltered for visual appearance) at the
bottom of the resection cavity.
Patient 12 was undergoing surgery on a tumour which was had previously been
operated on as a grade II glioma. This second surgery graded the tumour as a
grade III oligodendroglioma. Figure 4.27 shows some of the images from this
patient. Near letters A and B of gure 4.27(a) there some saturation in some of
the images, this would manifest in the dierence images as solid green areas
indicating no dierence. These dierence images shown in 4.27(b){4.27(d)
indicate in red very similar regions which correlate well with the resected margin
(shown in gure 4.27(a) in magenta). These dierence images show that there
are consistent dierences in a number of spectral bands all associated with tissue
inside the resection margin. The largest area of tissue not resected was that in
the top right corner this correctly identied in 4.27(b){4.27(d) indicated by
yellow/greens and even blue colours demonstrating little or no spectral dierence
between these bands.
Another way to visualise these images is shown in gure 4.28. This shows the
intensity at two dierent wavelengths plotted in the X and Y axis, the colours
relate to the tissue type; all pixels are plotted in blue, pixels designated as
normal have green added, those designated tumour have red added. ThisChapter 4 Intraoperative imaging of human brain 115
(a) Clear image
(b) 630-700nm (c) 800-700nm (d) 970-700nm
Figure 4.27: Images from PT12 undergoing a second surgery for oligodendroglioma
collected using lter set 4 and tumour camera 2; 4.27(a) shows the clear image with the
resection extent in magenta; 4.27(b){4.27(d) show the dierences of dierent spectral
bands indicated by the X-Ynm
therefore presents normal pixels as in blue{green (including cyan), and tumour
as blue-red (including magenta). Yellow or white pixels indicate that the spectral
characteristics of the tissue types are not separable. Some cross-over is expected
due to the continuous nature of these variables and that these images are only
considering two wavelengths. Figure 4.28(a) shows clearly that there is a distinct
area of magenta which is separate from the cyan this is indicating that the tissue
designated tumour has a distinctly dierent spectral character from the normal
tissue | in this case indicating dierences in the water content. Figure 4.28(b)
again shows two areas one clearly cyan and one magenta, there is more cross-over
in this image indicating that the dierences are not as distinct however again a
line can be drawn separating tumour from the normal groups.
The results from patient 2283840 appear to be separable with the tumour and
normal tissue existing in dierent areas of this space. This is generally the case.
This is obviously dependant on the selection and the designation of the areas.
This has been done conservatively with a gap between that designated tumourChapter 4 Intraoperative imaging of human brain 116
(a) X=970nm, Y=900nm (b) X=580nm, Y=610nm
Figure 4.28: An alternate visualisation of the images from patient 2283840 allows
assessment of the grouping of the pixel values between the diseased and normal tissue
(magenta indicates tumour, cyan normal, blue for the remaining pixels); 4.28(a) shows
the values at 970nm and 900nm in the X and Y axis respectively; 4.28(b) shows values
at 580 and 610nm in the X and Y axis
(a) Patient 2283840 (b) Patient 1
Figure 4.29: Two images representing the spectral content of the 970 and 610 in
the tumour and normally designated tissue in dierent patients; 4.29(a) from patient
2283840; 4.29(b) from patient PT1
and normal but no large areas have been excluded from the analysis. Angles in
these images are dependant on the relative normalisation between the two axis
and therefore arbitrary. Figure 4.29 shows side-by-side two of these images from
dierent patients demonstrating similar trends.Chapter 4 Intraoperative imaging of human brain 117
4.3.2 Bold systems
The opportunity to image functional activation of exposed cortex became
possible because of the high dynamic range imaging and the narrow band lters
able to select specic wavelength regions. Initially the rst tumour camera was
used as a data collection system. In addition to the other limitations of this
camera a low frame-rate introduced aliasing aects into the collected images.
However the results were encouraging.
(a) At rest (b) Activation
Figure 4.30: Functional images taken using the rst tumour camera in patient
5015360; 4.30(a) shows the at rest period; 4.30(b) shows the active period.
Figure 4.30 shows some of the images collected by this system. Patient 5015360
was undergoing surgery for a relatively benign tumour in the temporal cortex. In
the bottom left of the image 4.30(b) labelled B is tumour. There is some
saturation in the area labelled A which unfortunately means that there is a loss
of information in region. The area labelled A was also identied as eloquent by
electrocortical stimulation. The tumour showing as active in these images is
interesting and could be interpreted in a number of ways including; that it shares
a blood supply with the active region or that it contains some non-critically
useful tissue. Vascular structures should be ignored in these images as any slight
registration inaccuracy will create large signals in these regions. Functional
activation can be seen clearly when plotted through time as shown in the gure
4.31, this shows two periods of activation, one starting at around frame 10
lasting for 15frames, the second starting around frame 60 and nishing around
frame 140.
It can be clearly seen in gure 4.31 that the traces are not smooth, this is
probably due to the frame-rate of the camera system being similar to the heart
rate of the patient and therefore aliasing this changing signal. Patients imagedChapter 4 Intraoperative imaging of human brain 118
Figure 4.31: Two pixels plotted through time from patient 5015360, the x-axis denot-
ing frame number collected at approximately 2 fps; Blue trace is from an active area;
Red trace from an inactive area. Oset introduced to aid clarity.
where there was no eloquent tissue found by cortical stimulation did not show
any signal.
These results were suciently encouraging that a new system described in
section 4.2.4 was built which has a much faster frame-rate and can be attached
to a standard Zeiss operating microscope. This allowed a better perspective on
the imaging not limited by the physical constraints of the rst tumour camera,
much more of a \surgeon's-eye view". The images collected by this new system
has more serious registration inaccuracies than the rst system and due to the
higher spatial resolution and frame-rate so computational expense is also an
issue. A unfortunate side-aect of the poorer registration is that the non-uniform
illumination of the operating microscope becomes a signicant factor. In fact the
relative change of the illumination relative to the eld is more signicant than
any change in the absorption of the tissue.
The light eld generated by the microscope is shown in gure 4.32 this eld can
be modelled eectively by a fourth order polynomial. However as the eld does
not change with the zoom of the microscope the size and position of the eld
must be extracted from each data-set individually. The registration algorithms
used elsewhere can be exploited for this purpose. The size or scale of the light
eld can be recovered by using a Fourier-Mellin transform which is spatially
invariant. Then the location can be recovered by the standard phase correlation
method. An example of images before and after light eld subtraction are
presented in 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Figure 4.32: An example of the light eld generated by the Zeiss operating microscope
(a) Before subtraction (b) Calculated light eld (c) After subtraction
Figure 4.33: Images taken from patient PT9 before and after subtraction of the light
eld calculated and shown in 4.33(b)
Patient 9 was undergoing surgery for a oligoastrocytoma near the sensorimotor
cortex. Figure 4.34(b) shows the dierences between a period of rest and a
period of activation. This image has been thresholded to improve the visual
appearance, the area in the top left of the image clearly shows some dierences
between activation and rest. There are strong signatures around some of the
vascular structures this is primarily due mis-registration. Surface deformation is
a large contributor to the mis-registration. In this case the activation was arm
movement. These are the rst results of an active map with this camera and the
results are encouraging however there is still much work to do improving the
images.Chapter 4 Intraoperative imaging of human brain 120
(a) Reference image (b) Active image
Figure 4.34: Images from PT9 showing functional activity; 4.34(a) the surgeon in-
dicates with patties the area dened as eloquent by stimulation; 4.34(b) an image
displaying the dierence between periods of rest and activityChapter 5
Conclusions and future work
These conclusions are specic to the areas of the work, so will logically be
presented separately.
5.1 Prion
Prion diseases are characterised by the deposition of mis-folded protein in
amyloid plaques. This mis-folded protein has a primarily -sheet conformation in
contrast to the primarily -helix conformation of the prion precursor protein.
By using synchrotron illumination and Fourier transform infrared spectroscopy
this project has found structurally relevant bands associated with the deposition
of PrPsc. A change in both the intensity of the -sheet component around
1640cm 1and a decrease in the location of the peak of the amide I band are both
associated with the change between normal PrPc and PrPsc. This change
demonstrates the deposition of PrPsc at both the early and late stage of disease
progress (12 and 20 weeks post inoculation).
Also identied as a signicant marker of disease progression is the band around
1740 associated with the carbonyl group. The most signicant contributor to
this absorption is likely to be glutamic acid which is known to be a
neurotransmitter. This neurotransmitter is stored in synapses which are the
earliest casualties of the neurodegeneration. Data presented in this thesis suggest
that this marker will be identiable much earlier in the disease progress and may
be able to track the decline in synapses before any neuronal loss.
The use of a linear search algorithm was demonstrated to identify the
structurally signicant bands. Contrast enhancement was also demonstrated to
improve the identication of these bands.
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The absorption relating to the carbonyl group has not been reported previously
be associated with prion disease and may be the earliest optical marker yet
observed. Unlike the prion markers which have been shown by others to only be
detectable at high spatial resolution, collection of the carbonyl data does not
necessarily require synchrotron illumination as the area of high synaptic density
is suciently large, evenly distributed and the absorption strong enough to allow
lower resolution imaging. This should enable this to become a laboratory
technique. Further data collection from earlier in the disease progress may
identify the earliest loss of synapses. This could provide critical information
about the disease mechanism and eventually result in methods to combat the
disease.
5.2 Intraoperative identication of tumour margins
The need for intraoperative delineation of tumour margins stems from the fact
that many primary brain tumours are visually indistinguishable from healthy
tissue. Therefore it is dicult to accurately assess the extent of resection during
surgery. Pre-operative imaging has been shown to help but as surgery progresses
the registration accuracy of these images decreases so it is of limited utility. Also
while pre-operative imaging is very good at identifying high grade tumours is not
as sensitive to low grade tumours or even the inltrating margins of the high
grade tumours. This is potentially an area in which the systems developed
within this project will excel.
Spectral dierences from point measurements have been demonstrated elsewhere.
This project has demonstrated for the rst time that diuse spectral imaging
can resolve the dierences between normal and malignant brain tissue. These
dierences have been correlated with resection margins. The location of these
spectral dierences is associated with the type of disease. Spectral regions
including 970, 900, 800, 750, 700, 630, 610, 580 and 470nm have been shown to
have evidence of spectral dierences. Imaging of tumour angiogenesis appears
possible by using the shorter wavelengths where haemoglobin absorbs strongly.
Other features and deeper penetration is possible with the longer wavelengths;
including in the 970{900nm band which is associated with water content
dierences. Blood from compromised blood brain barriers can interfere with the
spectral imaging, correct selection of wavelengths can minimise this impact
however further investigation is required.
This project has succeeded in developing a camera which is suitable for use in
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and spectral resolution and dynamic range. The software toolkit has proved
versatile and powerful.
The future of this project is guaranteed by three year grant funded by the
National Institute for Health Research (NIHR). The application for which was
entirely based on the work detailed in this document (the application can be
found in appendix B). More data is required and routine histopathological
analysis must be established. This analysis of the tissue types around the
resection margin and at the bottom of resection cavities will establish the
validity of the margins delineated by the camera. The collaboration with the
pathology department that will enable this is developing and will allow denite
statements about the pathological state of the tissue under investigation.
Investigations further into the infrared may yield interesting results; proteins,
lipids and various other tissue constituents have a unique spectral features in the
mid infrared region. There is some evidence in the literature that these features
can be diagnostically useful. This is another area that would benet from further
research and something that the continued project aims to investigate.
5.3 Intraoperative delineation of function
Identication of functionally useful areas of brain is already conducted
intraoperatively using point measurement techniques which have poor spatial
and temporal resolution when compared with optical techniques. The
identication of function is important to help minimise post-surgical neurological
decit due to damage of those areas. It is particularly important in tumour
surgery as functional areas can be moved by a growing tumour. It may also have
application in other areas of neurosurgery including epilepsy.
This project has developed a camera that attaches to a standard neurosurgical
operating microscope and so is clinically straightforward and simple to use and
integrates seamlessly with the operating theatre environment. This project has
solved the image registration and uneven light-eld problems for this application.
The results have demonstrated that it is possible to identify functional activity
with a single cycle of activation. Previous reports have averaged over multiple
cycles. This project has demonstrated that the areas delineated by this system
correlate with the current standard for intraoperative measurement of function.
Again this work will continue under the grant awarded by the NIHR. Data from
more individuals is required. Follow-up of the patients should be able toChapter 5 Conclusions and future work 124
correlate any immediate and long-term decits with the proximity of the
resection margin to identied functional tissue.
Dierent wavelengths should be considered as longer wavelengths will give
greater penetration and possibly greater signal to noise. Other applications of
the same technology are also worth investigation, epilepsy is one potential target,
another is surgery for aneurysms where the blood supply to an area of brain may
be disrupted real-time monitoring of the oxygen content of that region could
potentially give vital information.Appendix A
Assignment of the IR vibrational
absorption of liquid water
Wavelength Wavenumber (cm 1) Assignment
0.2mm 50 intermolecular bend
55m 183.4 intermolecular stretch
25m 395.5 L1, librations
15m 686.3 L2, librations
6.08m 1645 v2, bend
4.65m 2150 v2 + L2
3.05m 3277 v1, symmetric stretch
2.87m 3490 v3, asymmetric stretch
1900nm 5260 av1 + v2 + bv3; a+b=1
1470nm 6800 av1 + bv3; a+b=2
1200nm 8330 av1 + v2 + bv3; a+b=2
970nm 10310 av1 + bv3; a+b=3
836nm 11960 av1 + v2 + bv3; a+b=3
739nm 13530 av1 + bv3; a+b=4
660nm 15150 av1 + v2 + bv3; a+b=4
606nm 16500 av1 + bv3; a+b=5
514nm 19460 av1 + bv3; a+b=6
Note that a and b are integers, >=0
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Intraoperative Multispectral
Imaging of Brain Tumours (iMSI)
APPLICATION NUMBER L032
Lead Applicant:
W. P. Gray
Professor of Neurosurgery
School of Medicine
University of Southampton
Joint Applicant:
H. N. Rutt
Head of School
School of Electronics and Computer Science
University of Southampton
Named Contributor:
P.R. Hoy
Optoelectronics Research Centre
University of Southampton.
Total requested:
$436,398
B.1 Layman's summary
Brain tumours account for 7% of cancer deaths in patients under 70 years of age
in the UK . Surgery remains the single most eective therapy, with the amount
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of tumour removed being strongly predictive of outcome . However accurately
identifying tumour boundaries during surgery is dicult, as they are often
visually indistinguishable from normal tissue . Removing a surrounding rim of
normal brain may be undesirable, if it has an important function like speech or
movement. Preoperative imaging is of limited utility, as deformation of the brain
during surgery causes signicant inaccuracy. There is a pressing need for a
non-invasive, real time tool that can be used during surgery to accurately
identify tumour and eloquent tissue for maximising tumour removal and
minimising loss of function.
The ability to perform high-resolution imaging of multiple spectra across the
visible and infrared spectrum has only recently become technologically available.
Intraoperative Multispectral Imaging utilises absorption in multiple parts of the
electromagnetic spectrum from visible into the infrared, to identify tumour tissue
from normal brain. In patients undergoing awake surgery this system can also
detect a signal related to deoxygenated blood allowing the identication of
functionally useful areas as these areas use more oxygen. This information can
then be presented in real time in a relevant manner to the operating surgeon to
maximise safe tumour resection.
A PhD project has demonstrated the feasibility of the technique using multiple
visible and near infrared spectra but it requires further development to
demonstrate proof of concept. Our objectives are to identify combinations of
spectra, ranging from the visible to the infrared, that are specic for brain
tumours. By the end of the project we hope to be in a position where a clinical
tool integrated into a standard operating microscope could be further developed
commercially.
B.2 Purpose and outcomes
The purpose of the iMSI project is to provide proof of concept that the
application of multispectral visible/infrared imaging has intrinsic value for
identifying tumour tissue intraoperatively.
Although the infrared spectrum of brain tumours (wavelengths from 2-10m) is
known from point measurement techniques , it has not been previously imaged
during surgery. The infrared spectra of frozen brain tumour tissue sections has
shown signicant dierentiation of tumour grade and tumour tissue from normal
brain as the origin of the infrared spectrum is governed by factors directly
related to tissue makeup (C-N bonds that reect protein composition, C-H bonds
that re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operating eld to generate an operative picture in real time. These images will
be generated from combinations of spectra across the complete visible and into
the infrared to maximise diagnostic accuracy | a technique that has not been
applied to tumour imaging but has shown value in defence and satellite imagery.
Because of our unique development of a multispectral tumour imaging system we
will also be able to incorporate BOLD imaging of functional brain tissue in
awake patients. This will represent a fundamental advance in the technology
used to identify brain tumours intraoperatively and will pave the way for the
development of a clinically useful system. This project will also provide phase 1
clinical data to support these outcomes.
Specic outcomes will be:
 Identication of combinations of visible and infrared spectra that
accurately identify human brain tumour tissue.
 Construction of a multispectral camera system sensitive to these spectral
features.
 Demonstrate a high correlation between preoperative imaging,
histopathology and the iMSI system.
 Demonstrate a correlation between existing techniques such as 5-ALA and
the iMSI system.
 Correlate functional imaging with intraoperative corticography.
 Develop both systems to the point where commercial R&D can be
undertaken.
 Develop relationships with potential exploiters of the technology.
These outcomes will be exploited by applications to i4i for further funding in
collaboration with an industrial partner and a user group from the Society of
British Neurological Surgeons to develop a clinically usable device that delivers
the relevant information to the operating surgeon in real time in a user-friendly
manner. We foresee patentable possibilities in the complete device, and the
spectral band combinations and processing used to interpret the spectral data
and display the functional images. Finally, funding for a clinical trial using the
device to demonstrate more complete and cost eective tumour resection with a
lower complication rate than standard surgery will be applied for from joint
industry and research council funding. Approximately 2000 craniotomies for
intrinsic tumours are performed in the UK each year and a substantial market
for such devices exists both nationally and internationally.Appendix B Intraoperative Multispectral Imaging of Brain Tumours (iMSI) 129
B.3 Background
Primary brain tumours diusely inltrate surrounding brain. Therefore although
surgery improves both life expectancy and quality of life, it rarely results in cure.
This has led to a debate over how much tumour should be removed as
conservative resection leads to earlier recurrence rates while aggressive resection
may lead to more post operative neurological decits. The goal should be to
remove all tumour without any surrounding brain. However the inltrative
nature of these tumours means that tumours can resemble healthy tissue so
closely that even experienced surgeons cannot visually distinguish them . Nor is
it possible to dierentiate eloquent from non-eloquent cortex. Preoperative
imaging is used extensively in planning resection and is presented to the surgeon
using an image guidance system that is integrated with the surgical microscope.
This is of limited use during surgery as tissue deforms by as much as 15mm and
accurate registration with preoperative images is lost. Figure B.1 demonstrates
the extent of this tissue deformation.
Figure B.1: Images taken using intraoperative MRI during a craniotomy demonstrat-
ing the extent of tissue movement during surgery Morton (2005).
Intraoperative MRI has been developed to improve the accuracy of resection ,
however this technique is prohibitively expensive and imposes signicant
restraints on the operating environment. Fluorescence techniques show promise
(one example is ) and there are products on the market, however this technique
is only of value in high grade gliomas where resection margins are relatively
easier to identify and the prognosis is poorer than the low grade gliomas, which
are found in a younger patient population . Fluorescence imaging is limited by
the autouorescence of tissue and often requires the injection of extrinsic
uorophores, the wavelength selection is limited and the technique is sensitive to
stray light so the operating theatre must be darkened. Spectroscopic techniques
have shown high sensitivity and specicity , however this is a point measurement
technique and so has signicant resolution and speed limitations.
The optical absorption of a material, including biological tissue, is determined by
the physical constituents of this material and its structure. In the visible andAppendix B Intraoperative Multispectral Imaging of Brain Tumours (iMSI) 130
near infrared (dened here as 300-1000nm) the absorptions are primarily
electronic transitions; i.e. the energy in a photon is enough to promote an
electron to a higher energy state, thereby absorbing that portion of the
spectrum, e.g. red dye absorbs blue and green light leaving the red light to be
reected (or transmitted) and observed. In the mid and long wave infrared
(dened here as 1-5m and 5-10m respectively), the absorption is primarily due
to the chemical bonds in the material. There are a number of dierent
mechanisms for this absorption, however there is a direct correlation between
absorption at a given wavelength and a given chemical bond e.g. the CH bond in
a fat or the amide bond in a protein. Figure B.2 gives an example of this.
Combining these wavelength regions may provide information about the tissue
which was not obvious in any one of the bands in isolation. The technique of
imaging a number of distinct wavelengths (either within a wavelength region or
between regions) is called multispectral imaging.
Figure B.2: An image of a mouse brain, the left hand side was imaged using mid and
long wave infrared spectra and processed to distinguish between protein and fat, the
right hand side has been stained to increase the tissue contrast.
Multispectral imaging compares the information content in a number of dierent
spectral bands and presents this in a method that is relevant to the user; the
technique originated in military applications where it has a strong track record.
There is evidence in the literature that normal and malignant brain tissue have
dierent spectral characteristics (i.e. the tissues absorb diering amounts of light
at specic wavelengths). This evidence is based on in vivo measurements using
point measurement spectroscopic techniques and in vitro techniques mentioned
above. We have evidence that this information can be used in an imaging
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The iMSI project started with a PhD project investigating the applications of
multispectral imaging. This work has established collaboration between
engineers in the University of Southampton Electronics and Computer Science
department and academic neurosurgeons at both Southampton University and
Southampton General Hospital. We have been awarded ethical approval for
taking multispectral images during surgery. A camera system has been
developed which is sensitive to light in the visible and near infrared bands. This
camera is very sensitive to small changes in reected light and by using narrow
band lters can accurately select which part of the absorption characteristic it is
sensitive to. This project has also developed the software required to analyse the
collected images. Figure 3 shows one set of intraoperative results. The scale bar
on the right shows high probability of tumour in red and a low probability in
blue. This image is an early result using a single pair of wavelengths but shows
indications in the red and yellow areas that discrimination is possible, additional
bands improves this dierentiation as seen below (Figure B.4).
Figure B.3: Images taken intraoperatively. Left: shows a black and white visible
view of the cortical surface. Right: shows a false colour image highlighting the tumour
tissue.
The images shown in Figure B.4 show a patient undergoing their second surgery
for high grade glioma; the false colour image on the right highlights tumour in
green to red and normal tissue in blue. This image had a good correlation with
the preoperative data (shown in the centre image) and clearly shows a high level
of contrast between the normal and the diseased tissue. The rightmost image is a
multispectral image composed of two dierent spectral bands and demonstrates
better contrast than the central image which only uses one spectral band. This
shows the advantage of using multispectral imaging to dierentiate between
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and near infrared; there is good literature evidence that extension to longer
wavelength infrared will produce substantial further improvement.
Figure B.4: Multispectral images taken intraoperatively. Left: black and white visible
image. Centre: false colour image of tumour tissue using a single spectral band (blue
low probability of tumour, red high probability of tumour) tumour outline shown in
magenta. Right: false colour image using two spectral bands (multispectral).
To date, this work has enrolled 13 patients in the tumour study. One of the
image sets had to be discarded due to a technical failure. About half of the
remaining patients were undergoing surgery for a tumour. Using multispectral
imaging, abnormal tumour tissue was identied in most cases (sensitivity 83% -
rising to 100% in later patients due to developmental improvements, compared
to 50% with single spectrum analysis). It was our impression that multispectral
imaging also improved the extent of tumour identied (see Fig. 3) but we require
a microscope integrated head-up display on our navigation system to combine
the MRI tumour margin with the visible image to accurately quantify this. The
specicity of our multispectral imaging was 100% as no tumour spectra were
identied in patients undergoing non-tumour surgery.
Another problem that the iMSI project will address is the lack of intraoperative
functional imaging. The current techniques for establishing function during
surgery (somatosensory evoked potentials and electrocortical stimulation) are
slow, low resolution point measurement techniques. The preoperative techniques,
functional MRI and PET, take a considerable amount of time and may involve
injection of radionuclides. The iMSI system hopes to identify functionally useful
areas of the brain using the same Blood Oxygen Level Dependant (BOLD) signal
used by fMRI. This signal can be accessed optically at higher resolution than
fMRI and intraoperatively across the operating eld in near real-time. The iMSI
system developed is sensitive to this signal. Figure 5 shows a part of the
temporal cortex, the region labelled 1 was found to be associated with speech by
electrocortical stimulation, region 2 was tumour. The image on the right hand
side of Figure 5 highlights the BOLD signal. It is clear that the eloquent region
shows a strong signal, however the tumour region also has a high response
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demonstrates the potential for an intraoperative functional capability with this
technique.
Figure B.5: Intraoperative functional images taken with the iMSI system. Left: black
and white visible image showing region 1 and 2. Right: output of iMSI system.
The BOLD image is collected as a series of images; a representation of this series
can be seen in Figure B.6. This shows the signal from a single point through
time, the red bars at the bottom indicate a period of stimulation (in this case the
patient was asked to read words from a card), the blue bars indicate periods of
rest. It can be clearly seen that there is an increased signal during the periods of
stimulation; this correlated well with the electrocortical stimulation results.
Figure B.6: Demonstrating the BOLD signal of a single point through time.
To date, 3 patients have been enrolled in the intraoperative functional imaging
study and a sensitivity and selectivity of 100% has been demonstrated. This
work will soon be presented at the OSA Frontiers in Optics Conference.
Normal cortex and white matter are highly organised structures at a microscopic
level. We therefore expect that light at some wavelengths will be polarised which
may allow dierentiation between nerve bre tracts in the brain, which could
signicantly improve the safety of resective surgery which can also result in
decit by severing critical connections between cortical areas of function. This
structure is also lost in tumours and could produce more information aboutAppendix B Intraoperative Multispectral Imaging of Brain Tumours (iMSI) 134
tumour margins deep in white matter. The iMSI camera will incorporate
polarisers to investigate this possibility.
Figure B.7: An Example neurosurgical microscope, the red box indicated by the
arrow is indicative of the size of the nished iMSI system.
It is standard practice during neurosurgery to use an operating microscope
similar to that shown in gure B.7. These microscopes can be integrated with a
guidance system (IGS) which projects the tumour outline generated from
preoperative imaging data straight onto the surgical eld. This is a valuable
addition to the microscope but as noted earlier this preoperative data loses
registration as the surgery progresses; having a system that can integrate with
the current technology and provide real-time information about the tumour
boundaries would be a signicant improvement. The completed system may be
no larger than the red box shown in Figure 7. The size is dependant on the
number of bands required for accurate delineation but this will be comparable to
the size illustrated (and certainly be available as a microscope attachment). If
mid and long wave infrared technology is used in the 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increase the size somewhat, however it could still be integrated with the
microscope head.
The complete system will operate as pictured in Figure B.9. The software could
completely integrate with current guidance systems which present preoperative
data allowing seamless switch over between preoperative and intraoperative
imaging.
Figure B.8: Microscope head showing a number of dierent views. A: the tumour
boundary highlighted in red-blue, bold highlighted in cyan, B: outline based on preop-
erative data, C: operates as a normal microscope.
Cost Benets:
Complete resections (MRI guided) are associated with an age-adjusted ve-fold
reduction in mortality risk over a ve-year period for low-grade gliomas . This
has obvious potential direct patient benets with both reduced postoperative
decits and signicantly improved disease free survival times, especially with
low-grade gliomas. However, iMSI is likely to be more cost-eective (commercial
system likely to cost approx $50k) than intraoperative MRI ($1 million per
installation) and will certainly be easier and more user-friendly in theatre. In
addition, iMSI may well be applicable to other areas of tumour surgery outside
of neurosurgery. Healthcare providers will also accrue both immediate direct cost
savings in reduced hospital stay from less decits as well as longer term savings
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Novelty of the proposed work: The main novelty of this proposal lies in
the multispectral analysis across the visible to infrared spectrum to provide a
high-resolution image of tumour probability and functional cortex in the
operative eld. This has been made possible by the recent development of
high-resolution infrared camera technology as well as the emerging utility of
multispectral analysis for useful information extraction.
The infrared spectra of frozen sections of brain tumour tissue sections has shown
signicant dierentiation of tumour grade and tumour tissue from normal brain
but the lack of high resolution infrared imaging has prevented the processing of
these data into an operative image to delineate tumour.
Multispectral analysis by combining, e.g. electronic transitions from the visible
spectrum, with water content from the near-infrared and protein and lipid
content from the mid and longwave infrared spectra will signicantly enhance
the detection of abnormal tumour tissue and in combination with BOLD imaging
will simultaneously detect eloquent cortex to guide safe surgical resection.
Multispectral analysis will also provide information on many other indices of
tissue structure and content such as cell density and DNA/RNA ratios which
may also be useful. Multispectral imaging has not been applied to tumour
imaging, but has shown value in defence and satellite imagery.
We will perform this visible and infrared imaging at high resolution across the
whole operating eld to generate a real time picture. These images will be
generated from combinations of spectra across the complete visible/infrared
range to maximise diagnostic accuracy. Because of our unique development of a
multispectral tumour imaging system, we will also be able to incorporate
simultaneous BOLD imaging of functional brain tissue in awake patients. This
combination of simultaneous structural and functional imaging has not
previously been achieved.
The development of an iMSI device will thus be a fundamental paradigm shift /
advance in intraoperative brain tumour imaging.
B.4 Research plan and methodology
We have ethics approval for this project REC 06/Q1704/139.
Based on our outcomes, our research plan is as follows:
1. Identication of combinations of visible/infrared spectra that
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Initially, published infrared spectra of gliomas will be used to choose pilot
bands and appropriate lters will be constructed for high-resolution
infrared imaging. We will also perform a complete visible and infrared
spectral analysis on fresh frozen tumour tissue to conrm literature results
and extend the analysis into other tumour types that have not been
previously reported. Control spectra of normal cortex will be performed on
normal tissue excised during non|tumour epilepsy surgery performed by
Prof Gray (REC 07/H0504/195).
2. Construction of a multispectral camera system sensitive to these
spectral features.
Filters will be selected based on section 1. Where available, these lters will
be purchased commercially (COTS). However these o-the-shelf lters do
not cover the complete infrared spectrum and where unavailable we will
have to construct these specically which is a costly process. We are
providing two high-resolution infrared cameras worth ($50k each) for this
project however these will need to be built into a camera system. This
system will include coaxial optics for all of the imagers and the selected
lters and polarisers. The construction of a camera system is complicated
by `normal' glass being opaque in the mid and long wave infrared, so more
exotic materials must be used (e.g. Calcium Fluoride or Germanium); this
signicantly increases the cost of optics in this region.
3. Demonstrate a high correlation between preoperative imaging,
histopathology and the iMSI system.
Over 100 craniotomies per year for intrinsic supratentorial tumours are
performed by Prof Gray and colleagues at the Wessex Neurological Centre.
Of these approximately 40% are performed under awake conditions. The
prototype iMSI system developed to date has been successfully used in 13
cases and will be extended to image the infrared. The iMSI camera is
mounted on a separate microscope stand. Currently we do not have
microscope integration of the Stealth image guided system and cannot
obtain through-the-microscope photographs of the operative eld with the
tumour outline projected onto it. Purchase of the Stealth heads up
microscope display will generate these images, providing co-registration
with the iMSI camera visible images, corrected for parallax errors. These
fused images will allow accurate comparison of the initial MRI generated
surface tumour boundaries (before shift) with the spectral characteristics of
the operative eld. Each point (pixel) in the operative eld will undergo an
acquisition across the complete spectral bands. Post processing of the
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density map of tumour tissue for individual and selected combinations of
spectra and the performance across patients and tumours will be quantied
and statistically analysed with respect to tumour extent (MRI), and type
(histopathology). This will be an iterative process with continuing
renement of the spectral combinations used to maximise the accurate
(sensitivity and specicity) identication of tumour tissue. Patients will
undergo MRI scanning within 72h of surgery to assess the presence and
location of residual tumour tissue in the operative bed. Neurological decit
and survival will be recorded in all patients as linked-anonymised data.
4. Demonstrate a correlation between existing techniques such as
5-ALA and the iMSI system.
For high-grade gliomas, patients will be given 5-ALA orally three hours
before surgery and tumour tissue visualised using uorescent visualisation
using the iMSI system and a uorescent light source. Porphyrin
uorescence will be imaged with the iMSI camera and compared to the
spectral emissions as above, at set points during and at the end of resection,
to see how the iMSI system performs for identifying high-grade gliomas
tissue. All patients will undergo MRI scanning within 72h of surgery to
assess the presence and location of residual tumour tissue in the operative
bed. 5-ALA is not suitable for Grade 3 gliomas, nor for low grade gliomas
where multispectral imaging may perform well because of its sampling of
dierent aspects of the tumour across multiple spectra (see above).
5. Correlate functional imaging with intraoperative corticography.
In cases undergoing awake craniotomy and intraoperative mapping of
cortical function, both in epilepsy surgery and tumour surgery cases,
identied areas of critical function (using an Ojemann bipolar cortical
stimulator) will be marked using a visible light image from the iMSI system
and compared with the multispectral information collected.
We expect to recruit at least 100 patients to the study over three years from a
total operative population of 300 patients for that period.
The Gantt chart in Figure B.9 shows how we plan to progress the project and
sequentially add more infrared and multispectral capability with continuous
collection and analysis of the data across all spectral bands. It also shows regular
periods of review and reporting. The functional imaging and visible spectra will
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Figure B.9: Gantt chart showing project progression.
B.5 Dissemination, implementation, route to market
Any intellectual property developed will reside within the University of
Southampton which will commercially exploit this technology by seeking
industrial partners principally among existing manufacturers of surgical
microscopes (for example Zeiss and Leica). Information that may be benecial to
the wider scientic community (but which will not prejudice the commercial
position) will be submitted to relevant journals (such as Neurosurgery, British
Journal of Neurosurgery, Lancet Neurology, Journal of Biomedical Optics) and
presented at appropriate conferences (e.g. the European Conference of
Biomedical Optics, BIOMED, and Medical Imaging).
B.6 Consumer involvement
Neurosurgeons would be the primary users. They require means of providing
safer and more accurate surgery which multispectral imaging promises to
provide. Through providing safer and more accurate surgery, patients are likely
to experience fewer complications (such as paralysis and speech decits) as well
as reducing their postoperative recovery and tumour recurrence. This will reduce
the burden on carers and costs to the NHS.
The Primary investigator on this project is a neurosurgeon with 10 years
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with other neurosurgeons in Southampton General Hospital. Once proof of
concept has been established we will apply to i4i for development of a clinical
device and will involve a user group of surgeons from the Society of British
Neurological Surgeons and patient groups with brain tumours.
B.7 Skills of research team
The main outcome of this project is to provide sucient information to enable
the commercial development of a system which can identify eloquent areas of
cortex and provide information about resection margin. We believe the team,
combining practising neurosurgeons with an experienced engineering focussed
optoelectronics group is exceptionally well placed to target a practical outcome.
Professor William Gray obtained an honours medical degree from University
College Cork, Ireland in 1986, Fellowship of the Royal College of Surgeons in
1990, MD by thesis in 1993 and his Fellowship in Surgical Neurology in 1995. He
was appointed Senior Lecturer in Neurosurgery in 1998 after completing two
years of stem cell research at post-doctoral level. He was appointed to the
University Chair of Neurosurgery at Southampton in January 2006. He
established a functional epilepsy surgery programme in Southampton in 2000
using awake craniotomy and cortical mapping to guide excision of tumours and
cortical lesions causing drug refractory epilepsy. His research interests are in
cerebral physiology, Health Technology Assessment in Neuroscience and Adult
neural stem cell biology. He has had a number of research grants with the
Research Councils and Industry. He is Secretary of the UK Chapter of the
International League Against Epilepsy (ILAE) and is Chairman of the Academic
Committee of the Society of British Neurological Surgeons (SBNS).
Professor Harvey Rutt took a rst class honours degree in Electronics Science at
the University of Southampton in 1968, followed by a PhD in Optoelectronics in
1971. After spending three years in Brazil setting up a laser research group in a
federal University, he returned to join the UKAEA Culham Laboratory,
eventually becoming Division Head of Beam Science & Technology, with some 75
sta. Technical interests included novel lasers, high power lasers, and high
brightness ion beams. Since 1992 he has been the Rank Professor of Infrared
Science and Technology, with wide ranging interests in infrared materials, lasers
and instrumentation. He was Deputy Director of the Optoelectronics Research
Centre, University of Southampton for nine year from 1998, prior to becoming
Head of School for the University`s School of Electronics and Computer Science
in 2007. Prof Rutt has experience of exploitation of IP resulting from UniversityAppendix B Intraoperative Multispectral Imaging of Brain Tumours (iMSI) 141
research via Directorships of University spin-out companies and licensing
negotiations.
B.8 Costs
We are able to provide well-equipped facilities for this research, including a wide
background of the infrared equipment needed; including e.g. FTIR microscope
facilities costing in excess of $100k. No large equipment items are included in
our costings, and we will provide two high specication infrared cameras for the
prototype work.
Please see attached detailed Costings with ination in Appendices.
B.8.1 Research and development costs
Justication:
The major costs are sta costs for the three-year appointment of Mr Hoy to
perform optics and spectral research. Mr Hoy has designed and built the current
system and is a named researcher on the ethics award.
The Consumable costs are necessary for the construction of the appropriate lter
sets. The Stealth Microscope interface is necessary to produce an image of the
operative eld with the MRI guided tumour outlines at the operating focal plane
for co-registration with the iMSI Camera images to measure the sensitivity and
specicity of the iMSI system for tumour detection.
B.8.2 Service support and treatment costs
There are no additional procedures or resources for this project above standard
clinical care for this proof of concept study. We are obtaining optical data during
surgery for later o-line analysis and image generation. The images obtained will
not be available to the operating surgeon and will not inuence patient care or
management decisions.
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CV and list of grants for Prof. Gray and Prof. Rutt.
Curriculum Vitae
Prof. William P. Gray
MB.B.Ch. B.A.O., M.D., F.R.C.S.I., F.R.C.S.(SN)
Division of Clinical Neurosciences,
School of Medicine, University of Southampton.
Room LD74, Level D, South Academic Block,
Southampton General Hospital, Southampton, SO16 6YD, England
Email: w.p.gray@soton.ac.uk
Tel: 02380 794271
Fax: 02380 794542
Qualications
M.B. B.Ch. B.A.O. (hons); M.D., F.R.C.S.I., F.R.C.S.(S.N.) GMC Reg: Full.
GMC, No. 4051787, 23rd August 1993.
Posts Held 2006 { present Professor of Neurosurgery, University of
Southampton
1998 { 2005 Senior Lecturer in Neurosurgery, University of Southampton
Resume
Professor William Gray obtained an honours medical degree from University
College Cork, Ireland in 1986, Fellowship of the Royal College of Surgeons in
1990, MD by thesis in 1993 and his Fellowship in Surgical Neurology in 1995. He
was appointed Senior Lecturer in Neurosurgery in 1998 after completing two
years of stem cell research at post-doctoral level. He was appointed to the
University Chair of Neurosurgery at Southampton in January 2006. He
established a functional epilepsy surgery programme in Southampton in 2000.
His research interests are in cerebral physiology, Health Technology Assessment
in Neuroscience and Adult neural stem cell biology. He has had a number of
research grants with the Research Councils and Industry. He is Secretary of the
UK Chapter of the International League Against Epilepsy (ILAE) and is
Chairman of the Academic Committee of the Society of British Neurological
Surgeons (SBNS). He has established a training programme in academic
Neurosurgery in Southampton (one of three nationally), obtaining a Walport
Clinical Lecturer, two Walport ACFs and three academic F2 training positions in
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Current research includes investigation of the eects of neuropeptides on adult
neural stem cells funded by the MRC, an analysis of cytokines and gene
expression in neural stem cells after brain injury funded by the MRC and
GlaxoSmithKline and characterisation of Adult Human Neural Stem Cells in 3D
culture (EPSRC). He has written a number of book chapters and reviews on
adult neural stem cells and brain Injury. His external collaborators include Prof.
Helen Scharfman, Columbia University, New York (BDNF and adult neural stem
cells), Prof. Herbert Herzog, Garvin Institute, Sydney, Australia (NPY receptor
knockout mice), Prof. Annette Beck-Sickinger, Univ Leipzig, Germany (NPY
receptor pharmacology), Prof. Christian Steinhauser, University of Bonn and
Prof. Frank Kircho, MPI, Gottingen (gial and neural stem cells) and Prof.
Claude Wasterlain, UCLA (Galanin and neurogenesis). He also has collaborative
industrial research links with the stem cell group at GlaxoSmithKline.
5 most recent Publications:
Watkins, A.J., Wilkins, A., Cunningham, C., Perry, V.H., Seet, M.J., Osmond,
C., Eckert, J.J., Torrens, C., Cagampang, F.R., Cleal, J., Gray, W.P., Hanson,
M.A. & Fleming, T.P. (2008) Low protein diet fed exclusively during mouse
oocyte maturation leads to behavioural and cardiovascular abnormalities in
ospring. The Journal of physiology, 586, 2231-2244.
Gray, W.P. (2008) Neuropeptide Y signalling on hippocampal stem cells in
health and disease. Molecular and cellular endocrinology; 288, p52-63.
Scharfman, H.E. & Gray, W.P. (2007) Relevance of seizure-induced neurogenesis
in animal models of epilepsy to the etiology of temporal lobe epilepsy. Epilepsia,
48 Suppl 2, 33-41.
Laskowski, A., Howell, O.W., Sosunov, A.A., McKhann, G. & Gray, W.P.
(2007) NPY mediates basal and seizure-induced proliferation in the subcallosal
zone. Neuroreport, 18, 1005-1008.
Howell, O.W., Silva, S., Scharfman, H.E., Sosunov, A.A., Zaben, M., Shatya, A.,
McKhann, G., 2nd, Herzog, H., Laskowski, A. & Gray, W.P. (2007)
Neuropeptide Y is important for basal and seizure-induced precursor cell
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Grants Prof W.P. Gray 2003- 2008 Research grants and contracts
Dates Award
Holder(s)
Funding Body Title Value
Jan 2004 {
June 2005
H.V. Wheal,
W.P. Gray,
L.E. Sund-
strom,
V. O'Connor
Epilepsy Research
Foundation
Studies on hip-
pocampal neurogen-
esis
$60,000
Oct 2004 {
Sept 2007
W.P. Gray FQMS PhD stu-
dentships x2
$150,000
Oct 2004 {
Sept 2007
W.P. Gray, V.
O'Connor
MRC Neuropeptide control
of adult hippocam-
pal stem cell prolifer-
ation
$236,000
Sept 2005 {
August 2008
C. James,
W.P. Gray
LSI PhD Studentship Seizure Prediction $30,000
Oct 2005 {
Sept 2008
W.P. Gray,
A.A. Chang
MRC CASE stu-
dentship
Regulation of neural
stem cell prolifera-
tion - analysis of cy-
tokines
$36,000
Oct 2006 {
Sept 2009
W.P. Gray,
E. Redhead
Epilepsy Research UK Role of altered neu-
rogenesis in spatial
memory dysfuntion
in chronic TLE
$60,000
Oct 2007 {
Sept 2010
W.P. Gray,
P. Newland,
G. Attard
Kerkut Trust Interneuron control
of stem cells
$36,000
Oct 2007 {
Sept 2009
N Hanley,
W.P. Gray,
D. Wilson
EPSRC Chameleon Spots -
3D culture of human
tissue and stem cells
$1,732,570
Oct 2008 {
Sept 2011
D Simpson,
R. Panerai,
W.P. Gray,
R. Allen,
A. Birch ,
J. Potter
EPSRC {
EP/G008787/1,
EP/G0101420/1
New methods for as-
sessing the control
of blood ow in the
brain
$400,000
$2.7 million
Summary Curriculum Vitae - Professor Harvey Nicholas Rutt FOSA,
FInstP, FIEE, SMIEEE.
Current Post, since 1st January 1992 Rank Professor of Infrared Science
and Technology, School of Electronics and Computer Science, University of
Southampton, Higheld, Southampton, SO17 1BJ. Tel. 023 8059 3814 Fax
023 8059 7442 Email h.rutt@ecs.soton.ac.uk Head of School,
Electronics and Computer Science, since 1st August 2007. The School has 119
academic sta, 130 research, 68 support, 268 post-graduate and over 900
undergraduate students. Turnover ~$27 million pa. ECS holds the maximum
possible 6* 'Research Assessment Rating' and maximum possible 'Teaching
Quality' rating, and came top in the recent Guardian league table of Universities
o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component, ~50%, of our new $55million clean room facility, and a member of
the senior management team, Senate etc.
Employment history 1975-1991 : UKAEA Culham Laboratory, Abingdon,
Oxon, OX14 3DB. 1971-1975 : Lecturer, Federal University of Rio Grande do
Sul, Porto Alegre, Brazil.
Education BSc First Class Honours, Zepler Prize, University of Southampton
1968. PhD `Proustite Parametric Oscillators' University of Southampton 1972.
Membership of learned societies, Directorships include Fellow of the
Optical Society of America
Fellow of the Institute of Physics
Fellow of the Institute of Electrical Engineering
Senior Member of the IEEE (USA)
Director, Photonics Innovations Limited from its origin in 1999. PIL is the
University vehicle for funding spin-out companies in the photonics eld.
Director, Stratophase Ltd, from 2003. Stratophase is a new University Photonics
spin-out company.
Director, ECS Partners Ltd.
Editor in Chief of the Elsevier journal Infrared Science and Technology since
approximately 2001, editor since approximately 1994.
Research Interests My research interests are principally in the generation,
manipulation, detection and uses of infrared radiation across the entire IR
spectrum from the near infrared to millimetre waves. This includes novel IR
sources and lasers, new IR transparent materials in bulk, thin lm and bre form,
and novel optical instruments. Applications have included ore analysis, medical
diagnostic instrumentation, down-hole oil well sensors, novel infrared modulators
for IR imagers, and methods of detecting the relative water content of surfaces
remotely. A recent theme is the development of infrared and `terahertz'
instrumentation for medical and biological applications. This includes imaging
for resection margin determination during neurosurgery, infrared measurements
of abnormal proteins in early Alzheimer's Disease, and fundamental studies of
protein folding. A `terahertz microscope' is also under development. A strongly
developing area of work is the use of multi-spectral imaging techniques to assist
surgeons in the operating theatre. Work is in progress on neurosurgery, breast
cancer surgery, and also for dermatological applications.
From 1992 to 2006, I was either Principle Investigator or co-investigator on
research grants totalling $7.75 million.
Teaching My primary responsibilities are in the direction of the ORC, ECS, and
in research. At post graduate level, I currently have 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supervised nine PhD students to completion. Although management and
research pressures now preclude undergraduate lecturing, in the recent past I
have taught Engineering Physics, and supervised undergraduate projects.
Summary of Publications etc. Over 80 papers in refereed academic journals
and 17 patents. More recent publications include:
Vargas-Rodriguez, E., Rutt, H., Rojas-Laguna, R. and Alvarado-Mendez, E.
(2008) Calibration of a gas sensor based on cross-correlation spectroscopy.
Journal of Optics A: Pure and Applied Optics . (In Press)
Hoy, P., Rutt, H., Gray, W. and Bulters, D. (2008) Optical Intraoperative
Measurement of Function in the Human Brain. In: Frontiers in Optics
(FiO)/Laser Science XXIV (LS) Conference 2008, 19-23 October 2008,
Rochester Riverside Convention Center, USA.
Kannath, A. and Rutt, H. (2007) Development of low cost instrumentation for
non-invasive detection of Helicobacter Pylori. In: Conference on Advanced
Biomedical & Clinial Diagnostic Systems, Jan 21-23 2007, San Jose.
Vargas-Rodriguez, E. and Rutt, H. N. (2007) An analytical method to nd the
optimal parameters for gas detectors based on correlation spectroscopy using a
Fabry-Perot interferometer. Applied Optics, 46 (21). pp. 4625-4632.
Rutt, H. N. (2007) The Partition Function of Large Biomolecules, and its
Relevance to Infrared and Terahertz Spectroscopy. In: IRMMW-THz 2007, The
Joint 32nd International Conference on Infrared & Millimetre Waves and 15th
International Conference on Terahertz Electronics, 2-7 September 2007, Cardi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Professor Harvey Nicholas Rutt Research grants and contracts
Dates Award Holder(s) Funding
Body
Title Value
1.9.2003 D.N. Payne,
R.W. Eason,
H.N. Rutt,
J.S. Wilkinson,
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D.J. Richardson
EPSRC Materials and Processes
for Microstructured
Photonic Devices
$653,446
1.4.2004 D.N. Payne,
R.W. Eason,
D. Hanna,
H.N. Rutt,
J.S. Wilkinson,
D.W. Hewak,
D.J. Richard-
son, P. Smith,
T.M. Monro
EPSRC Fabrication of Mi-
crostructured Glass
& Crystal Photonic
Materials & Devices
$2,801,404
16.1.2006 H.N. Rutt,
D.J. Richardson,
K. Frampton
EPSRC The Ultimate Soft Glass
Extrusion Machine
$79,482
2006 H. Perry,
H.N. Rutt, P. Hoy,
V. O'Connor,
C. Cunningham,
K. Hilton
CCLRC
SRS
Preliminary investiga-
tion of the detection of
early stage prion disease
in mouse brain sections
5 days use
of syn-
chrotron,
(Ref 46086
)
2008 H. Perry,
H.N. Rutt, P. Hoy,
V. O'Connor,
C. Cunningham,
K. Hilton
CCLRC
SRS
Preliminary investiga-
tion of the detection of
early stage prion disease
in mouse brain sections
5 days use
of syn-
chrotron
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